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This thesis ventures with the extracellular matrix protein (ECM) fibronectin (FN) as an 
interface protein in the interaction between cells and materials to design microenvironment 
for future use in tissue engineering. It is studied the FN adsorption and conformations, cell 
behaviour to different FN conformation, cell adhesion, reorganisation and remodelling of FN 
at the material interface, the role of growth factors (GF) and their interactions with 
components of the extracellular matrix (ECM), the immunology cell response, and the stem 
cell fate influenced by the extrinsic signals coming from the engineered microenvironments 
using ECM’s proteins.  
 
To investigate the FN response, in terms of adsorbed amount and conformation to different 
chemical properties of the material, model surfaces were used. Self assembled monolayers 
(SAMs) with different percentages of two different chemical groups were used: CH3 and 
OH. FN adsorption, initial cell adhesion and signalling (focal adhesions, integrin expression 
and phosphorylation of FAKs) is related with the reorganisation and secretion of FN and 
matrix degradation. It is shown that matrix degradation at the cell material interface depends 
on surface chemistry in metalloproteinase-dependent way. A direct relationship between FN 
activity at the cell-material interface and metalloproteinase 9 (MMP9) expression was found, 
being the product of a sequence of events that include integrin expression, focal adhesion 
formation, matrix reorganisation and focal adhesion kinase (FAK) phosphorylation. 
 
Two different materials with subtle variations in their chemical composition were employed 
as a drastically different FN conformation: from a globular conformation on PMA (poly 
(methyl acrylate)) to the formation of a well-interconnected FN network (similar to the FN 
physiological fibrillar network) triggered by PEA (poly (ethyl acrylate)). The formation of focal 
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adhesions (vinculin), FAK expression and phosphorylation, specific integrin binding, protein 
and gene expression for α5 and αv was studied, seeking to correlate cell adhesion with 
matrix degradation. It is demonstrated that the material-driven FN fibrillogenesis on PEA 
triggers proteolytic activity: MMP activity is higher as a compensatory mechanism to the 
inability of cells to reorganise this FN network. 
 
Looking into the role of protein–material interactions and stem cell fate, and with the 
knowledge on PEA, we engineer different synergistic microenvironments to direct cell and 
stem cell fate. FN has a growth factor (GF) binding domain on its molecule (FN III12-14) and 
has been demonstrated to produce a synergistic response when occurs at the same time 
the recognition of the cell binding domain (FN III9-10). It is demonstrated that this domain is 
available on the FN coated PEA, and exploiting these interactions between PEA, FN and 
GF, it is developed a microenvironment to control cell behaviour and tissue repair. It is 
studied the rhBMP-2 binding and presentation, the effect of rhBMP-2 presentation on MSC 
proliferation and differentiation. These systems allow not only enhanced activity of GF 
compared to soluble administration, but also reduce GF doses, improving safety and cost 
effectiveness. 
 
Finally, the immunological reaction of the microenvironment developed is studied using 
dendritic cells, beside the conformational structure of ECM protein importance in DC 
integrin-based activation it is studied, helping to establish the field of adhesion-based 
modulation of DC as a general mechanism that has previously not been defined. The 
microenvironment didn’t induce any maturation in DC, while different FN conformation 







En esta tesis se estudia la interacción de una protein de la matriz extracelular, fibronectina 
(FN) como interfase en la interacción entre células y materiales, para diseñar 
microambientes con el propósito de ser usados en el futuro en ingeniería tisular. Se estudia 
la adsorción y conformación de FN y la relación con el diferente comportamiento celular: la 
adhesión celular, la reorganización y remodelado de la FN en la interfase célula-material, 
el papel que juegan los factores de crecimiento y sus interacciones con los componentes 
de la matriz extracelular, la respuesta immunológica y el destino celular de células madre 
influenciadas por las señales extrínsecas provenientes de microambientes elaborados a 
partir de proteínas de la matriz extracelular. 
 
Con el objetivo de investigar la respuesta a la FN en términos de conformación y cantidad 
absorbida a diferentes propiedades químicas del material, se usaron materiales modelo: 
monocapas autoensambladas (self-assembled monolayers, SAMs). Las químicas 
estudiadas fueron CH3 and OH. La adsorption de FN, adhesion y señalización (adhesiones 
focales, expresión de interinas y fosforilación de quinasas de adhesiones focales (FAKs)) 
se estudiaron en relación a la reorganización y secreción de FN  y degradación de la matriz 
extracelular. Se demuestra que la degradación de la matriz extracelular en la interfase 
célula-material depende de la química de la superficie, a través de las metaloproteinasas. 
Se ha descubierto una relación directa entre la actividad de la FN que se encuentra en el 
material y la expresión de metaloproteinasa 9 (MMP9), a través de la expresión de 
integrinas, formación de adhesiones focales, reorganización de la matriz extracelular y 




En el siguiente capítulo se emplean materiales poliméricos con una sutil diferencia en la 
composición química, provocando una diferencia drástica en la conformación de la FN: se 
pasa de una conformación globular en PMA (polimetil acrilato) a una conformación en forma 
de red interconectada en PEA (polietil acrilato). Con el propósito de relacionar la adhesión 
celular con la degradación de la matriz extracelular, se estudia la formación de adhesiones 
focales (vinculina), la expresión y fosforilación de FAK, la unión específica de integrinas y 
la expresión de las integrinas α5 and αv. Se demuestra que la formación de una red de FN 
sobre PEA induce la actividad proteolítica: la actividad de las MMPs es mayor, actuando 
como mecanismo compensatorio a la incapacidad de reorganización de la red de FN. 
 
Haciendo uso de la conformación de la FN sobre PEA, se estudiaron las interacciones entre 
la proteína-material y el destino celular de células madres. La fibronectina posee un dominio 
de unión de factores de crecimiento (FN III12-14) y se ha demostrado que se produce una 
respuesta sinérgica cuando el reconocimiento ocurre junto con el dominio de unión celular 
(FN III9-10). En esta tesis se demuestra que el dominio de unión de factores de crecimiento 
está disponible en la conformación que adquiere sobre PEA y se diseñan microambientes 
para controlar el comportamiento celular y regeneración de tejido. Se estudia la unión y 
presentación de BMP-2 y su efecto en la diferenciación de células madre mesenquimales. 
Los microambientes desarrollados, ademas de mejorar la actividad de los factores de 
crecimiento comparado con la administración soluble, también reduce la cantidad de 
factores de crecimiento que se tendría que administrar, mejorando la seguridad y 
efectividad. 
 
Finalmente se estudió la reacción inmunológica a los microambientes desarrollados usando 
células dendríticas, estudiando además la influencia de la estructura de la conformación de 
las proteínas en la activación de las células dendríticas a través de las integrinas. Los 
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microambientes no indujeron ninguna maduración de células dendríticas, mientras que la 
conformación de la FN muestra controlar la morfología de las células dendríticas y su nivel 





En aquesta tesi s'estudia la interacció entre una proteïna de la matriu extracel.lular, 
fibronectina (FN) com interfase en la interaccio entre cèl·lules i materials, per a dissenyar 
microambients amb el propòsit d’utilitzar-se al futur en enginyeria tissular. S’estudia 
l'adsorció i conformació de la FN i la relació amb el diferent comportament cel·lular: l'adhesió 
cel·lular, la reorganització i remodelat de la FN a la interfase cèl·lula-material, el paper que 
juguen els factors de creixement i les seus interaccions amb els components de la matriu 
extracel·lular, la resposta immunològica i el destí cel·lular de cèl·lules mare influenciades 
pels senyals extrínseques provinents de microambients elaborats a partir de proteïnes de 
la matriu extracel·lular. 
 
Amb l’objectiu d’investigar la respostar a la FN en termes de conformació i quantitat 
absorbida a diferents propietats químiques del material, s’utilitzaren materials model: 
monocapes autoacoblades (self-assembled monolayers, SAMs). Les químiques estudiades 
van ser CH3 and OH. L’absorció de FN, adhesió i senyalització (adhesions focals, expressió 
d'integrines i fosforilació de quinases d'adhesions focals (FAKs)) es van estudiar en relació 
a al reorganització i secreció de la FN i degradació de la matriu extracel·lular. Es demostra 
que la degradació de la matriu extracelular en la interfase cèl·lula-material depèn de la 
química de la superficie, a través de les metal·loproteïnases. S’ha descobert una relació 
directa entra l’activitat de la FN que es troba en el material i l'expressió de metaloproteinasa 
9, a través de l'expressió d'integrines, formació d’adhesions focals, reorganització de la 
matriu extracel·lular i fosforilació de FAKs. 
 
Al següent capítol es fan servir materials polimèrics amb una subtil diferència en la 
composició química, provocant una diferència dràstica en la conformació de la FN: es passa 
d'una conformació globular en PMA (polimetil acrilat) a una conformació en forma de xarxa 
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interconnectada en PEA (polietil acrilat). Amb el propòsit de relacionar l'adhesió cel·lular 
amb la degradació de la matriu extracel·lular, s'estudia la formació d'adhesions focals 
(vinculina), l'expressió i fosforilació de FAK, la unió específica d'integrines i l'expressió de 
les integrines α5 and αv. Es demostra que la formació d'una xarxa de FN sobre PEA indueix 
l'activitat proteolítica: l'activitat de les MMPs és més gran, actuant com a mecanisme 
compensatori a la incapacitat de reorganització de la xarxa de FN. 
 
Fent ús de la conformació de la FN sobre PEA, es van estudiar les interaccions entre la 
proteïna-material i el destí cel·lular de cèl·lules mares. La fibronectina posseeix un domini 
d'unió de factors de creixement (FN III12-14) i s'ha demostrat que es produeix una resposta 
sinèrgica quan el reconeixement ocurreix juntament amb el domini d'unió cel·lular (FN III9-
10). En aquesta tesi es demostra que el domini d'unió de factors de creixement està 
disponible a la conformació que adquireix sobre PEA i es dissenyen microambients per 
controlar el comportament cel·lular i regeneració de teixit. S'estudia la unió i presentació de 
BMP-2 i el seu efecte en la diferenciació de cèl·lules mare mesenquimals. Els 
microambientes desenvolupats, a més de millorar l'activitat dels factors de creixement 
comparat amb l'administració soluble, també redueix la quantitat de factors de creixement 
que s'hauria d'administrar, millorant la seguretat i efectivitat. 
 
Finalment es va estudiar la reacció immunològica als microambients desenvolupats usant 
cèl·lules dendrítiques, estudiant a més la influència de l'estructura de la conformació de les 
proteïnes en l'activació de les cèl·lules dendrítiques a través de les integrines. Els 
microambients no van induir cap maduració de cèl·lules dendrítiques, mentre que la 
conformació de la FN mostra controlar la morfologia de les cèl·lules dendrítiques i el seu 
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ALP: Alkaline phosphatase activity 
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In regenerative medicine, engineering biomaterials involves a myriad of aspects to be 
considered for the successful interaction with cells and integration with living tissues (i.e., 
material properties, biological activity, cytotoxicity). There have been different technologies 
used to functionalism synthetic biomaterials and promote cell adhesion, cell growth and cell 
differentiation. One of the aspects most important ones has been the biological activity of a 
biomaterial, what can be translated to the cell-protein-material interaction. The organisation 
in a biomimetic way of the extracellular matrix (ECM) - a mesh of proteins that surround cells 
and constitute the scaffolding of a tissue - is the spotlight of tissue engineering strategies 
using functional materials instead of cell therapies.  
 
Biomaterial substrates are able to trigger the regeneration of a cell population making use 
of tissue engineering techniques. The first step of the regeneration process is cell adhesion 
and plays a fundamental role in subsequent cell differentiation, growth, viability and 
phenotype expression (Gumbiner, 1996). It is well established that cell adhesion on 
biomaterials is mediated by a layer of proteins previously adsorbed on the material surface, 
coming from either the physiological fluids in vivo or intentionally deposited in vitro, e.g., 
from (competitive) adsorption of serum proteins or even after chemical attachment to the 
substrate (Garcia, 2006; Griffith & Naughton, 2002; Grinnell, 1986; Sipe, 2002)] (Figure 1). 
 
Regenerative medicine aims at healing damaged tissues and organs in a broad variety of 
diseases (musculoskeletal degeneration (e.g. osteoarthritis), cardiovascular problems (e.g. 
myocardial infarct), neurological disorders (e.g. Parkinson’s) (S.P. Liu et al., 2013; Tuan, 
 
24 
2013; Vono et al., 2012). In the adult human body, we can find adult stem cells in different 
locations as bone marrow and adipose tissues. As they can be isolated with relatively simple 
procedures, these cells are at the centre of the strategies. Stem cells have the potential to 
differentiate into a variety of mature cells and generate a new tissue if the appropriate 
conditions are provided. To take advantage of this property are key the development of 
technologies to control stem cell differentiation in vitro, encapsulate and transplant stem 
cells and promote stem cell recruitment from surrounding tissues in vivo for the successful 
implementation of these novel therapeutical approaches. Engineering biomaterials has 
emerged as a powerful tool to control stem cell behaviour and repair damaged structures 




The main aim of biomaterials in regenerative medicine is to develop a natural or synthetic 
extracellular matrix to support cell growth, differentiation and production of a functional and 
natural ECM. This means that high design criteria have to be taken into account in the 
production of the cellular microenvironment with biomaterials. As synthetic biomaterials 
consist of inert structures, funtionalization with adhesive proteins and other active 
biomolecules (e.g. growth factors) has to take place to enhance the bioactivity of the system. 
By doing so, the biomaterial becomes recognised by cells, allowing cell adhesion and 
differentiation, to promote tissue regeneration (Garcia, 2005; Petrie et al., 2010; Petrie et 
al., 2008; Woolfson & Mahmoud, 2010). Besides that, cell adhesion involves different 
physico-chemcal phenomena (i.e., roughness, substratum hydrophobicity, etc.), in which 
biological molecules from the ECM proteins, cell membrane proteins and cytoskeleton 
proteins participate. All the molecules involved in cell adhesión further interact and start a 
specific signalling, promoting transcription factors and regulating gene expression. What 
happens after the initial adhesion, is key for the next steps into cell differentiation: cells 
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spread on the substrate and acquire a flattened morphology, developing the actin 
cytoskeleton that provides mechanical stability and transmits forces to the cell interior 
(Anselme, 2000; Boyan et al., 1996). The first cell-material interaction happens after the 
adsorption of proteins from the ECM, soluble matrix proteins found in the biological fluids, 
such as fibronectin (FN), vitronectin (VN) and fibrinogen (FG) (Grinnell, 1986). Upon longer 
contact with tissues many other ECM proteins, such as collagens and laminins, will also 
associate with the surfaces, influencing the cellular interaction. How cells recognise these 
matrix proteins is via a family of trans-membrane proteins called integrins, and their function 
is to provide links between the ECM and the actin cytoskeleton, triggering the formation of 
clusters and promoting the signalling through the cell (Hynes, 2002). Firstly, when integrins 
recognise their ligands, they cluster and develop an aggregate of different proteins called 
focal adhesions, being the actually anchor the cell to the substrate (Figure 1). Focal 
adhesions are supramolecular complexes that contain various structural proteins such as 
vinculin, talin, α-actinin, and signalling molecules, including FAK (Focal Adhesion Kinase), 
Src and paxilin, which attach the cells to the surface and trigger the subsequent cellular 
response (Figure 1) (Garcia, 2005; Geiger et al., 2001). Thus, the initial cell-material 
interaction is a complex multi-step process consisting of early events, such as adsorption of 
proteins, followed by cell adhesion and spreading; and late events, related to cell growth, 
differentiation, matrix deposition and cell functioning. All together are going to guide the cell 
fate and therefore, the implantation and success of the biomaterial. Measuring and 
quantification of some of these parameters leads to comprise the classical approach to 




Figure 1. Representation of the cell-protein material interaction and how the different properties can 
affect the cell behaviour. Magnification draws the main protein present in the focal adhesion. (Llopis-





In the human body, ECM proteins have a key role in three processes guiding cell fate: cell 
adhesion, morphology, and migration. They will be essential if there is tissue damage and it 
has to be repaired. In regenerative medicine, it has to be considered also the importance of 
the biomaterial in the system to be developed, with the nature of cell surface interactions 
contributing to survival growth, and differentiation. As previously mentioned, the interaction 
of cells with adsorbed proteins are mediated via integrins: cell membrane proteins that 
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recognise and bind a variety of cell-surface-associated and ECM-associated proteins. 
Integrins are formed by two different subunits, α and β, that in distinct combination bind 
specific ligands (Humphries et al., 2006). In vertebrates, it has been found at least 24 
integrins heterodimers, with 18 types of α-subunits and 8 types of β-subunits in various 
combinations. Some of the proteins that integrins are able to bind are FN, VN, collagen and 
laminin (LN). The most abundant integrins are α5β1 (main FN receptor) and α β3 (VN 
receptor). The best-known peptidic sequence for intregrin ligands is RGD (Arg-Gly-Asp). In 
FN, this site is located within the type III10 repeat (Figure 2). Another important site of FN is 
the synergy sequence PHSRN, within the type III9 repeat. This sequence promotes specific 
α5β1 integrin binding to FN, and raise α5β1 to the status of the main FN receptor (Geiger et 
al., 2001; Hynes, 1990; Mao & Schwarzbauer, 2005). The formation of the focal adhesion 
(cell adhesion complexes) consists of integrins clustered together with several cytoplasmatic 
proteins. Through these focal adhesion the intracellular signalling cascades are regulated 
and the cell fate is determined (including cell differentiation) (Figure 1). This sequential 
process consist of integrin binding to the ECM, clustering into focal adhesion with proteins 
such as talin, vinculin, and paxillin, together with signalling molecules like FAK (focal 
adhesion kinase), a nonreceptor protein tyrosine kinase which is activated in response to 
cell-matrix adhesion. Many other intracellular signalling proteins (involved in the 
transmission of signals received from the ECM by integrins and directed to the cell nucleus), 
such as FAK, bind to and associate with this integrin-adapter protein–cytoskeleton complex 
(Geiger et al., 2001). After focal adhesion formation, it starts the signalling cascades 
influenced by the extrinsic signals coming from the ECM; mechanical force and regulatory 
signals are transmitted triggering gene and protein expression changes and consequently 
determine cell fate. Namely, by engineering synthetic biomaterials, we have a powerful tool 




Matrix protein interaction with synthetics surfaces 
 
 
Role of surface properties on protein adsorption 
 
The most common proteins adsorbed on materials for cell adhesion are soluble matrix 
proteins found in the blood, such as FN, VN, and FG, coming from either the physiological 
fluids in vivo or culture medium in vitro. After adsorption, different properties are going to 
play an important role in the biofunctionality of a synthetic material. That´s why it is of 
supreme importance to understand the biological response to a substrate. The activity of a 
protein after adsorption on a synthetic material is measured by parameters such as 
concentration, distribution, and motility of the adsorbed protein layer. As mentioned before, 
cells mainly interact with these proteins via integrins, responding to cell-matrix adhesion, 
clustering into focal adhesion after interaction with the ECM proteins.  
 
Proteins are hence considered to be key factors in mediating the cell/material interactions 
and their status (amount, conformation and strength of interaction) on a material surface 
determines the biocompatibility of the system. The amount of proteins adsorbed and their 
conformation depend on the chemical groups of the substrate on which they adsorb, that 
determine the energetic and entropic interactions with proteins (Castner & Ratner, 2002). In 
addition to time-dependent compositional changes, those proteins that finally remain on the 
surface may undergo conformational and orientational rearrangements to increase the 
contact area with the substrate and minimise the interaction energy. Protein adsorption is 
also dependent of the protein concentration, as it increases on the surfaces, they may go 
through ordering transitions (Castner & Ratner, 2002; Garcia, 2006; Tsapikouni & Missirlis, 
2007). In tissue engineering, different model materials have been prepared to learn more 
about cell/material interactions, especially in what cell adhesion is concerned. One of the 
downside parts of these works is that they mainly concentrate on the effect of material 
properties on the biological activity of the substrate, only a few percentage investigate this 
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effect by addressing first protein adsorption and conformation on the material surface to 
correlate subsequently this phenomenon with cell behavior (Castner & Ratner, 2002). 
Extracellular proteins have present different cell adhesion domains, e.g. RGD domain. Upon 
adsorption, proteins might in fact expose different domains, eliciting specific interactions with 
cell receptors. Despite the belief that cell/protein/material interactions are critical to the 
engineering of new biomaterials, clear links between the material properties, the adsorbed 
protein layer and their influence on cells remain far from being understood; in particular, an 
analysis of the behaviour of surface associated matrix proteins is generally missing. 
 
Even if cells do not interact directly with the surface of synthetic materials, but it is mediated 
by ECM proteins previously adsorbed on the substrate’s surface, it is said that cells respond 
to three different kinds of surface parameters: chemical, topographical and mechanical 
(Dalby et al., 2014; Ghasemi-Mobarakeh et al., 2015; Rico et al., 2014). For example, the 
influence of surface chemistry on protein adsorption and cell adhesion has been addressed 
on surfaces with well controlled chemistry, in order to investigate the role of well-defined 
chemical groups, e.g., using self-assembly monolayers (SAMs) (Llopis-Hernandez et al., 
2011). In order to understand cell/protein/material interactions, it is fundamental to develop 
more powerful material-based tools in tissue engineering and regenerative medicine 
strategies. The design of material substrates with defined physical and chemical properties 
(chemistry, topography, stiffness, gradients) in three dimensional environments must lead 
in the near future to a greater understanding of the specific roles of protein adsorption and 
the effect of material properties on cell adhesion, cell differentiation, matrix reorganisation, 
deposition and degradation at the cell-material interface (Benoit et al., 2008; Dalby et al., 






Proteolytic remodelling at cell-materials interface 
 
Similar to the natural interactions of cells with the ECM, the cell-material interaction is a 
dynamic and complex bi-directional process (Griffith & Naughton, 2002; Sipe, 2002). From 
cues in the ECM, cells within tissues are constantly accepting information (Altankov & Groth, 
1994) and, at the same time are producing and remodelling their matrix (Avnur & Geiger, 
1981; Grinnell, 1986; Hynes, 2002). Protein remodelling at the cell-material interface is an 
important factor able to direct cell behaviour on biomaterials for regenerative medicine and 
tissue engineering. Cells tend to adhere and rearrange adsorbed ECM proteins on the 
material surface in a fibril-like pattern, presumably as an attempt to arrange their own matrix 
(Altankov & Groth, 1994; Grinnell, 1986; Pankov et al., 2000; Tzoneva et al., 2002). 
Afterwards, the ECM undergoes proteolytic degradation, which is a mechanism for the 
removal of the excess ECM usually approximated with remodelling. ECM remodelling is a 
dynamic process that consists of two opposite events: assembly and degradation. The 
proteolytic remodelling of matrix proteins at the biomaterials interface has only received 
attention in the last decade (Kenny et al., 2008; Page-McCaw et al., 2007; Wan et al., 2008; 
Yang et al., 2004).  
 
The main mechanism for ECM degradation and removal is the proteolytic cleavage of ECM 
components (Koblinski et al., 2000; Mohamed & Sloane, 2006). The major enzymes that 
degrade ECM are matrix metalloproteinases (MMPs), a family composed of 24 members of 
zinc dependent endopeptidases. They are involved in the degradation of ECM proteins 
together with adamalysin-related membrane proteinases that contain disintegrin and 
metalloproteinase domains (ADAMs or MDC), such as thrombin, tissue plasminogen 
activator (tPA), urokinase (uPA) and plasmin. MMPs can be secreted or anchored to the cell 
membrane by a transmembrane domain or bind directly to the uPA receptor (uPAR) and 
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integrin αvβ3 (Buck et al., 1992). The role of MMPs in both development and diseases has 
been extensively studied and reviewed (Page-McCaw et al., 2007) because it is tightly linked 
with the mechanisms for tumour invasion and metastasis (Mohamed & Sloane, 2006). Also, 
MMPs regulate cell behaviour through finely tuned and tightly controlled proteolytic 
processing of a large variety of signalling molecules that can also trigger beneficial effects 
in disease resolution (Rodriguez et al., 2010). 
 
Using model surfaces (mostly SAMs) it has been shown that the cellular activity to rearrange 
the adsorbed matrix proteins at the material interface is abundantly dependent on the 
surface properties of materials, such as wettability (Altankov et al., 1997), surface chemistry 
and charge (Pompe et al., 2005). This evidence raises the possibility that tissue compatibility 
of such materials may be connected with the allowance of cells to remodel surface 
associated proteins presumably as an attempt to form their own matrix. Much is known about 
the interactions between different ECM proteins, but surprisingly less is our knowledge about 
the ECM composition, organisation, and stability at the materials interface (Salmeron-
Sanchez & Altankov, 2010). 
 





Fibronectin is an extracellular protein encoded only by one gene. Its mRNA is 8 kb and can 
be alternatively spliced, having the possibility to express 20 different monomeric isoforms in 
human and up to 12 in mouse (Pankov, 2002). Fibronectin is always found in a dimeric form, 
considering the different isoforms, there is an even larger variety of FN isoforms, if it is 
factored in the possible combination between monomers. Each subunit of the FN molecule 
ranges in size from 230 to 270 kDa, depending on alternative splicing of the mRNA, and 
binds into dimers via two disulfide bonds at the C-terminus of the protein. The two main 
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forms of FN are cellular FN (cFN) and plasma FN (pFN). The latter is produced by 
hepatocytes and secreted into the blood, where it remains in a soluble form in order to avoid 
fibrillar formation (see next section), leading to severe diseases (White & Muro, 2011). FN 
dimerization depends on covalent association of the subunits mediated by a pair of disulfide 
bonds at the C-terminus of the FN molecule (Figure 2). Studies with recombinant monomeric 
FN lacking these cysteines ablated dimerization. The resulting monomeric FN was secreted 
but did not form fibrils (Schwarzbauer, 1991). Other results indicate that the dimer structure 
is involved in matrix incorporation even in the absence of cell binding (Singh et al., 2010). 
 
When analysed into pieces, it can be seen that FN is a multi domain protein (Figure 2). It 
has some domains that interact with other ECM proteins, such as collagen and other FN 
molecules, domains able to interact with glycosaminoglycans (GAGs), integrins, growth 
factors (GFs) and also pathogens such as bacteria (Martino & Hubbell, 2010; Martino et al., 
2011). Having such a wide combination of domains allows the simultaneous binding of FN 
to cells and other molecules. When broken down these domains, it can be seen that there 
are three types of repeating modules, types I, II and III (Figure 2). There are 12 type I 
modules, 2 type II modules and 15-17 type III modules (15 constitutively expressed and 2 
alternatively spliced). The type II units and I contain two intramodular disulfide bonds to 
stabilise the folded structure, while type III units lack this kind of bridges. Both type I and II 
protein modules are structured in β-sheets enclosing a hydrophobic core containing highly 




Figure 2 Fibronectin structure. Fibronectin is a dimeric molecule formed by three different types of domains 
(I (blue cube), II (red barrel) and III (green sphere)). The most important regions are represented with purple 
or pinky shadows: main domains involved in the FN-FN interactions for matrix assembling (I1-5 and III1-2), 
cell binding domains (III9-10) and growth factor binding domain (III12-14). At the C-terminus there is a pair of 
disulfide bounds resulting in the FN dimerisation. (Llopis-Hernandez et al., 2015) 
 
 
Natural fibronectin matrices (fibronectin fibrillogenesis) and regulation 
of matrix assembly 
 
 
FN matrix assembly is a cell-dependent process and is mediated by the binding of FN dimers 
to integrin receptors. Integrins act as transducers between FN present in the ECM and the 
actin cytoskeleton and other cytoskeletal-associated proteins. It is important to remark that 
this linkage is key for matrix assembly. Thus, FN-integrin binding promotes FN-FN 
association and fibril formation. For example, in the human body, in case of a vascular injury 
or wound, integrins are shifted to their active conformation by a platelet-mediated 
mechanism, and pFN can bind and assemble into fibrils that are required for thrombus 
growth and stability (Cho & Mosher, 2006; Ni et al., 2003). 
 
The essential domains for FN assembly are: FN dimerization, the N-terminal type I repeats 
1-5, the 70-kDa fragment, the conserved sequence RGD and the synergy site (PHSRN). 
The N-terminal assembly domain is composed by the first five repeats of type I units and 
also is part of the 70-kDa fragment. This domain acts as a nexus point binding FN molecules 
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to each other by non-covalent interactions (revealed by functional analyses using various 
mutant recombinant fragments). Therefore, FN fibril formation and consequently FN matrix 
assembly depends directly on the N-terminal assembly domain (Sottile et al., 1991). The 
70-kDa fragment extends from type I1 to I9 including the assembly and the collagen/gelatine 
binding domains. This fragment binds to cells in monolayer culture and, when added in 
excess, it blocks FN matrix assembly. Likewise, the assembly is blocked when antibodies 
to this region are used (McDonald et al., 1987; Sechler et al., 1998). The inhibitory effect of 
FN I1-9 has been attributed to the high affinity binding sites for FN, thus blocking FN-FN 
interactions required to align and crosslink FN molecules into fibrils. Within the 70-kDa 
fragment, the 40-kDa collagen/gelatine binding modules do not appear to play a direct role 
in the assembly. It seems that the binding activity resides only in type I1-5 portion of the 
molecule (the N-terminal assembly domain). 
There are other FN binding domains also involved in FN matrix assembly. For example, 
repeats III1-2 and III12-14 can bind FN. In addition, III1 can bind to III7, and III2-3 can 
interact with III12-14 (Mao & Schwarzbauer, 2005). All these domains can promote FN 
fibrillogenesis due to the property of binding FN, but they can also participate in 
intramolecular interactions that keep soluble FN in a compact form (Johnson et al., 1999). 
Additionally, some of them are priming domains, for example III1, III5, III8 and III10.  The 
cryptic nature of these sites may indicate that perhaps they participate in the formation of 
stable insoluble matrix as they are available only when the FN molecule unfolds (Mao & 
Schwarzbauer, 2005), but experiments performed using recombinant proteins lacking these 
sites, showed that they are not essential for FN fibril formation. The soluble FN can bind 
selectively to cell surface receptors. FN in solution has a compact conformation and does 
not form fibrils even at extremely high concentrations. This compact form is maintained by 
intramolecular interactions between III2-3 and III12-14 type modules (Johnson et al., 1999).  
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On the other hand, FN assembly is also a cell-mediated process that requires the binding of 
the primary FN receptor, α5β1 integrin to the Arg-Gly-Asp (RGD) sequence (located in the 
repeat III10) and the synergy sequence PHSRN (located in repeat III9) (Ruoslahti & Obrink, 
1996). These two domains are also all together named cell binding domain (Figure 2). 
Experiments using blocking antibodies directed against either the cell binding domain of FN 
or its α5β1 receptor have been shown to inhibit the formation of fibrils (Fogerty et al., 1990; 
McDonald et al., 1987). Conversely, the RGD sequence is required only during the initial 
steps of matrix assembly (Schwarzbauer, 1991; Sechler et al., 1997; Sechler et al., 1998). 
 
Regarding the integrins able to bind to FN, not only α5β1 integrin binds to RGD, but also 
several additional integrins can bind to this conserved motif of FN, including all members of 
the αv subfamily, α8β1, α9β1 and the platelet-specific αIIbβ3. Interestingly, in absence of α5β1 
integrin expression in cells or ablation of α5 integrin gene in mice, FN can still be assembled 
by the operation of other integrins, most notably the αv integrin subfamily (Wennerberg et 
al., 1996; C. Wu et al., 1995).  
 
Other domains of interest in the FN are the two heparin binding domains on I1-5 and III13-
15, both involved in the binding of proteoglycan cell surface receptors. A mechanism for the 
exposure of cryptic sites is the proteolysis process that occurs during extracellular matrix 
remodelling. An example of this is the case of α4β1 interaction with FN matrix induced by 
proteolysis (Singh et al., 2010). 
 
FN-integrin binding leads to signalling inside the cell: after the recognition, it induces  integrin 
clustering, which groups together cytoplasmic molecules such as FAK, Src Kinase, paxilin 
and others, promoting the formation of focal complexes. As a consequence, the 
polymerisation of the actin cytoskeleton and kinase cascades-mediated intracellular 
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signalling pathways is activated (Geiger et al., 2001). The cluster promoted by dimeric FN 
helps to organise FN into short fibrils. Subsequent, the contractility of the cytoskeleton 
contributes to FN fibril formation. This molecular process is controlled by Rho kinases, 
activated by Rho GTPases. Rho kinases are able to enhance cell contractility by inducing 
actin-myosin interactions and actin rearrangement into stress fibres (Hall, 2005). Rho 
activation also stimulates FN incorporation into a matrix (Yoneda et al., 2007). The stretching 
happening due to cell contractility ends up in a progressive extension of the FN molecule 
and the exposition of binding sites mentioned before, that would mediate lateral interactions 
between different FN molecules. Indeed, one FN characteristic that hasn't been mentioned 
is the intrinsic protein–disulfide isomerase activity in the C-terminal type I module I12. In 
account of this activity, intermolecular disulfide bonds between fibrils can be created 
(Langenbach & Sottile, 1999). Initial thin fibrils then grow in length and thickness as matrix 
matures and FN fibrils are converted in an insoluble form (Singh et al., 2010). To produce a 
stable matrix, continuous FN polymerisation is needed, a phenomenon that shows the tight 
relationship between FN polymerisation and turn-over, mediated by endocytosis of soluble 
FN (Shi & Sottile, 2008).  
 
To conclude, the dynamic interactions between FN, integrins and intracellular proteins are 
essential for FN matrix assembly and its regulation. More in detail, there are specific 
signalling pathways that are crucial for the initiation and maintenance of the matrix 
assembly. For example, FAK, mentioned before as being important during the integrin 
clustering, has a key role in integrin signalling and binding to β1 integrin, being able to reduce 









Artificial fibronectin matrices 
 
As demonstrated before, FN is a core component of the ECM, whose organisation into 
fibrillar networks is driven by cells through an integrin-mediated process (Mao & 
Schwarzbauer, 2005). In the human body has been demonstrated that during tissue repair, 
FN promotes cell processes that are critical to tissue regeneration and regulates the 
deposition and organisation of other ECM proteins. That’s to say, the development of 
biologically active FN networks through cell-free routes is of special interest to 
bioengineering interest. Being able to develop synthetic FN networks would enhance the 
bioactivity of biomaterials. Indeed, the use of bio-inspired new coating materials promoting 
cells to adhere and that stimulate cells to produce new, native ECMs would in turn promote 
cell functions crucial for tissue regeneration and homeostasis (Cai & Heilshorn, 2014). 
 
The challenge to create new synthetic materials able to serve as biologically active materials 
supporting the key aspects of tissue regeneration (re-establishment of a functional ECM 
included) has been driving multidisciplinary efforts. The identification of cell-free routes that 
allow the development of engineered biomimetic structures with similar characteristics when 
compared with the natural ECM it is needed (Cai & Heilshorn, 2014). In fact, when looking 
within tissues as mentioned, cells are surrounded by fibrillar matrices that support and 
regulate interactions, direct cell fate and determine tissue repair.  
 
Cells interact with synthetic material surfaces via the previously deposited layer of FN. The 
sequence of events would be the following: FN is a macromolecule that displays a globular 
conformation in solution; upon adsorption on a particular surface chemistry, interactions 
between the chemical groups of the surface and the FN domains triggers changes in the 
conformation of the protein that might lead to complete unfolding and exposure of groups 
that were hidden in solution. Consequently, the effect of the material surface chemistry is 
 
38 
indirectly received by cells via the adsorbed layer of FN. Nevertheless, to reconstitute the 
network structure and bioactivity of FN fibrillar matrices with material-based approaches is 
a challenge in the field where significant efforts have been made.  
 
These routes are based on the assumption that unfolding of soluble FN dimers from their 
globular conformation is needed for FN-FN interactions to occur, leading eventually to FN 
polymerization and fibril formation. To promote FN fibril assembly the use of unfolding or 
denaturing agents and the application of forces are needed, denoting that changes in the 
structure of FN are required to drive its assembly into fibers. Methods used in literature 
include the addition of reducing (Sakai et al., 1994; Williams et al., 1983) or oxidizing (Vartio, 
1986) agents to the protein solution. Other methods use denaturing (Chen et al., 1997; 
Mosher, 1987; Mosher & Johnson, 1983; Peters et al., 1998), cationic (Vuento et al., 1980; 
Vuento et al., 1980) or anionic (Jilek & Hörmann, 1979) compounds; force-based assembly, 
via application of mechanical tension (Baneyx & Vogel, 1999; Kaiser & Spatz, 2010; Ulmer 
et al., 2008; Volberg et al., 2010; Zhong et al., 1998) or shear forces (Ahmed & Brown, 1999; 
Ahmed et al., 1999; Little et al., 2008; Underwood et al., 2001) and the use of peptidic FN 
fragments (Briknarova et al., 2003; Hocking et al., 1996; Morla et al., 1994). One last 
approach is the surface-initiated assembly (Feinberg & Parker, 2010; Nelea & Kaartinen, 
2010; Pellenc et al., 2006; Pernodet et al., 2003; Salmeron-Sanchez et al., 2011). M 
Salmeron-Sanchez group has previously shown that individual FN molecules adsorption 
onto particular surface chemistries induces exposure of self-assembly sites, driving FN fibril 
assembly, and poly(ethyl acrylate) (PEA) was identified as a potential surface chemistry 
suitable for this purpose (Brizuela Guerra et al., 2010; Gonzalez-Garcia et al., 2010; 
Gugutkov et al., 2009; Rico et al., 2009).  The FN adsorption on PEA, or what has been 
called material-driven assembly of FN, upon simple adsorption, occurs in a physiological-
like way. The 70-kDa amino-terminal regions are identified essential for cell-mediated FN 
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assembly, and within this region, the I1-5 repeats confer FN-FN binding activity (Mao & 
Schwarzbauer, 2005; Schwarzbauer, 1991). This domain is not available in the folded, is 
mandatory compact structure of FN in solution and a conformational change of the molecule 
is needed for physiological matrix assembly to occur (Mao & Schwarzbauer, 2005; 
Schwarzbauer, 1991). Material-driven fibrillogenesis absolutely requires the 70-kDa amino-
terminal region of FN. It has been previously shown the biological activity of this material-
driven FN network, in terms of cell adhesion, signalling, cytoskeleton organisation, matrix 
reorganisation and cell differentiation (Brizuela Guerra et al., 2010; Gonzalez-Garcia et al., 
2010; Gugutkov et al., 2009; Rico et al., 2009). Therefore, this material was used to address 
the link between material-driven FN assembly and matrix protein remodelling (degradation) 
at the cell-material interface, which it is hypothesised must be related to integrin-mediated 
adhesion through the conformation of the adsorbed protein. To compare with a globular 
conformation, another similar chemistry: poly(methyl acrylate) (PMA) was investigated, 
which differs in one single carbon in the side chain (Figure 34) (Manuel Salmeron-Sanchez 
et al., 2011). 
 
Growth factors in tissue repair 
 
The ECM acts as a reservoir of signalling molecules, both adhesion molecules and growth 
factors (GFs). Using these two elements, the ECM provides the instructions for cell decision 
processes. GFs are soluble and bound to ECM components, such as heparan sulfate 
proteoglyans and FN (Lindahl & Li, 2009; Wijelath et al., 2006). In both forms they are active 
and when bound to cell-surface receptors they trigger specific signalling inside the cell 
(Makarenkova et al., 2009). A classic example of the GF-ECM interaction is binding of GFs 
to the proteoglycan components of the ECM (Capila & Linhardt, 2002). The GF-
proteoglycans binding can create very strong bindings (measured in Kd, dissociation 
constant), varying from 1 to 100 nM. A few examples are basic fibroblast growth factor (FGF-
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2), vascular endothelial growth factor (VEGF), and transforming growth factor beta (TGF)-1 
(Maciag et al., 1984; McCaffrey et al., 1992; Nugent & Edelman, 1992). On the other hand, 
ECM proteins, such as fibrin and vitronectin have been shown to bind GFs including FGF-2 
(Peng et al., 2004; Sahni et al., 1998), insulin-like growth factor (IGF)-II (Kricker et al., 2003; 
Noble et al., 2003), TGF-1 (Schoppet et al., 2002), and hepatocyte growth factor (HGF) 
(Rahman et al., 2005). For instance, in the case of fibrin, FGF-2 is able to provide GF-
specific bioactivities such as potentiation of endothelial cell proliferation, even when bound 
to fibrin (Sahni et al., 2006). Recently it has been shown that GFs also have strong 
interactions with nonproteoglycan extracellular matrix proteins. The FN is able to bind a wide 
range of growth factors very strongly (Martino & Hubbell, 2010). The 12th–14th type three 
repeats of FN (FN III12–14) have been shown to bind insulin-like growth factor binding-
protein-3, FGF-2, and VEGF-A with high affinity (Martino & Hubbell, 2010). 
 
 
Delivery systems of growth factors 
 
 
In regenerative medicine the importance of the GFs is known but the currently used methods 
to deliver GFs to enhance tissue healing, maintaining their activity, have led to poor clinical 
impact. There is an extensive range of strategies employed to control the delivery of GF by 
hydrogels, among which, direct loading, electrostatic interaction, covalent binding, and the 
use of carriers have been the main approaches used (Makarenkova et al., 2009). A wide 
number of synthetic polymers have been shown to be useful implantable hydrogel materials 
(Lutolf & Hubbell, 2005; Zisch et al., 2003). One examples is polyethylene glycol diacrylate 
(PEGDA) providing several advantages for regenerative therapeutics such as incorporation 
of protease-degradable sites, adhesive ligands, and growth factors (Hahn et al., 2006;  Hahn 
et al., 2006; Lutolf & Hubbell, 2005; Moon et al., 2009; Moon et al., 2007). PEGDA-based 
bioartificial matrices have been shown to promote cell survival and endothelial tube 
formation in vitro (Moon et al., 2007). On another hand, protein engineering has been also 
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incorporated in the design of hydrogels to include bioactive features, as for example matrix 
metalloproteinase (MMP)-degradable sites, adhesive ligands, and bone morphogenetic 
protein (BMP)-2. PEG-based matrices have been used to develop provascularization 
therapies to induce the growth of new vasculature into the implant in vivo containing a 
combination of protease-degradable sites, adhesive ligands, and VEGF (Phelps et al., 
2010). Other example is using PEG vinyl-sulfone based matrices (Vigen et al., 2014). These 
designs provide a double functionality serving as a delivery vehicles and temporary matrices 
that are going to support the initial tissue ingrowth and remodelling. Another approach was 
the functionalisation of fibrin matrices with GFs that can be cleared via cell-induced 
proteolysis by incorporating protease sensitive sequences that will be released via cell-
induced proteolysis (Ehrbar et al., 2004; Patterson & Hubbell, 2010). Two similar 
approaches are the use of hyaluronic acid derivatives functionalised with engineered 
recombinant fragments and collagen matrices with a GF fused to a collagen binding 
sequence derived (for example, if FN is used, the GF release is going to depend on the 
binding sequence affinity for collagen (Comoglio et al., 2003; Giancotti & Tarone, 2003)).  
 
The GFs interact with proteins and molecules found in the ECM, but the main interaction is 
with their respective GF receptors. The approaches in GFs delivery includes the interactions 
between GFs and ECM molecules, but they lack interaction with their receptors, leaving a 
crucial point outside the design. Integrins and GF receptors have the ability of forming 
clusters (Figure 3) (Yamada & Even-Ram, 2002), once they have recognised their targets 
simultaneous subsequent cell signalling is synergistically enhanced. For FN, this has been 
shown between α5β1 integrin and the GF receptors when FN III9-10 and FN III12-14 are 
proximally presented in the same polypeptide chain (Guo & Giancotti, 2004; Martino & 
Hubbell, 2010). These approaches give a synergistic response. That leads to an increased 





Figure 3 Activation of GF receptors Collaborative activation compared to the direct integrin activation of 
growth factor receptors. a) Transmembrane integrin and GF receptor are induced to cluster by a matrix protein 
b) Transmembrane integrin and abundant EGF (epidermal GF) receptor are clustered by an integrin ligand, 
forming relative transient complexes with several proteins such as Cas, MAPK and Crk, that are dependent 
on Src (tyrosine kinase). These complexes don´t recruit FAK, a difference with the activation in a. P in the 
figure indicates phosphorylation. (Yamada & Even-Ram, 2002)  
 
As mentioned previously, in in vitro and in vivo experiments it is still common to use GFs in 
solution either directly added to the culture media or released from a biomaterial carrier 
(Rice et al., 2013; Sacchi et al., 2014). This thus ignores that GFs in vivo are bound to the 
ECM, both to proteins and glycosaminoglcans (Hynes, 2009). Solid-phase presentation of 
GFs bound to a surface is more efficient compared to soluble administration, resulting in 
enhanced biological function with lower doses used (Briquez et al., 2015; Martino et al., 
2015; Mitchell et al., 2016). Cavalcanti-Adam showed that matrix immobilised BMP-2 
promoted cell migration and signalling compared to the soluble delivery of BMP-2 (Hauff et 
al., 2015). Some of the pioneering works on ‘solid-phase’ presentation of GFs used covalent 
tethering of GFs to surfaces (Kuhl & GriffithCima, 1996). However, exploiting the natural 
affinity of ECM components (GAGs and structural proteins) towards GFs has resulted in the 
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development of affinity-based release systems, to control release of therapeutics locally 
(Azevedo & Pashkuleva, 2015; Delplace et al., 2016). In addition, affinity-based systems 
allow engineering ‘solid-phase’ presentation of GFs that can be further internalized by cells 
after binding, as this is key to activate certain signaling pathways (Ehrlich, 2016). Seeking 
to engineer localised GFs reservoirs, Picart et al. showed that the well-known layer-by-layer 
(LbL) technique using polyelectrolytes was a powerful and versatile strategy to work as a 
delivery reservoir for BMP-2 (Silva et al., 2016). The key role of the interplay between GFs 
presentation and the physical properties of the synthetic matrix used as a vehicle for GFs 
presentation has been further demonstrated using self-assembling peptide amphiphiles 
(PA). In relation to the interplay between GFs delivery systems and cell adhesion, it has 
been shown that the soluble administration of GFs was more effective if cells were 
previously targeted for integrins to bind specifically to the GFs delivery system. These works 
further revealed the importance of both receptors in maximising GF effects. For example, 
Garcia et al. showed that protease-degradable hydrogels released controlled amounts of 
VEGF that were more effective in promoting vascularisation in a rat subcutaneous implant 
when the hydrogel had been functionalized with RGD molecules (Phelps et al., 2010). Sobel 
et al. used recombinant FN fragments to identify the heparin II binding region of fibronectin 
(FNIII12–14) as a VEGF binding site and reported that only bivalent FN constructs 
encompassing the integrin binding site and VEGF binding domains significantly promoted 
endothelial migration, proliferation and signaling (Wijelath et al., 2006). Building on this 
result, Martino et al. showed that FNIII12–14 was actually a highly promiscuous GF binding 
region able to sequester not only VEGF but also a large number of other GFs from different 







Bone Morphogenic Protein 2 
 
Homodimeric bone morphogenetic protein-2 (BMP-2) is a member of the TGF-β superfamily 
that induces bone formation and regeneration. During embryonic development, BMP-2 
determines important steps at early stages in both vertebrates and non-vertebrates 
(Clemens Scheufler). BMP-2 is part of the bone morphogenetic proteins group and is one 
of the main representatives been originally defined by their bone and cartilage-inductive 
activity at non skeletal sites in vivo  (Sampath & Reddi, 1981; Urist, 1965).  
 
When in its native form, BMP-2 is a homodimer and its subunits are related by a 2-fold axis 
(Scheufler et al., 1999). During their synthesis, the BMP factors suffer changes. In the 
particular case of the BMP-2, it is translated as a 396-amino-acid (pre)proprotein containing 
a 19-amino-acid signal sequence for targeted secretion, a 263-aminoacid pro-region, and a 
114-amino-acid mature segment. Within the mature region of BMP-2 seven cysteines and 
one N-linked glycosylation recognition site can be found for post-transcriptional 
modifications. The mature protein has a predicted mass of 14 kDa with an observed mass 
of 18 kDa, likely due to glycosylation (Scheufler et al., 1999). The functional protein exists 
as a homodimer that is linked by two disulfide bridges. In some special situations, 
heterodimeric complexes are formed, although in normal physiological settings homodimeric 
complexes among the BMPs are most common (Sampath et al., 1990; von Bubnoff & Cho, 
2001). The BMP GFs are a family quite preserve between species, with  considerable amino 
acid sequence similarity between them.  
 
BMP-2 is able to interact with two types of receptor chains, as well as with proteins of the 
ECM and several regulatory proteins. There are two types of BMP receptors (BMPRs).  BMP 
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signalling is started at the cell surface through interaction with these two distinct 
serine/threonine kinase receptors: a type I receptor (50–55 kDa, BMPR-I) and a type II 
receptor (heavier than 75 kDa, BMPR-II) (Figure 4) (Yamashita et al., 1996). BMPR-II 
receptor most probably is able to bind exclusively to BMPs, but others as the activin types 
IIA and IIB have affinities for specific BMPs (BMP-7, BMP-2 and GDF-5), in addition to their 
more common activin binding (Yamashita et al., 1996). BMPR-II has a weak binding by itself, 
but once it is bound dramatically increase in the binding affinity follow by a recruitment of 
the type I receptors. Specially BMP-2 ligand and receptor interactions have been carefully 
studied (Nickel et al., 2001).  BMP-2 protein contains two distinct domains that facilitate 
receptor interaction during BMP-2 receptor activation. The first named “wrist epitope” is a 
large high-affinity binding site, which interacts with the BMPR-IA. The second is a low-affinity 
binding site (termed the “knuckle epitope”), which interacts with BMPR-II. Through the 
juxtapositioning of these two regions the two receptors BMPR type II and type I can be in a 
close proximity and initiate the intracellular signalling via BMPR type II phosphorylation to 
type I. Next to the transphosphorylation Smad (mothers against decapentaplegic) proteins 
is activated and signal transmission to target downstream responsive genes initiated (Figure 





Figure 4 Bone morphogenetic protein signal transduction pathway. BMPs interact with specific receptors 
on the cell surface, referred to as bone morphogenetic protein receptors (BMPRs) (BMPRI and BMPRII). 
Signal transduction through BMPRs results in mobilization and phosphorylation (represented with a P) of 
members of the Smad family (Smad 1,5,8), going to the nucleus and starting the expression of   specific genes. 
(Yavropoulou & Yovos, 2007)  
 
 
Mesenchymal Stem Cells 
 
 
Adult stem cells, including mesenchymal (or skeletal) stem cells (MSCs) are defined as a 
multipotent population of self-renewing and slow growing cells with a low rate of metabolism 
within a defined tissue niche (Delorme et al., 2006; Minguell et al., 2001). In vitro, we can 
select MSCs by specific surface markers, for example STRO-1, ALCAM (activated leukocyte 
cell adhesion molecule, CD166), CD146 (melanoma cell adhesion molecule) and CD63 
(HOP-26), and their multipotency demonstrated in, for example, defined media with 
concomitant formation of cartilage, bone and fat (McMurray et al., 2011; Mirmalek-Sani et 
al., 2006). In vitro, can occur a loss of multi-lineage potential when grown on standard tissue 
culture plastics (Delorme et al., 2006; Minguell et al., 2001). A typical scenario is the rapid 
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diminution as spontaneous differentiation occurs, having as a result a heterogeneous MSCs 
population of a predominantly fibroblastic phenotype (Motaln et al., 2010). 
 
Immunological cell-protein-material interactions 
 
Growing use of biomaterials in targeted therapeutics, tissue constructs and implanted 
devices has generated increasing need to understand how biomaterials can influence 
immune responses. Understanding fundamental mechanisms of leukocyte and biomaterial 
interactions are important in this regard. It has been shown that adsorbed proteins on 
implanted biomaterials modulate inflammatory responses (Acharya et al., 2008). As said 
before (see ‘Matrix protein interaction with synthetics surfaces’) after implantation of the 
biomaterial, some ECM proteins spontaneously adsorb onto synthetic biomaterials 
(Anderson, et al., 2008; Chang et al., 2009) and can modulate leukocyte adhesion and 
inflammatory responses to implants (Anderson et al., 2008; Hunter et al., 1999; Jenney & 
Anderson, 2000; Keselowsky et al., 2007; Shen & Horbett, 2001; Tang & Eaton, 1993). The 
adaptive immune response to the new biomaterial can be altered by these inflammatory 




Dendritic cells (DCs) are a critical regulator of immunity (Figure 5) and therefore a particular 
interest is biomaterials directed modulation of them. DCs are central regulators of the 
immune system that operate in both innate and adaptive branches of immunity (Figure 5) 
(Steinman & Nussenzweig, 1980). The activation of DCs by numerous factors, such as 
danger signals, has been well established; however, modulation of DCs functions through 




In particular, eight of the twenty-four known integrins bind RGD peptide (Barczyk et al., 2010; 
Hynes, 2002), several of which are expressed by DCs, including the αv integrins (Ammon et 
al., 2000; Brown et al., 1997; Dubey et al., 1995; Maestroni & Mazzola, 2003; Puig-Kroger 
et al., 2000; Sung et al., 2006). The RGD integrin binding motif is present in several ECM 
proteins including FN and VN (Dickinson et al., 1994; Humphries et al., 2006), and is one of 
the motives that has been investigated with numerous cell types (Fittkau et al., 2005; Mann 
et al., 2001; Schaffner & Dard, 2003). However, the role that the specific DCs integrin 
binding plays in the modulation of DCs functions has only recently been explored (Acharya 
et al., 2008; Acharya et al., 2010). DCs adhesion to ECM proteins is of interest 
physiologically as DCs act as sentinels constantly patrolling the body and they reside for 
much of their lifetime in connective tissues comprised largely of ECM proteins in both 
lymphoid and non-lymphoid organs (Liu & Nussenzweig, 2010; Schmidt et al., 2012). This 
may influence immune responses in the wake of tissue transplantation. 
 
DCs present both self and non-self antigens to lymphocytes such as B-cells and T-cells 
(Fernandez et al., 1999; Lambrecht et al., 1998; Moser, 2004). Immature DC (iDC) 
mature/activate following interaction with pathogen associated molecular patterns or 
‘‘danger signals’’ (Matzinger, 2002; Medzhitov & Janeway, 1998), as well as self-molecules 
(e.g. uric acid) (Shi et al., 2003). DCs subsequently up-regulate antigen-presenting 
molecules, co-stimulatory molecules, cytokines and chemokine receptors. The latter 
mediate migration to secondary lymphoid tissues where they initiate adaptive immune 
responses and direct the development of T-cell responses. DCs are the principal antigen-
presenting cell involved in activation of naive T-cells, as they provide three required signals: 
antigen presented in the context of major histocompatibility (MHC) molecules, co-stimulatory 
molecules (e.g., CD80, CD86, CD83), cytokines (e.g., interleukin-12; IL-12) and other 
factors that direct T-cell functional development. Through these factors, DCs direct the 
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differentiation of T-cells into functional groups: interferon-g (IFN-g) producing effector T 





Figure 5 Stimulatory and regulatory DCs in health and disease. DCs are a plastic lineage able to process 
and integrate signals from the microenvironment. Under pro-inflammatory conditions stimulatory DCs promote 
an effective immuneresponse by stimulating T cell proliferation and shaping T cell responses toward TH1, TH2, 
or TH17 phenotypes. This crucial role allows the immune system to clear pathogens and keep transformed 
cells in check. Nevertheless, uncontrolled DC activation can lead to tolerance ablation, fostering the 
development of autoimmune diseases like rheumatoid arthritis. Under a tolerogenic environment DCs acquire 
regulatory functions suppressing T cell activation and proliferation and providing signals that enable Treg and 
Tr1 differentiation and expansion. This function maintains tolerance in organs like the gut which are exposed 
to a variety of harmless antigens. However, DC regulatory function can be exploited by tumors and pathogens 






Dendritic cells and biomaterials interaction 
 
It has been shown that DCs interactions with various biomaterials modulate DCs functions 
(Babensee, 2008; Jones, 2008) and that DCs express multiple integrins (Ammon et al., 
2000; Brown et al., 1997; Dalgaard et al., 2005; Dubey et al., 1995; Hamakawa et al., 2006; 
Lu et al., 1995; Sung et al., 2006), but there are surprisingly few investigations into the 
effects of integrin binding to ECM proteins on DCs maturation and only a few investigations 
have begun to elucidate the mechanisms involved into the modulation of DC functions 
(Acharya et al., 2009; Acharya et al., 2008; Acharya et al., 2011; Brand et al., 1998; Kohl et 
al., 2007; Shankar et al., 2010). DCs have been cultured on surfaces presenting a uniform 
gradient of the integrin targeting RGD peptide and demonstrate the utility of the surface 
density gradient platform as a high-throughput method to investigate RGD density-
dependent DCs adhesive responses (Acharya et al., 2010). Other recent study 
systematically characterised DCs responses to ECM adhesive substrates in vitro, 
demonstrating substrate-dependent DCs maturation and T-cell stimulatory capacity 
(Acharya et al., 2008; Acharya et al., 2011). Adhesive substrates elicit differential DCs 
maturation and adaptive immune responses (Acharya et al., 2008). 
 
The understanding of how DCs respond to the different protein-materials inputs will inform 















Chapter 2. Objectives  
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The aim of this work is to understand the influence of materials properties on fibronectin 
fibrillogenesis, seeking to comprehend the effect of fibronectin presentation on matrix 
remodeling, growth factor presentation and immunoresponse, with the perspective of 
exploting efficient ways of fibronectin presentation to develop microenvironments applicable 
to tissue engineering. 
 
Fibronectin (FN) is an extracellular matrix protein, which plays an important role in mediation 
of cell adhesion onto material substrates. In this work, it will be performed different studies 
where FN is used as interface protein, and evaluate the cell response after investigating the 
state of the adsorbed FN layer. The objectives of this work are: 
 
1. Investigate and characterise the role of material chemistry on fibronectin adsorption. 
 
2. Investigate the role of cell material chemistry and fibronectin conformation on cell 
response; by assessing cell adhesion, cell protein expression, matrix remodelling and 
matrix degradation. 
 
3. To develop a reliable high efficient growth factor presentation microenvironment using 
fibronectin and BMP-2. 
 
4. To investigate and characterise the cellular response of human mesenchymal stem cells 
to the microenvironments developed above. 
 
5. Study the effect of fibronectin conformation on dendritic cells including morphology, 






Chapter 3. Materials and Methods  
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General description of the protocols used along the Thesis. More details and exceptions 







Self assembled surface monolayers (SAMs)  
 
SAMs with different water contact angle were employed as model surfaces to study the 
effect of the hydrophilic (OH) and hydrophobic (CH3) groups in the protein adsorption. SAM 
surfaces were prepared and characterised as described elsewhere (Keselowsky et al., 
2003) from alkanethiols 1-dodecanethiol (HS-(CH2)11-CH3), 11-mercapto-1-undecanol (HS-
(CH2)11-OH) (Sigma). Gold (Au) coated glass coverslips (Fisher Scientific) were prepared 
by deposition of thin films of Ti (150 A°) followed by Au (150 A°) using a high vacuum 
evaporator (Polaron E6100) at a deposition rate of 2 A°/s and a chamber base-pressure of 
2x1026 Torr. Glass coverslips were cleaned with 70% H2SO4 and 30% H2O2 at room 
temperature for 1 h, rinsed with deionized H2O, rinsed with 95% ethanol, and dried under a 
stream of N2 prior to metal deposition. Freshly prepared Au-coated surfaces were immersed 
in alkanethiol solutions (1 mM in absolute ethanol) with different ratios (CH3/OH), and SAMs 
were allowed to assemble overnight. SAMs were rinsed in 95% ethanol, dried under N2 and 
allowed to equilibrate in DPBS prior to incubation in FN solutions. Surfaces were validated 












Poly(ethyl acrylate) and poly(methyl acrylate) polymer sheets were obtained by radical 
polymerisation of a solution of the corresponding vinyl monomer of alkyl acrylate, i.e. methyl 
(MA) and ethyl (EA) (Sigma-Aldrich) using benzoin (98% pure, Scharlau, 1 wt% and 0.35 
wt% respectively) as a photoinitiator of the reaction (a free radicals initiator). The 
polymerisation was carried out up to limiting conversion in a UV oven for 12 h. After 
polymerisation, low molecular-mass substances (i.e. residual monomer) were extracted 
from the material by drying in vacuo in continuous extraction at 60 ºC for several days, to 
constant weight.  
 
Preparation of films 
Spin coating was used to coat glass coverslips and produce thin films of the polymers 
mentioned above. Polymer solutions were made in toluene with 6% PEA or 2.5% PMA.  Spin 
coating was performed on 12 mm glass coverslips at 2000 rpm for 30 s (Brewer Science, 
Rolla, MO). Samples were dried in vacuum at 60 ºC for several hours to remove solvent 
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traces before further characterisation. In all cases, glass coverslips were previously washed 
in ethanol, making use of an ultrasound device (Bandelin Sonorex Digitec), and then rinsed 





Water contact angle (WCA) 
 
Water contact angles measurements were made on the SAMs to correlate the different WCA 
to wettability. A Dataphysics OCA equipment was used. The volume of the ultra pure water 
drop was 20 µl and the measurement was performed after 10 s of substrate-water contact. 
Three replicates per condition were studied. 
 
Atomic force microscopy (AFM) 
 
AFM was used to scan the different surfaces employed along the thesis, as well as protein 
adsorption and growth factor binding. AFM experiments were performed using a Multimode 
AFM equipped with NanoScope IIIa controller from Veeco (Manchester, UK) operating in 
tapping mode in air; the Nanoscope 5.30r2 software version was used. Si-cantilevers from 
Veeco (Manchester, UK) were used with force constant of 2.8 N/m and resonance frequency 
of 75 kHz. The phase signal was set to zero at a frequency 5–10% lower than the resonance 
one. Drive amplitude was 600 mV and the amplitude setpoint Asp was 1.8 V. The ratio 
between the amplitude setpoint and the free amplitude Asp/A0 was kept equal to 0.8. 
 
Immunogold 
To be able to detect specific proteins under tapping mode using AFM and specifically, 
localise the growth factor after the fibronectin adsorption, an immunogold assay was 
develop. Fixed samples (4% formaldehyde, 30 min at RT) were used with the different 
protein-coating conditions. Samples were incubated with an anti–BMP-2/BMP-4 antibody 
(Santa Cruz Biotechnology, sc-9003; 1 h at RT). After the samples were washed three times 
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with DPBS/0.5% Tween 20 in agitation, they were incubated with 15-nm gold particle–
conjugated anti-rabbit immunoglobulin G (IgG) (Aurion, 815.011; 1 h at RT). Finally, the 





Protein quantification by western blot 
 
FN (human plasma, Sigma, St. Louis, MO) solutions in phosphate-buffered saline (PBS) 
were used for AFM and quantification studies. Standard denaturing conditions were 
employed to separate FN from the samples as explained elsewhere (Rico et al., 2009). 
Using a semidry transfer cell system (Biorad, Hercules, CA), proteins were transferred to a 
polyvinylidene difluoride membrane (GE Healthcare, Madrid, Spain), and blocking was done 
by immersion in 5% skimmed milk in PBS. A rabbit antihuman FN polyclonal antibody 
(Sigma, 1:500) was used in PBS/0.1% Tween-20/2% skimmed milk to incubate the blot for 
1 h at room temperature and then washed with PBS/0.1% Tween-20. Subsequently, the blot 
was incubated in HRP-conjugated secondary antibody (GE Healthcare) diluted 1:20000 (in 
PBS/0.1% Tween-20/2% skimmed milk). Prior to exposing the blot to X-ray, a 
chemiluminescence-based system was used (GE Healthcare). Calibration was done using 
several dilutions of the FN solution and quantified by custom-made image analysis software 
(Rico et al., 2009). Three replicates per condition were performed. 
 
Protein conformation by ELISA – Cell binding domain in the FN 
 
After rinsing (PBS) and blocking (bovine serum albumin (BSA)/Dulbecco’s PBS (DPBS)), 
HFN7.1 antibody (Developmental Hybridoma, Inc., Iowa City, IA) was used to assess the 
availability of the flexible link that joins the 9th and 10th type III FN domains. Primary antibody 
incubation (1:4000) was done for 1 h at 37ºC. Washing (0.5% Tween 20/DPBS) and 
subsequent incubation in alkaline phosphatase–conjugated secondary antibody (1:5000) 
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was done at 37ºC for 1 h. Finally, surfaces were incubated in 4-methylumbelliferyl phosphate 
(4-MUP; Sigma) for 45 min at 37ºC. A plate reader (Victor III, PerkinElmer, Waltham, MA) 
was used to quantify the reaction with fluorescence at 365 nm/465 nm. Three replicates per 
condition were performed. 
 
Protein conformation by ELISA – Growth factor binding domain in FN 
 
After coating with FN, a monoclonal antibody for the FN III12-14
 
domain (also known as 
heparin II domain) was used (Santa Cruz Biotechnology, sc-18827; 1:30, 2 hours at 37°C). 
Samples were washed three times with DPBS/0.5% Tween 20. An anti-mouse IgG 
horseradish peroxidase–conjugated antibody (Invitrogen, 626520; 1:2000, 1 hour at RT) 
was then used. After the samples were washed twice, they were exposed to the substrate 
solution (R&D Systems, DY999) and incubated for 20 min at RT in the dark. A stop solution 
(R&D Systems, DY994) was added before the absorbance was read at 450 nm. Three 
replicates per condition were performed. 
Growth factor adsorption quantification 
 
The amount of nonadsorbed GF that remained in the supernatant was measured via a 
sandwich ELISA (R&D Systems, DY355) following the kit manufacturer’s instructions. The 




Sample disks (12 mm diameter) placed in a 6 or 24-well tissue culture plate were sterilised 
in UV and coated with FN. After coating time, samples were washed with PBS to remove 
the non-adsorbed protein. Cells were trypsinised and the cell pellet was resuspended in 
DMEM in serum-free conditions and then, cells were placed onto each substrate and were 
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maintained at 37 ºC in a humidified atmosphere under 5% CO2 for different culture times. 







Two different cells lines were used: MC3T3-E1 (RIKEN Cell Bank (Japan), osteoblast 
precursor cell line derived from mouse calvaria) and NIH3T3 (European Collection of Cell 
Cultures (ECACC), mouse embryonic fibroblast cell line). Prior to seeding on substrates, 
cells were maintained in DMEM medium supplemented with 1% penicillin-streptomycin and 
10% fetal bovine serum (for MC3T3-E1 cells) or calf serum (for NIH3T3 cells), and passaged 
twice a week using standard techniques. 
 
Mesenchymal stem cells (non marker-selected) 
 
Human bone marrow mesenquimal stem cells were obtained form Promocell. Human bone 
marrow MSCs from PromoCell were maintained in basal medium [α-minimum essential 
medium, 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, 1% fungizone, 2 mM L-
glutamine, FGF-2 (1 ng/ml)] at 37°C with 5% CO2. Cells (104/cm2) were seeded onto the 
materials using the seeding medium (high-glucose Dulbecco’s modified Eagle’s medium, 
1% penicillin/streptomycin, 1% FBS), and the medium was changed twice a week. For all 
cultures, the first 2 h (initial cell adhesion) were in the absence of serum and GFs. Cells 





Mesenchymal stem cells (Stro-1 selected) 
 
Human bone marrow stromal cells were obtained from hematological normal patients 
undergoing routine hip-replacement surgery as described previously with full ethical 
approval and patient consent (Yang et al., 2001). Skeletal/mesenchymal stem cell 
populations were enriched from the bone marrow stromal cell population with Stro-1 
selection using magnetic activated cells sorting (MACS) as previously detailed (Howard et 
al., 2002). Stro-1 has been used as a stringent marker for enhancing the most primitive 
multipotent population of the bone marrow (Mirmalek-Sani et al., 2006; Simmons & 
Torokstorb, 1991; Triffitt et al., 1998; Yang et al., 2003). Thus, these cells can be used at 
very low passage preventing phenotypical drift due to prolonged culture/excessive 
passaging. Prior to seeding on FN-coated substrates, STRO-1+ cells were cultured in 75 
cm2 tissue culture flasks and cells were maintained in basal medium (α MEM supplemented 
with 10% foetal bovine serum and 2% antibiotics) at 37ºC. All cells used in differentiation 




Immature bone marrow-derived dendritic cells were generated from 7-week-old female 
C57BL6/j mice in accordance with protocol approved by the University of Florida (protocol 
number E751) using a modified 10-day protocol (Acharya et al., 2008; Lutz et al., 1999). 
Briefly, femur and tibia from mice were isolated and kept in wash media composed of 
DMEM/F-12 (1:1) with L-glutamine (Cellgro, Herndon, VA) and 10% fetal bovine serum 
(BioWhittaker). The ends of the bones were cut and bone marrow was flushed out with 10 
ml wash media using a 25 G needle and mixed to make a homogeneous suspension. The 
suspension was then strained using 70 µm cell strainers (Becton Dickinson) and cells were 
collected by centrifugation at 330 g for 6 min. Precursor cells were isolated by centrifuging 
NycoPrep gradient (10 ml) and cell suspension (25 ml) at 670 g for 20 min at 22ºC. 
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Leukocytes were isolated by pipetting out the layer of cells that forms at the interface of 
wash media and gradient. The precursor cell suspension was then washed twice with wash 
media and re-suspended in DMEM/F-12 with L-glutamine (Cellgro, Herndon, VA), 10% fetal 
bovine serum, 1% sodium pyruvate (Lonza, Walkersville, MD), 1% non-essential amino 
acids (Lonza, Walkersville, MD), 1% penicillin–streptomycin (Hyclone) and 20 ng/ml GM-
CSF (R&D systems) (DCs media). This cell suspension was then seeded in a tissue culture 
treated T-flask (day 0). After 48 h (day 2), floating cells were collected, re-suspended in 
fresh media and seeded on low attachment plates for 6 additional days. Half of the media 
was changed every alternate day. At the end of 6 days (day 8), cells were lifted from the low 
attachment wells by gentle pipetting, re-suspended and seeded on tissue culture-treated 
polystyrene plates for 2 more days. Cells were then lifted (at day 10) using 5 mM Na2/EDTA 
solution in phosphate-buffered saline (PBS, Hyclone) and used for all the experiments. 
Purity, yield and immaturity of DC (CD11cþ and MHC-II) were verified via 
immunofluorescence staining and flow cytometry, whereas cell viability (>99% viable) was 
determined using Trypan blue. Marrow derived DC stimulatory capacity in terms of up-
regulation of cell-surface markers MHC-II, CD80 and CD86, when cultured in the presence 







After the cell culture, cells were washed in DPBS (Gibco) and fixed in 10% formalin solution 
(Sigma) at 4°C. To permeabilise, cells were incubated for 5 min with 103 g/l sucrose, 2.92 
g/l NaCl, 0.6 g/l MgCl2, 4.76 g/l HEPES buffer, 5 ml/l Triton X-100, pH 7.2. After blocking 
(1% BSA/DPBS), cells were incubated with vinculin primary antibody (Sigma, 1:400) for 1h 
at RT and then rinsed in 0.5% Tween-20/DPBS. Cy3-conjugated secondary antibody 
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(Invitrogen, Paisley, United Kingdom; 1:200) and BODIPY FL phallacidin (Invitrogen, 1:100) 
were dissolved together in 1% BSA/ DPBS cells were then incubated with the mixture 1 h 
at RT. After washing, samples were mounted in Vectashield containing 4¢,6-diamidino-2-
phenylindole (Vector Laboratories, Burlingame, CA). Visualization was done with a Nikon 
Eclipse 80i (Amsterdam, The Netherlands) fluorescent microscope. Three replicates per 
condition were studied. 
 
Fibronectin reorganisation and secretion 
 
The ability of cells to reorganise adsorbed FN (i.e., early matrix) was monitored by coating 
all samples with FN solution prior seeding in serum containing medium. The evolution of FN 
in the ECM was followed by immunofluorescence after different culture times and following 
the same procedure as described before. Samples were incubated with anti-FN antibody 
(1:400, Sigma) and Cy3-conjugated secondary antibody before washed and mounted with 
Vectashield containing DAPI. Three replicates per condition were studied. 
Integrin binding (α5 integrin) 
 
 
Integrin binding to FN-coated materials was analysed via immunostaining following cross-
linking of bound integrins to FN and extraction of cellular components. Cultures were rinsed 
in DPBS and incubated in ice-cold DTSSP (1.0 mM final concentration in DPBS/2 mM 
dextrose) for 30 min. Unreacted cross-linker was quenched with 50 mM Tris in DPBS for 15 
min and bulk cellular components were extracted in 0.1% SDS/350 mg/ml 
phenylmethylsulfonyl fluoride in DPBS. The samples were rinsed and blocked with 5% 
FBS/0.1% Tween-20 for 1 h, bound integrins were immunostained with anti α5 integrin 
(Millipore, 1:400) for 1 h at 37 ºC. After rinsed the samples in DPBS cy3-conjugated 
secondary antibody (Jackson Research, 1:200) were used. Finally, samples were washed 
and mounted in Vectashield containing DAPI (Vector Laboratories). A Nikon Eclipse 80i 
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Matrix Metalloproteinases (MMP2 and MMP9) 
 
 
After 3 h of culture, MC3T3-E1 cells were washed in DPBS (Gibco) and fixed in 10% formalin 
solution (Sigma) at 4ºC. Cells were incubated with permeabilising buffer (103 g/l sucrose, 
2.92 g/l NaCl, 0.6 g/l MgCl2, 4.76 g/l HEPES buffer, 5 ml/l Triton X-100, pH 7.2) for 5 min, 
blocked in 1% BSA/DPBS and incubated with primary antibody against MMP2 (Abcam, 2 
mg/ml) or MMP9 (Abcam, 1:100). Samples were then rinsed in 0.5% Tween-20/DPBS. Cy3-
conjugated secondary antibody in 1% BSA/DPBS (Invitrogen) and BODIPY FL phallacidin 
(Invitrogen) were used. Finally, samples were washed and mounted in Vectashield 
containing DAPI (Vector Laboratories). A Leica DM6000B fluorescent microscope was used 
for cellular imaging. Three replicates per condition were studied. 
 
Mesenchymal stem cell differentiation 
 
 
After 14 days of culture, cells were washed in DPBS and fixed with 4% formaldehyde in 
DPBS at 37°C for 15 min. Afterward, the samples were rinsed in DPBS and a permeabilising 
buffer (10.3 g of sucrose, 0.292 g of NaCl, 0.06 g of MgCl2, 0.476 g of Hepes buffer, 0.5 ml 
of Triton X, in 100 ml of PBS (pH 7.2) was added at 4°C for 5 min. The samples were then 
saturated with 1% BSA/DPBS at 37°C for 5 min. Subsequently, they were incubated at 37°C 
for 1 h with a primary antibody against RunX2 (SantaCruz Biotechnology sc-10758, 1:50), 
osteocalcin (Santa Cruz Biotechnology, sc-73464; 1:50) or osteonectin (Santa Cruz 
Biotechnology, sc-10758; 1:50) in 1% BSA/DPBS. After washing in PBST, an anti-rabbit 
secondary antibody (Vector Laboratories; 1:50) was incubated for 1 h at 37°C. Finally, the 
samples were rinsed in DPBS before they were mounted in Vectashield containing DAPI 
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staining (Vector Laboratories). A Zeiss fluorescence microscope was used for imaging. 





Gelatin zymography was used to detect the activity of metalloproteinases and study the 
ECM remodeling and degradation, It was performed using 15 μl of supernatant after 4 and 
24 h of culture. The samples were mixed with an equal volume of 2x loading buffer (2.5 mM 
Tris- HCl pH 6.8, 25% glycerol, 4% SDS, 0.01% bromophenol blue) and incubated for 10 
min at room temperature before loading to 10% gelatin-ready zymogram gel (Biorad, 
1611167). Gels were run at 50 V for 4 h at 4°C. The gels were incubated in 2.5% Triton X-
100 for renaturation for 30 min. They were then equilibrated in fresh developing buffer (50 
mM Tris base, 200 mM NaCl, 5 mM anhydride CaCl, 0.02%, 30% brij-35) and incubated at 
37°C overnight. Gels were stained with 0.5% Coomassie R-250 (40% methanol, 10% acetic 
acid) for 2 h and finally destained with destaining buffer (40% methanol, 10% acetic acid) 
for 1 h. Areas of protease activity appear as clear bands against a dark blue back- ground 
where the protease had digested the gelatin substrate. Three replicates per condition were 
used. 
 
Western blot assays 
 
 
Protein extraction was done by lysing cells using RIPA buffer (50 mM Tris-HCl pH 7.4, 1% 
nonidet p-40, 0.25% so- dium deoxycolate, 150 mM NaCl, and 1 mM EDTA) supple- mented 
with protease inhibitor cocktail tablets (Roche, Madrid, Spain) after 4 h of culture. Microcon 
YM-30 Centri- fugal Filters units (Millipore) were use to concentrate the lysates that were 
afterwards separated in 7%–10% SDS PAGE under denaturing conditions. Standard 
Western blot was used (described above, ‘Protein quantification by Western blot’) for FAK, 
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pFAK, integrin α5, MMP2, MMP9, RunX2, pSmad 1, pSmad1/5 and GAPDH. The same 
amount of protein was charged in every case as measured with NanoDrop 
(ThermoScientific, Waltham, MA). The blots were incubated separately with primary 
antibody against FAK (abcam, 400 ng/ml), pFAKs (abcam, 1 µg/ml), MMP2, MMP9 and 
RunX2 (abcam, 1 µg/ml), α5 integrin (Santa Cruz Biotechnology, 1:100), pSmad 1 and 
pSmad 1/5 (Cell Signalling Technology 12656; 1:1000). In all cases the secondary antibody 
was HRP linked and the dilutions used were: 1:50000 & 1:250000 for FAKs, 1:10000 for p-
FAKs, 1:20000 for MMP2, MMP9 and RunX2; 1:150000 for α5 integrin and 1:2000 for 
pSmad1 and pSmad1/5 (antirabbit IgG antibody, Cell Signalling Technology, 7074). 
Supersignal West Femto Maximum Sensitivity Substrate (Pierce, Rock- ford, IL) was used 
before X-ray exposition. Three replicates per condition were used. For FAK, pFAK, RunX2, 
integrin α5, MMP2, MMP9 image analysis of the western bands was done using in house 
software (Rico et al., 2009). ImageJ was used for pSmad 1 and pSmad 1/5. 
 
Polymerase chain reaction (PCR) 
 
 
Gene expression (mRNA) of α5 and αv integrins, MMP2, and MMP9 was analysed after 4 h 
and 1 d of culture. RNAeasy Mini Kit (Qiagen) was used for RNA extraction, which was 
quantified using NanoDrop measurements (ThermoScientific). Afterwards, 1 µg was used 
as a template for SuperScript III RT (Invitrogen) and oligo(dT)12-18
 
(Invitrogen) for 
amplification. PCR experiments were done using Ampli Taq Gold 360 DNA polymerase 
(Invitrogen) Oligonucleotides are shown in Table 1. Independent experiments were done in 




Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
β actin TTCTACAATGAGCTGCGTGTG GGGGTGTTGAAGGTCTAAA 
GAPDH GTGTGAACGGATTTGGCCGT TTGATGTTAGTGGGGTCTCG 
β integrin GGAGGAATGTAACACGACTG TGCCCACTGCTGACTTAGGAATC 
FAK GGAGTTTTCAGGGTCCGACTG CATTTTCATATACCTTGTCATTGG 
RUNX2 GTGCTCTAACCACAGTCCATGCAG GTCGGTGCGGACCAGTTCGG 
MMP2 TGGTGTGGCACCACCGAGGA GCATCGGGGGAGGGCCCATA 
MMP9 AGCACGGCAACGGAGAAGGC AGCCCAGTGCATGGCCGAAC 
α5 integrin GGACGGAGTCAGTGTGCTG GAATCCGGGAGCCTTTGCTG 
αν integrin CACCAGCAGTCAGAGATGGA GAACAATAGGCCCAACGTCT 
 
Table 1 PCR primers sequence. The primers used for amplification were designed based on sequences 
found in the GenBank database. 
 
Quantitative real time PCR 
 
 
RNA extraction was performed after the specific days of cell culture. Cells were lysed, and 
total RNA was extracted using a Qiagen RNeasy micro kit (deoxyribonuclease treatment 
included), and the quantity and integrity of the RNA were measured with a NanoDrop 
(Thermo Fisher Scientific). qPCR was carried out and analysed to assess the expression of 
RunX2, osteocalcin, osteonectin and osteopontin, using GAPDH to normalize gene 
expression (a list of the primers used is shown in Table 2). Briefly, RNA samples were 
reverse-transcribed using the QuantiTect Reverse Transcription Kit (Applied Biosystems). 
qPCR was carried out using the SYBR Select Master Mix (Life Technologies) and the 7500 
Real Time PCR System (Applied Biosystems). GAPDH served as the housekeeping gene, 
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and the expression for the genes of interest was normalized to the GAPDH expression. 
When the SYBR Green method was used, primer sequences for the genes were validated 
by dissociation curve/melt curve analysis. The comparative cycle threshold method was 
used for quantification of gene expression. The relative transcript levels were expressed as 
means ± SD (with 3 samples used for each group).  
 Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
SYBR 
Osteocalcin CAGCGAGGTAGTGAAGAGACC TCTGGAGTTTATTTGGGAGCAG 
Osteopontin AGCTGGATGACCAGAGTGCT TGAAATTCATGGCTGTGGAA 
Osteonectin AGAATGAGAAGCGCCTGGAG CTGCCAGTGTACAGGGAAGA 
GAPDH GTCAGTGGTGGACCTGACCT ACCTGGTGCTCAGTGTAGCC 
Taqman 
RunX2 (Hs00231692_m1 116) 
GAPDH (Hs99999905_m1 122) 
 
Table 2 Quantitative real time PCR primers sequence. The primers used for amplification were designed 






Immunoprecipitation was used to determine colocalisation of integrin and GF receptor. After 
45 min of cell culture, cell lysates [radioimmunoprecipitation assay (RIPA) buffer] were used 
to perform immunoprecipitation of integrin β1 and the BMP-2 receptor BMPRIa. Proteins (15 
µg) were measured using NanoDrop (Thermo Fisher Scientific). First, an integrin β1 antibody 
(Abcam, 183666; 10 µl per reaction) was incubated together with protein A-Agarose beads 
(Santa Cruz Biotechnology, sc-2001). Second, after denaturation and elution of beads, the 
samples were run in NuPAGE 4-12% bis-tris gels (Life Technologies). A mouse BMPRIa 
antibody was used to probe the membrane (Abcam, 166707; 1:1000). An anti-mouse 
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secondary antibody was used (Santa Cruz Biotechnology, sc-2031; 1:5000). The enhanced 
chemiluminescence detection system (GE Healthcare) was used before the blot was 






Dendritic cell maturation was quantified by measuring cell-surface marker levels by flow 
cytometry. Briefly, DCs were lifted by incubating with 5 mM Na2EDTA solution in 1 M PBS 
solution at 37ºC for 20 min. Dendritic cells were then washed with 1% fetal bovine serum in 
PBS and incubated with antibodies against CD16/CD32 (Fcg III/II Receptor) (clone 2.4G2, 
IgG2b,k (BD Pharmingen)) for 40 min at 4°C to block Fcg receptors on DCs. Cells were 
washed and then stained with antibodies against CD80 (clone 16-10A1, IgG2, k), CD86 
(clone GL1, IgG2a, k), I-A/I-E (clone M5/ 114.15.2 IgG2b, k), CD11c (clone HL3, IgG1, l2) 
(BD Pharmingen) for 40 min at 4ºC. Appropriate isotypes were used for each antibody 
species as negative controls. Data acquisition was performed using (FACScalibur, Becton 
Dickinson) flow cytometry and the geometric fluorescent intensities determined. More than 
20,000 events were acquired for each sample and data analysis was performed using FCS 




In order to assess the amount of endotoxin present on the fibronectin and substrates, the 
chromo-Limulus Amebocyte Lysate (chromo-LAL) assay was performed as per the 
manufacturer’s instructions (Cape Cod) using a 50 µl reaction volume per substrate with a 




Enzyme-linked immunosorbent assay (ELISA) 
 
ERK 1/2 phosphorylation 
 
ERK 1/2 phosphorylation was quantified using phospho-ELISA kits. The results were 







Cell culture supernatants were collected after 24 h of cell culture, centrifuged to remove any 
cell debris and stored at 20ºC until analysis. The IL-12 cytokine subunit, IL-12p40, and IL-
10 cytokine production was analysed using ELISA. NUNC/Maxisorp plates were coated 
overnight at 4ºC with the captured antibodies at 1:250 dilution in PBS (Mouse IL-12/IL-23 
(p40) ELISA MAX capture antibody and BD OptELA Mouse IL10 purified capture antibody). 
Between each step of the protocol it was performed 3 washes with washing solution (0.05% 
Tween 20/PBS). The wells were blocked using a 1% BSA solution for 1 h at RT. Samples 
and standard were added to the wells and incubated for 2 h at RT. Starting point for the 
standard curves were 1000 pg/ml. Recombinant standard mouse IL-12/IL-23 (p40) 
(Biolegend, 431601) and standard mouse IL-10 (BD OptELA, 555252) in PBS were used. 
Detection antibodies from the same company were used at 1:250 in 10% FBS/PBS at RT 
for 1 h. Anti-biotin antibodies were used at 1:10.000 dilution in PBS for 1 h at RT. A MUP 
homemade solution was used as a substrate. Samples were kept in a 37ºC incubator and 







Unless specified, all image processing and analysis was done using Adobe Photoshop CS5 
and ImageJ.  Briefly, brightness and contrast were modified in bright field images in order to 
define the cell shape with Adobe Photoshop CS5. Thereafter cell morphology was quantified 
using ImageJ software by calculating parameters such as cell area, aspect ratio (major 
axis/minor axis), circularity (4π x area/perimeter2) and roundness (4 x area/π x [major 
axis]2). Circularity and roundness correspond to a value of 1 for a perfect circle. At least 20 




Results are shown as average ± standard deviation and were analysed by one-way ANOVA. 
If treatment level differences were determined to be significant, pair-wise comparisons were 
performed using Tukey post hoc test. Statistically significant differences are indicated with 







Chapter 4. Matrix remodelling 





























*Results presented in this chapter have been published in: 
- Llopis-Hernández V, Rico P, Ballester-Beltrán J, Moratal D, Salmerón-Sánchez M. Role 
of Surface Chemistry in Protein Remodelling at the Cell-Material Interface. PLoS ONE 
2011:6(5): e19610. https://doi.org/10.1371/journal.pone.0019610 
- Llopis-Hernandez V, Rico P, Moratal D, Altankov G, Salmeron-Sanchez M. Role of 




Matrix remodelling and degradation at the 
material interface 
 
This work provides a broad overview of matrix remodelling at the cell-material interface, 
establishing correlations between surface chemistry, fibronectin adsorption, cell adhesion 




Extracellular matrix (ECM) remodelling is a dynamic process, which consists of two opposite 
events: assembly and degradation. These processes are mostly active during development 
and regeneration of tissues but, when miss-regulated, can contribute to diseases such as 
atherosclerosis, fibrosis, ischemic injury and cancer (Heymans et al., 2006; Holmbeck et al., 
1999; Reisenauer et al., 2007). The proteolytic cleavage of ECM components represents a 
main mechanism for ECM degradation and removal (Koblinski et al., 2000; Mohamed & 
Sloane, 2006). The major enzymes that degrade ECM and cell surface associated proteins 
are matrix metalloproteinases (MMPs). MMPs are a family (24 members) of zinc dependent 
endopeptidases, which together with adamalysin-related membrane proteinases that 
contain disintegrin and metalloproteinase domains (ADAMs or MDC), such as thrombin, 
tissue plasminogen activator (tPA), urokinase (uPA) and plasmin are involved in the 
degradation of ECM proteins. MMPs are either secreted or anchored to the cell membrane 
by a transmembrane domain or by their ability to bind directly uPA receptor (uPAR) and 
integrin αvβ3 (Buck et al., 1992). The role of MMPs in both development and diseases has 
been recently extensively studied and reviewed because it is tightly linked with the 
mechanisms for tumour invasion and metastasis (Mohamed & Sloane, 2006; Page-McCaw 
et al., 2007). Also, MMPs regulate cell behaviour through finely tuned and tightly controlled 
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proteolytic processing of a large variety of signalling molecules that can also trigger 
beneficial effects in disease resolution (Rodriguez et al., 2010). 
 
In this chapter, it is address the relationship between fibronectin (FN) activity at the material 
interface and the remodelling and degradation phenomena, including proteolytic cascades, 
depending on the surface chemistry. To do so, we have taken advantage of two different 
families of biomaterials. Using two acrylates with similar chemistries (poly(ethyl acrylate) 
(PEA) and poly(methyl acrylate) (PMA), Figure 34), the FN remodeling and degradation of 
the ECM was studied. When the FN is adsorbed on PEA and PMA (slightly different surface 
chemistry), FN molecules remain globular and isolated on PMA but material-driven 
fibronectin fibrillogenesis occurs on PEA. On another hand, the degradation of the ECM was 
in paralel studied using SAMs as model surfaces presenting two different chemistries, -OH 
and –CH3. SAMs constitute an excellent model to vary surface wettability in a broad range 
while maintaining controlled and simple surface chemistry. SAMs are model organic 
surfaces that provide defined chemical functionalities and well-controlled surface properties 
(Keselowsky et al., 2003; Raynor et al., 2009). 
 
Fibronectin adsorption was investigated (adsorbed surface density, distribution and 
conformation) and correlated to cell behaviour. Cell adhesion and signalling on FN-coated 
samples were characterised via the formation of focal adhesions, integrin expression and 
phosphorylation of FAKs. The reorganisation and secretion of FN was linked to the activity 
of FN after adsorption on the different chemistries. More detailed studies were performed to 
get further insights into integrin binding by crosslinking and extraction followed by 
immunofluorescence, as well as protein and gene expression for α5 and αv. Seeking to 
correlate cell adhesion with matrix degradation, expression (gene and protein) and activity 
(zymography) of matrix metalloproteinases (MMPs) were measured. 
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In this chapter, we address the relationship between FN activity at the material interface and 
remodelling, including proteolytic cascades. Overall, here it is demonstrated that material-
driven FN fibrillogenesis triggers proteolytic activity: MMP activity was higher on the 
material-driven FN fibril, as a compensatory mechanism to the inability of cells to reorganise 
this FN network.  
 
Materials and Methods 
 
Preparation of samples  
 
Self-assembled monolayers (SAMs) 
 
SAM surfaces were prepared and characterised as described in general Materials and 
methods chapter. Freshly prepared Au-coated surfaces were immersed in alkanethiol 
solutions (1 mM in absolute ethanol) with different ratios (CH3/OH), and SAMs were allowed 
to assemble overnight. SAMs were rinsed in 95% ethanol, dried under N2 and allowed to 
equilibrate in DPBS prior to incubation in FN solutions. Surfaces were validated by water 




Polymer sheets were obtained by radical polymerisation of a solution of the corresponding 
alkyl acrylate, i.e. methyl (MA) and ethyl (EA) (Sigma-Aldrich, Steinheim, Germany), using 
the procedure explained in the general Materials and methods of this thesis. The samples 
were performed on 12 mm and 25 mm (for protein and gene expression respectively) glass 
coverslips at 2000 rpm for 30 s. Samples were dried in vacuum at 60 ºC before their use. 
 
 
Atomic force microscopy 
 







FN from human plasma (Sigma) was adsorbed from solutions of concentrations of 2, 5 and 
20 µg/ml in PBS. After adsorption, samples were rinsed in PBS to eliminate the non-
adsorbed protein.  
 
FN surface density 
 
 
Separation of FN adsorbed on different samples was performed using 5%-SDS PAGE and 
denaturing standard conditions as described in general Materials and methods. Each 
experiment of FN adsorption included the loading in the gel of two known amounts of FN 
(reference points) that correspond to points included in the calibration curve so that the 
position of the whole calibration curve could be verified for each adsorption experiment. 
 
HFN7.1 ELISA (FN conformation, cell binding domain) 
 
 
After FN adsorption, SAM and polymeric surfaces were rinsed in PBS and blocked in 1% 
BSA/DPBS. Primary monoclonal antibody HFN7.1 (Developmental Hybridoma, Inc., Iowa 
City, IA) directed against the flexible linker between the 9th and 10th type III repeat was 
used. Substrates were incubated in primary antibody (1:4000) for 1 h at 37°C. After washing 
(0.5% Tween 20/DPBS), substrates were incubated in alkaline phosphatase conjugated 
secondary antibody (1:5000) for 1 h at 37°C and incubated in 4-methylumbelliferyl 
phosphate (4-MUP) (Sigma) for 45 min at 37°C. Reaction products were quantified using a 








MC3T3-E1 cells were obtained from the RIKEN Cell Bank (Japan) to be used on the SAMs. 
Prior to seeding on FN-coated substrates, cells were maintained in DMEM medium 
supplemented with 1% penicillin-streptomycin and 10% foetal bovine serum and passaged 
twice a week using standard procedures. SAMs sample disks placed in a 24-well tissue 
culture plate were coated with a solution of FN 20 µg/ml. Then, 3x103 cells per substrate 
were seeded and maintained at 37°C in a humidified atmosphere under 5% CO2 for 3 h. 
Each experiment was performed in triplicate. 
 
NIH3T3 cells were obtained from European Collection of Cell Cultures (ECACC) and used 
in the polymeric samples. Cells were maintained prior to seeding on FN-coated substrates, 
in DMEM medium supplemented with 1% penicillin-streptomycin and 10% calf serum and 
passaged twice a week using standard procedures. Polymer sample disks placed in a 24-
well or 6-well tissue culture plate were coated with a solution of FN 2 µg/ml or 20 µg/ml. 
Then, 2.6·104 (24-well) or 3·105 (6-well) cells respectively per substrate were seeded and 
maintained at 37 ºC in a humidified atmosphere under 5% CO2 for 3 h. All cultures were 
realised in absence of calf serum except for integrin binding and gene expression (first hour 
in absence of serum). Each experiment was performed in triplicate. 
 
Immunofluorescence (Vinculin, MMPs, FN) 
 
 
Cells were cultured for different times according to the experiment ((3 h, MC3T3-E1 culture, 
SAMs, vinculin), (4 h for NIH3T3, acrylates, vinculin), (1 d, SAMs, MMPs), (2.5 h, 5 h and 1 
d, SAMs, FN)). After the corresponding cell culture time, cells were washed in DPBS (Gibco) 
and fixed in 10% formalin solution (Sigma) at 4°C. Cells were incubated with permeabilising 
buffer (103 g/l sucrose, 2.92 g/l NaCl, 0.6 g/l MgCl2, 4.76 g/l HEPES buffer, 5 ml/l Triton X-
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100, pH 7.2) for 5 min, blocked in 1% BSA/DPBS and incubated with primary antibody 
against vinculin (Sigma, 1:400), MMP2 (Abcam, 2 µg/ml) or MMP9 (Abcam, 1:100) for 1 h 
at RT. Samples were then rinsed in 0.5% Tween-20/DPBS. Cy3-conjugated secondary 
antibody (Invitrogen, 1:200) in 1% BSA/DPBS (Invitrogen) and BODIPY FL phallacidin 
(Invitrogen, 1:100) were used. Finally, samples were washed and mounted in Vectashield 
containing DAPI (Vector Laboratories). A Leica DM6000B fluorescent microscope was used 
for cellular imaging. 
 
The ability of cells to reorganise adsorbed FN (i.e., early matrix) was monitored by coating 
all samples with 20 µg/ml solution prior seeding in serum containing medium. The evolution 
of FN in the ECM was followed by immunofluorescence after different culture times and 
following the same procedure as described before. Samples were incubated with anti-FN 
antibody (1:400, Sigma) and Cy3-conjugated secondary antibody before washed and 
mounted with Vectashield containing DAPI. 
 
Immunofluorescence (Integrin binding, α5 integrin) 
 
 
Integrin binding to FN-coated materials was analysed via immunostaining following cross-
linking of bound integrins to FN and extraction of cellular components. NIH3T3 (acrylates) 
were seeded on FN-coated materials for 1.5 and 4 h. Cultures were rinsed in DPBS and 
incubated in ice-cold DTSSP (1.0 mM final concentration in DPBS/2 mM dextrose) for 30 
min. Unreacted cross-linker was quenched with 50 mM Tris in DPBS for 15 min and bulk 
cellular components were extracted in 0.1% SDS/350 mg/ml phenylmethylsulfonyl fluoride 
in DPBS. The samples were rinsed and blocking with 5% FBS/0.1% Tween-20 for 1 h, bound 
integrins were immunostained with anti α5 integrin (Millipore, 1:400) for 1 h at 37 ºC. After 
rinsed the samples in DPBS cy3-conjugated secondary antibody (Jackson Research, 1:200) 
were used. Finally, samples were washed and mounted in Vectashield containing DAPI 
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(Vector Laboratories). A Nikon Eclipse 80i fluorescent microscope was used for cellular 
imaging. 
 
Western blot (FAK, pFAK, MMP2, MMP9, RunX2, α5 integrin) 
 
After 3h (SAMs: FAK, pFAK), 4 h (acrylates: FAK, pFAK, α5 integrin) or 1 d (SAMs: MMP2, 
MMP9 and RunX2) of cell culture total protein extraction was performed lysing the cells with 
RIPA buffer (50 mM Tris-HCl pH 7.4, 1% nonidet p-40, 0.25% Na-deoxycholate, 150 mM 
NaCl and 1 mM EDTA) supplemented with protease inhibitor cocktail tablets (Roche). The 
lysates were concentrated with Microcon YM-30 Centrifugal Filters units (Millipore) and 
separated in 7%–10%-SDS PAGE under denaturing conditions. To analyse the different 
expression patterns of FAKs, p-FAKs, MMPs, RunX2 and α5 integrin, a conventional 
western blot procedure was done as previously described. The same amount of protein was 
charged in every case as measured with NanoDrop (ThermoScientific). The blots were 
incubated separately with primary antibody against FAK (Abcam, 400 ng/ml), pFAKs 
(Abcam, 1 µg/ml), MMP2, MMP9 and RunX2 (Abcam, 1 µg/ml) and α5 integrin (Santa Cruz 
Biotechnology, 1:100). In all cases the secondary antibody was HRP linked and the dilutions 
used were: 1:50000 & 1:250000 for FAKs, 1:10000 for p-FAKs, 1:20000 for MMP2, MMP9 
and RunX2 and 1:150000 for α5 integrin. The Supersignal West Femto Maximum Sensitivity 
Substrate (Pierce) was used prior to exposing the blot to X-ray film. Image analysis of the 
western bands was done using in house software (Rico et al., 2009). 
PCR (α5, αν, β1 integrin, RUNX2, FAKs, MMP2 and MMP9) 
 
 
For SAMs samples, gene expression (mRNA) of β1 integrin, RUNX2, FAKs, MMP2 and 
MMP9 was analysed after 1 d of culture and, for the polymer samples, gene expression 
(mRNA) of α5 and αν integrin, MMP2 and MMP9 was analysed after 4 h and 1 d of culture. 
Total RNA was extracted from cells using RNeasy Mini Kit (Qiagen). The quantity and 
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integrity of the RNA was measured with NanoDrop (ThermoScientific) and used 3 or 1 μg 
RNA respectively as template for SuperScript III RT (Invitrogen) and oligo(dT)12–18 
(Invitrogen) as specific primer for amplification of mRNA. PCR reactions were performed 
with Ampli Taq Gold 360 DNA polymerase (Invitrogen). The oligonucleotides sequence used 
for PCR reactions are listed in Materials and methods section. All reactions were done at 





Gelatin zymography was performed to analyse metalloproteinase activity analysis using 15 
μl supernatant after 4 h and 24 h of culture. The samples were mixed with an equal volume 
of 2X loading buffer (2.5 mM Tris-HCl pH 6.8, 25% glicerol, 4% SDS, 0.01% azul 
bromofenol) and incubated for 10 min at room temperature before loading to 10% gelatin-
ready zymogram gel (Biorad, 1611167). Gels were run at 50 V for 4 hours at 4ºC. The gels 
were incubated in 2.5% Triton X-100 for renaturation for 30 minutes. They were then 
equilibrated in fresh developing buffer (50 mM Tris base, 200 mM NaCl, 5 mM anhydride 
CaCl, 0.02%, 30%-brij-35) and incubated at 37 ºC overnight. Gels were stained with 0.5% 
Coomassie R-250 (40% methanol, 10% acetic acid) for 2 h and finally destained with 
destaining buffer (40% methanol, 10% acetic acid) for 1 h. Areas of protease activity appear 










Results and discussion 
 
Here we present results providing a link between surface chemistry, FN adsorption and cell-
mediated matrix protein remodelling (including reorganisation, secretion and degradation) 
on a family of model surfaces (SAMs) with controlled ratio of methyl/hydroxyl groups. We 
translate this knowledge into biomaterials using acrylates with different chemistry, 
(poly(methyl acrylate) (PMA) and poly(ethyl acrylate)) (PEA).  
 
SAMs prepared in this work have been extensively used and characterised in previous 
studies making use of XPS, FTIR and ellipsometry (Martins et al., 2003; Rodrigues et al., 
2006). As a routine control, it was measured the water contact angle (WCA) to assess that 
it was in accordance with published results. WCA decreases as the fraction of hydroxy 
groups increases from 115° on the methyl terminated SAM to 20° on the hydroxyl terminated 
one (Figure 7). The WCA on the acrylates was previously measured (Brizuela Guerra et al., 
2010), being similar for PEA and PMA (80º). 
 
  
Figure 7 Surface wettability measured by water contact angle on the CH3/OH mixed SAMs. The 
horizontal axis displays the percentage of OH groups in SAMs. The error bars represent the standard deviation 







The molecular distribution of FN upon adsorption on the different SAMs and PEA/PMA can 
be obtained by AFM. Figure 8 shows the organisation of FN on three of the SAM surfaces 
(CH3, OH and the surface with 70% OH, that display qualitatively different WCA) after FN 
adsorption from solutions of different concentrations. FN fibrils are found on the methyl-
terminated SAM after adsorption from a solution of 2 µg/ml (average thickness of the fiber 
is approximately 13±5 nm), less organised molecules are observed on the 70% OH surface 
that became isolated globular-like molecules on the hydroxyl terminated SAM (average size 
of the globular aggregates 20±4 nm). Increasing the concentration of the FN solution results 
in a dense network-like structure of FN on the methyl terminated surface and large molecular 
aggregates that cover the whole surface for the more hydrophilic surfaces. The fibrillar 
nature of the adsorbed FN on the methyl-terminated SAM and the globular distribution on 
the other two surfaces is clearly grasped from this figure. Figure 8 also includes the 
organisation of FN on PEA and PMA after adsorption from solutions at two different 
concentrations (2 and 20 µg/ml). Despite having the same WCA these two acrylates, the 
conformation and distribution of the protein following passive adsorption onto these surfaces 
are completely different (Figure 8b). Interconnected FN fibrils are organised upon adsorption 
from a solution of concentration 20 μg/ml on PEA, in a process that we refer to as material-
driven fibrillogenesis, whereas only dispersed molecules are present on PMA. On another 
hand, as well as happens with the SAMs, FN organisation and distribution on the surface 
depends on the concentration of the initial solution from which the protein is adsorbed. The 
lowest concentration (2 µg/ml) results in isolated FN molecules homogeneously distributed 
on the material surface. As the concentration of the FN solution increases, the formation of 
a FN network occurs on PEA - e.g. material-driven FN fibrillogenesis - but not on PMA 
(Salmeron-Sanchez et al., 2011). FN interactions with chemical groups of the substrate 
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(CH3) give rise to conformational changes in the molecule that must lead to the occlusion of 
the cell binding domains (III9–10). It is known that FN has a compact folded structure in 
physiological buffer that is stabilised through ionic interactions between arms (Aota et al., 
1994). It is likely that FN orients at the CH3 surface, so that its hydrophobic segments interact 
with the methyl groups in the CH3-SAMs and PEA, maybe throughout the heparin-binding 
fragment (Gugutkov et al., 2009). Different supramolecular organisation of the protein at the 
material interface is also reflected in protein distribution on the material surface, as directly 
observed with AFM images in Figure 8a: globular aggregates on the hydrophilic surfaces 
and fibrillar-like structures on the methyl terminated SAMs. 
 
The surface density of adsorbed FN was quantified by western blot analysing the amount of 
protein remaining in the supernatant after adsorption on the material surface (Figure 8c,d). 
A calibration curve was built loading gels with known amounts of FN and the resulting bands 
were quantified by image analysis making use of the Otsu's algorithm to systematically 
identify the band borders (Rico et al., 2009). Figure 8c shows the surface density of FN on 
the different SAMs after adsorption from a solution of concentration 20 µg/ml. The amount 
of adsorbed protein diminishes monotonically as the –OH density increases from 225 ng/cm2 
on the methyl terminated SAM to 50 ng/cm2 on the hydroxyl terminated one. Regardless of 
surface chemistries on PEA and PMA, both surfaces show similar wettability and total 
amount of adsorbed FN. On the acrylates, FN adsorption was studied from two different FN 
solutions: 2 and 20 µg/ml were FN conformation was different as seen using AFM. Figure 
8d shows the surface density of FN on PMA and PEA substrates after adsorption. The 
amount of adsorbed FN increases with the concentration of the protein solution. On the 
contrary, there is no significant difference for the amount of adsorbed FN between material 
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substrates at every FN concentration, which remains constant and approximately 47 and 
340 ng/cm2 for the 2 and 20 µg/ml FN solutions respectively.  
 
Figure 8 FN adsorption on the CH3/OH mixed SAMs and acrylates (PEA and PMA). SAMs are identified 
by the percentage of OH groups and acrylates by their acronyms. a FN distribution on the different SAMs as 
observed by the phase magnitude in AFM. The protein was adsorbed for 10 min from different solutions of 
concentration 20 µg/ml, 5 µg/ml and 2 µg/ml. The first row is the SAM surface without any FN at different 
magnifications: 5 µm a), 2 µm b) and 1 µm c). Arrowheads in f) identify one of the FN fibers assembled on the 
material surface upon adsorption (fiber diameter 1365 nm), arrows in l) identify globular aggregates of 
molecular size (diameter 2064 nm). Images including FN are 1 µm side. b FN distribution on the different 
acrylates (PEA and PMA) as observed by the phase magnitude in AFM using different FN concentrations. Size 
image is 1 µm side. c FN surface density after adsorption from a solution of concentration 20 g/ml on the SAMs 
d FN surface density after adsorption from two solutions with concentrations of 2 and 20 µg/ml.  The error bars 
represent the standard deviation of three independent experiments. (Llopis-Hernandez et al., 2011; Llopis-




The availability of the cell adhesion domains in the adsorbed FN was evaluated by ELISA 
with monoclonal antibodies, which is a well established method to probe for structural or 
conformational changes in adsorbed proteins (McClary et al., 2000; Ugarova et al., 1995) 
(Figure 9). The antibody used (HFN7.1) was directed against the flexible linker between the 
9th and 10th type III repeats of FN (Schoen et al., 1982). It has been previously 
demonstrated that HFN7.1 is a receptor-mimetic probe for integrin binding and cell adhesion 
(Schoen et al., 1982). HFN7.1 antibody binding is similar on the different SAMs regardless 
the composition of the surface after FN adsorption from a solution of concentration 20 µg/ml 
(Figure 9a). However, taking into account that the amount of adsorbed FN differs among 
SAMs, the availability of the HFN7.1 antibody was obtained by normalising to the total 
amount of adsorbed FN on each surface (Figure 9b). This magnitude increases as the 
fraction of hydroxyl groups on the surface does. As we observed with the FN western blot, 
the amount of adsorbed FN on mixed CH3/OH surfaces is lower as the fraction of hydroxyl 
terminated chains increases (Figure 8) and this is in agreement with results obtained on this 
family of SAMs by radiolabeling the protein (Barrias et al., 2009). That is to say, it is known 
that FN is adsorbed in higher amount on hydrophobic (CH3) surfaces than hydrophilic ones 
(OH) (Keselowsky et al., 2003)). Our results established the existence of a linear correlation 
between surface wettability (Figure 7) and the density of adsorbed FN (Figure 8a) for this 
family of mixed SAMs. By contrast, the activity of FN after adsorption is higher as the fraction 
of OH groups on SAMs increased due to the better availability of cell adhesion domains of 
FN. That the activity of FN upon adsorption on SAMs was greater on OH terminated SAMs 
than CH3 terminated ones was previously assessed (Keselowsky et al., 2003; Michael et al., 
2003), and our results confirm the finely tuned chemistry-mediated conformation of FN that 
leads to a monotonically dependence of FN activity on surface composition, as the CH3/OH 
balance on the surface is altered (Figure 9c). To see if the results in model surfaces with 
different WCA can be correlated into polymeric surfaces, we studied also how available is 
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the integrin domain when the FN conformation is modulated using the polymeric samples, 
were the WCA of the samples was the same, with a slightly difference in the chemistry. The 
amount of FN adsorbed on the two acrylates was approximately the same for both 
concentrations of the protein solution (Figure 8d). However, the different distribution of the 
protein revealed by AFM (Figure 8b) (dispersed globular aggregates on PMA versus a 
network of assembled FN fibrils on PEA) also involve different availability of the integrin 
binding domain in FN: Figure 9c shows significant higher signal for the HFN7.1 antibody. To 
fully assess these results, as done with the SAMs, we have included in Figure 9d a 
representation for the availability of HFN7.1 antibody versus the amount of FN adsorbed on 
every surface, that clearly reveals the synergistic effect of the material-driven FN 
fibrillogenesis on FN activity, and it disregards any influence of the total amount of adsorbed 
FN when results between PEA and PMA are compared. The higher availability of cell 
adhesion domains for the material-driven FN fibrils on PEA supports previous results for the 
biological activity of this surface in terms of cell adhesion and differentiation (Brizuela Guerra 
et al., 2010; Gonzalez-Garcia et al., 2010; Gugutko et al., 2009; Rico et al., 2009; Salmeron-
Sanchez et al., 2011). With the adsorption from the 2 µg/ml solution results in the same FN 
activity on PEA and PMA. Further increase of the concentration of the protein solution (20 
µg/ml) provides higher activity of FN on PEA, but not on PMA. It is interesting to note that 
the amount of protein on a surface and its biological activity are two independent 
parameters. In our case, increasing the amount of protein on the surface approximately 10 
times on PMA, the activity measured by HFN 7.1 binding is almost the same, which reveals 
the role of protein-protein interactions in hiding the availability of the integrin binding 
sequence of FN. Since the same amount of FN is adsorbed on every material for each one 
of the adsorbing solutions, Figure 9d represents the activity of the protein (availability of cell 
adhesion domains) as a function of the protein surface density, which reveals higher activity 
of FN on PEA than PMA for the highest FN density. Moreover, this higher activity of FN on 
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PEA is very much dependent on the concentration of the protein solution and it is drastically 
diminished upon adsorption from the 2 μg/ml FN solution when compared upon adsorption 




Figure 9 Availability of the cell adhesion domain on SAMs and acrylates (PEA and PMA). SAMs are 
identified by the percentage of OH groups and acrylates are identified by their acronyms. a Monoclonal 
antibody binding for HFN7.1 on the different SAMs after FN adsorption from a solution of concentration 20 
µg/ml. b Activity of the adsorbed FN on the different SAMs obtained by normalizing the monoclonal antibody 
binding for HFN7.1 relative to the FN surface density calculated in b). c Monoclonal antibody binding for 
HFN7.1 on the different substrates (PEA, PMA and glass) after FN adsorption from two solution of 
concentrations 2 and 20 µg/ml. d Activity of the adsorbed FN on the different substrates obtained by plotting 
the monoclonal antibody binding for HFN7.1 relative to the FN surface density calculated in c. The error bars 
represent the standard deviation of three independent experiments. + there is a statistically significant 
difference between the conditions of 2 and 20 µg/ml. * conditions with a significant difference (P ≤ 0.05). (Llopis-









The organisation of proteins involved in the formation of focal adhesion complexes provides 
an opportunity to learn more about the effectiveness of cell-to-substrate interactions. To gain 
insights into the mechanisms controlling matrix remodelling on material-driven FN networks 
and how it depends on the wettability, we began by examining the organisation of proteins 
involved in the formation of focal adhesion complexes by immunofluorescence on the SAMs 
and the acrylates. Figure 10 shows the distribution of vinculin in cells adhering on the 
different model substrates. Well-defined focal adhesions were found only on the more 
hydrophilic substrates (OH- terminated and 70% OH). Even if vinculin is expressed also in 
cells on the more hydrophobic substrates, it is not afterwards organised into focal contacts 
but randomly distributed throughout the cell. Likewise, the formation of prominent F-actin 
fibers terminating in well-developed focal adhesion complexes occurs on the hydroxyl-
terminated surfaces. More dispersed actin distribution (either lacking stress fiber formation 
or mostly peripheral staining) is observed as the fraction of OH groups on the surface 
diminishes (Figure 10). Poorly developed focal adhesions were observed in both PEA and 
PMA for the 2 μg/ml FN coating. However, well-defined focal plaques were formed on PEA, 
but not on PMA, for the 20 μg/ml FN coating. Likewise, although the formation of F-actin 
fibers on PEA and PMA already occurs at the lowest FN concentration, more prominent F-
actin cables terminating in well-developed focal adhesion complexes are found on PEA at 









Figure 10 Early cell adhesion on FN coated SAMs and acrylates (PEA and PMA). a MC3T3 cells adhesion 
after 3 hours on FN coated materials. To identify each SAMs the percentage of OH groups has been used. 
First column shows F-actin cytoskeleton, second one the distribution of focal adhesion protein vinculin and its 
incorporation into focal contact plaques, which is enhanced as the fraction of OH groups increases (see e.g. 
peripheral organization of well-defined focal contacts in 70% and OH SAMs). The third column is the 
superposition of the other two ones. The scale bar is 50 µm. b Adhesion of NIH3T3 cells after 4 hours on FN 
coated materials (acrylates are identified by their acronyms). Materials are identified by their acronyms with 
different FN adsorption at 4 hours of culture. First column shown F-actin cytoskeleton, second column shows 
the distribution of focal adhesion protein vinculin and its incorporation into focal contact plaques, and the third 
column is the superposition of the other two ones. The scale bar is 50 μm. (Llopis-Hernandez et al., 2011;  
Llopis-Hernandez et al., 2013) 
 
FAK localises to focal adhesions to activate multiple signalling pathways that regulate cell 
migration, survival, proliferation, and differentiation (Cary et al., 1996; Frisch et al., 1996; Ilic 
et al., 1995; Thannickal et al., 2003; Zhao et al., 1998). It was examined the phosphorylation 
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of Y-397, the autophosphorylation site in FAK and a binding site for Src and PI-3 kinases 
(Reiske et al., 1999; Schaller et al., 1994). On the model surfaces, according to Figure 11 
the level of FAK remains constant at gene and protein level (both as obtained by analysis 
of western-blot and PCR bands) (Figure 11a, b). By contrast, the ratio between 
phosphorylated and total FAKs on the different mixed SAMs decreases as the fraction of 
hydroxyl-terminated groups diminishes (Figure 11). That is to say, the phosphorylation of 
specific sites in FAKs depends monotonically on the hydroxyl content of the surface. 
Likewise, gene expression for FAK as obtained by RT-PCR shows no difference among the 
different surfaces, while integrin (β1) gene expression increases as the fraction of OH on the 
SAMs does (Figure 13). The phosphorylation of FAK in Y-397, remains the same for PEA 
and PMA at the lower FN concentration, and it increases at the highest FN concentration 
(20 μg/ml, FN network conformation). Moreover, higher levels of pFAK are obtained on PEA 
than PMA, revealing enhanced signalling from the substrate-assembled FN networks. In the 
past, phosphorylation of FAK has been shown to be sensitive to surface chemistry 
(Keselowsky et al., 2004). In our case, increasing the fraction of hydroxyl groups on the 
sample leads to similar FAK levels (both for gene and protein expression, Figure 4) but with 
higher and higher levels of phosphorylation of Y-397, the autophosphorylation site in FAK 
and a binding site for Src and PI-3 kinases (Schaller et al., 1994), which suggests a stepwise 
activation of signalling cascades as a function of hydroxyl groups on the surface increases. 
That is to say, activation of signalling pathways is directly related to integrin binding and 
focal adhesion formation, which are regulated by the availability of binding domains in FN 
upon adsorption on different chemistries. It has been demonstrated that FAK regulates cell 
adhesion strengthening via integrin activation and binding (Michael et al., 2009). Moreover, 
our results are consistent with the role Y-397 autophosphorylation site plays in adhesion 





Figure 11 FAK expression and phosphorylation of tyrosine Y-397 on FN coated SAMs and acrylates 
(PEA and PMA). SAMs are identified by the percentage of OH groups and acrylates are identified by their 
acronyms. a RT-PCR analysis of FAKs gene expression, b-actin and GAPDH are included as constitutive 
genes. b Representative Western blot for total and phophorylated tyrosine residue Y-397 on FAK. c 
Quantification of the fraction of phosphorylated FAKs relative to the total FAK expression by image analysis of 
the western blot bands in b). d Representative Western blot bands for total and phophorylated tyrosine residue 
Y-397 on FAK with quantification by image analysis of western blot bands. The error bars represent the 
standard deviation of three independent experiments. + there is a statistically significant difference between 
FN concentrations (2 and 20 µg/ml). * conditions with a significant difference (P ≤ 0.05). (Llopis-Hernandez et 
al., 2011; Llopis-Hernandez et al., 2013) 
 
To gain insights into the adhesion mechanism on these synthetic FN matrices assembled at 
the material interface, we examined expression and binding of α5β1 integrin to the adsorbed 
FN since this receptor provides the primary adhesion mechanism (Ruoslahti & Obrink, 
1996). Due to the clear differences in FN conformation and activity, a first study of the 
integrin binding in detail was performed on the acrylates. Integrin binding to FN-coated 
materials was analysed via immunostaining following cross-linking of bound integrins to FN 
and extraction of cellular components (Figure 12a). No significant differences were found 
among PEA and PMA regardless FN concentration, demonstrating that the substrate-
assembled FN network does not alter integrin binding in the presence of serum (Salmeron-
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Sanchez et al., 2011). This experiment revealed no significant differences in integrin binding 
among FN on different surfaces. To enhance the visualisation of integrin clusters, this 
experiment was performed in the presence of serum, that is know to contain large amounts 
of FN and vitronectin which might perturb the effect of the provisional FN matrix previously 
assembled at the material surface. This is the reason why wit was investigated protein and 
gene expression in absence of any additional serum, but focusing on the sole effect of FN 
at the material interface. α5 integrin protein expression was higher for cells seeded on the 
material-driven FN network (PEA) than on the dispersed globular-like FN matrix adsorbed 
on PMA (Figure 12b). It was examined α5 integrin expression by western blot. No difference 
was found on PEA between the two FN concentrations used, with a similar expression level 
on PMA with FN at 2 μg/ml. Surprisingly, a very low integrin expression was found on PMA 






Figure 12 α5 integrin expression after 4 h on the acrylates (PEA and PMA).  Acrylates are identified by 
their acronyms. a α5 integrins bound to FN are observed after crosslinking and extraction of cellular 
components. Scale bar is 10 µm. b Representative WB bands for α5 integrin and quantification by image 
analysis of WB bands. The expected band for this antibody might be quite wide according to the manufacturer, 
which is why we developed in-house software to detect the band based on the intensity threshold criterion. 
Error bars represent the standard deviation of three independent experiments. + statistically significant 
difference between FN concentrations (2 and 20 µg/ml). * conditions with a significant difference. (P ≤ 0.05) 
(Llopis-Hernandez et al., 2013) 
 
 
Gene expressions for α5 and αν integrins were obtained by RT-PCR (Figure 13b). α5 
expression decreases with time but increases with FN concentration. At the lowest FN 
concentration (2 µg/ml), α5 expression is higher on PEA than PMA (Figure 13b), as it is at 
20 μg/ml FN concentration. In addition, the opposite trend is found for αv expression that 
remains higher on PMA than PEA at both FN coatings (Figure 13b). These results reveal 
that α5 is the main receptor involved during the initial cell interaction with the material-driven 
FN network on PEA, as it happens for the interaction of cells with natural-physiological 
matrices (Ruoslahti & Obrink, 1996). α5β1 binding has been related to the simultaneous 
availability of the synergy and RGD sequences within fibronectin (Ruoslahti & Obrink, 1996). 
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On the contrary, when FN is adsorbed as discrete aggregates on PMA, the availability of 
the whole integrin binding site of FN is reduced (Figure 9) and cell adhesion mostly occur 




Figure 13 Integrin adhesion quantified by gene expression of β1, α5 and αν integrins on FN coated SAMs 
and acrylates (PEA and PMA). SAMs are identified by the percentage of OH groups and acrylates are 
identified by their acronyms. a On SAMs samples b On acrylates. Quantification of gene expression for α5 and 
αν integrins on the different substrates. The intensity of each band was related to the level of GAPDH under 
the same conditions. For the acrylates, they were represented as fold change relative to the values obtained 
for 2 µg/ml on glass. Error bars are represented by the standard deviation of three different experiments. * 
conditions with a significant difference for every protein concentration and culture time (P ≤ 0.05). (Llopis-




After initial adhesion and previously to secrete their own matrix, cells tend to reorganise the 
adsorbed layer of proteins at the material interface (Altankov & Groth, 1994). In this way, 
cells assemble synthesised FN into a network of fibrils. During this process, however, FN 
needs to experience distinct conformational changes, which can be limited on adsorption to 
the substrate (Mao & Schwarzbauer, 2005; Schwarzbauer, 1991). This may explain the role 
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of the properties of material surfaces (e.g. wettability) in FN matrix formation (Altankov & 
Groth, 1994; Altankov & Groth, 1996). It was previously shown that cell-mediated FN 
reorganisation does not occur on the material-driven FN network assembled on PEA, due 
to the high strength of interaction between FN fibrils and the underlying surface chemistry 
(Gugutkov et al., 2010).  The enhanced initial biological response of the material-driven FN 
network (Figure 8b) can be explain to be a consequence of the following phenomena 
occurring at the cell-material interface after FN assembly into physiological-like fibrils: i) the 
availability of the integrin binding sequence (Figure 9d); ii) α5 integrin expression, which lead 
to enhanced focal adhesion formation and cytoskeleton development (Figure 13b); iii) 
enhanced phosphorylation of FAK (Figure 11). Reorganisation of the FN was studied 
making use of the model surfaces (SAMs) with different hydrophobicity. After 2.5 h, cells are 
able to reorganise the adsorbed layer of FN on the most hydrophilic surfaces (Figure 14a) 
and this ability decreases as the fraction of CH3 groups on the surface increases, were the 
FN forms a network, correlating with PEA FN reorganisation. Figure 14 shows the cellular 
reorganisation of adsorbed FN after 2.5 h of culture on the different SAMs. It is observed 
that cells are able to reorganise FN on the hydroxyl-terminated and the 70%-OH SAMs, as 
it is shown by movements of the adsorbed FN layer with dark zones in the pericellular area, 
mostly coincident with focal adhesion plaques. Late FN matrix formation was studied for 
longer times on the different SAMs (Figure 14b). It is observed that matrix production 
increases as time goes by on every substrate. However, cells are able to synthesise and 
deposit FN matrix more abundantly and better organised into fibrillar networks on the 
hydroxyl terminated and the 70%-OH SAMs surfaces. As mentioned before, the ability of 
cells to reorganise the adsorbed layer of proteins at the material interface must be a 
consequence of the strength of interaction between the ECM proteins and the material 
surface. However, additional reasons must be considered when seeking the molecular origin 
of this fact, which must also be a consequence of the following sequence of events: i) the 
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availability of cell adhesion domains after FN adsorption on the SAM surface is higher in the 
samples with higher OH content (Figure 9b); ii) integrin expression and focal adhesion 
formation is enhanced on the more hydrophilic surfaces (Figure 13a and 10a); iii) 
phosphorylation of FAK is enhanced on the SAMs with higher OH contents (Figure 11a). To 
reorganise the adsorbed layers of proteins, cells must develop mechanical forces on the 
substrate through a contractile mechanism. Contractility results from dynamic interactions 
between actin filaments and myosin, which are regulated via phosphorylation of myosin light 
chain (MLC). Rho GTPases control the formation of stress fibers and focal adhesion 
assembly by modulating MLC phosphorylation and generating actin-myosin contractility 
(Kaibuchi et al., 1999). It is well known that inhibitors of contractility also down-regulated 
tyrosine phosphorylation of FAK (ChrzanowskaWodnicka & Burridge, 1996; Gallagher et al., 
1997; Kaibuchi et al., 1999); more recently it has been shown that contractility-mediated cell 
forces also require FAK phosphorylation (Dumbauld et al., 2010), a fact that supports our 
reorganisation patterns in dependence of the fraction of OH groups: FN is better reorganised 
on those substrates on which FAK phosphorylation occurs more efficiently (Figure 11). On 
the SAMs it can be seen that the dynamics of FN secretion and formation of a fibrillar matrix 
(late matrix) occurs preferentially on the samples with the higher contents of OH groups 
(Figure 14); see e.g. the 70%-OH SAM in Figure 14b, where the presence of defined FN 
fibrils of higher fluorescence intensity can be observed. SAMs that promote FN secretion 
are precisely the substrates on which FN reorganisation takes place more intensively (Figure 
14). These results support the hypothesis that late matrix formation is in need not only of 
cell adhesion on the substrate, but some cell movements, in the range of the size of the 
focal adhesion plaques, must take place so matrix deposition occurs normally (Gonzalez-




Figure 14 Reorganisation of adsorbed FN on SAMs SAMs are identified by the percentage of OH groups. 
a Selected cells for cellular reorganization of adsorbed FN on the different SAMs after 2.5 h of culture as 
obtained by immunofluorecence of FN. The red bottom shows FN homogeneously distributed on the material 
surface. When reorganization of adsorbed FN occurs, black areas (related to the removal of substrate-bound 
FN) and fibrillar bright areas (as a result of enhanced fluorescence for the incorporation of removed FN into 
FN fibrils) are observed. The scale bar represents 50 µm. b Cellular reorganization of adsorbed FN on the 
different SAMs after different times of culture. The scale bar in the first image represents 50 µm. (Llopis-







Matrix dynamics involves not only the organisation of new secreted matrix, but also 
proteolytic degradation, which is a mechanism for the removal of the excess ECM usually 
approximated with remodeling. The importance of matrix remodeling has been recognised 
in the design of new biomaterials that include MMP sensitive sequences (Lutolf et al., 2003; 
Phelps et al., 2010; Schneider et al., 2010). On another hand, the effect of material chemistry 
on the proteolytic activity of cells has been barely addressed so far. Expressions of MMP2 
and MMP9 have been observed in cells cultured on tissue culture polystyrene. Only a few 
examples have related the use of synthetic materials on the transcription and activity of 
MMPs (Chung et al., 2009; Ducy et al., 1997; Uchida et al., 2000; Wan et al., 2008b; 
Zambuzzi et al., 2009). It has been reported a direct relationship between MMP activity and 
osteblasts markers (Hayami et al., 2008). In this sense, MMP9 is a direct target of RunX2 in 
bone tissue, suggesting a regulatory link between RunX2, the expression of MMP9, and cell 
migration (Hess et al., 2001; Pratap et al., 2005). Seeking to understand the relationship 
between FN adsorption, cell adhesion and matrix remodelling the ability of cells to degrade 
ECM was investigated by characterising the expression of different matrix 
metalloproteinases (MMPs) and correlated with RunX2 expression. Figure 15 shows 
characteristic western blot bands for RunX2, MMP2 and MMP9 as well as their relative 
quantification after 1 day of culture. MMP9 and RunX2 expression increases as the fraction 
of hydroxyl-terminated groups in the SAMs does. However, MMP2 remains constant 





Figure 15 RunX2, MMP2 and MMP9 protein expression on SAMs after 1 day of cell culture. SAMs are 
identified by the percentage of OH groups. Representative western blot bands and quantification for all the 
SAMs after 1 day. Error bars are represented by the standard deviation of three different experiments. * 
conditions with a significant difference. (P ≤ 0.05) (Llopis-Hernandez et al., 2011) 
 
To gain further insights, we investigated gene expression by RT-PCR (Figure 16). Similar 
levels of MMP2 are found on the different SAMs surfaces. By contrast, MMP9 and RunX2 
expressions are highly dependent on SAMs surface chemistry and with enhanced level on 
the hydrophilic surfaces. Further, immunofluorescence was used to spatially locate MMP2 
and MMP9 during cell culture (Figure 17). On the polymeric materials with globular (PMA) 
and fibrillary (PEA) FN conformation it was examined the MMPs forms 2, 9 and 13 at gene 
expression and protein activity levels. Figure 16 shows gene expression for MMP2 and 9 
after 4 h and 1 day. MMP2 level (Figure 16b) is lower on PEA than PMA at the highest 
concentration of the FN coating (20 µg/ml), i.e. on the material-assembled FN fibrils. Only 
at the shorter time (4 h) and lower FN concentration (2 µg/ml), MMP2 expression is similar 
on PEA and PMA. The opposite trend was found for MMP9 expression (Figure 16b): similar 
levels were found on both PEA and PMA at every time but at 4 h at the lowest FN 





Figure 16 Matrix degradation quantified by gene expression of MMP2 and MMP9 on FN coated SAMs 
and acrylates (PEA and PMA). SAMs are identified by the percentage of OH groups and acrylates are 
identified by their acronyms. a On SAMs after 1 day of cell culture. b On PEA, PMA and glass GAPDH was 
included as a constitutive gene. The intensity of each band was related to the level of GAPDH under the same 
conditions. For the acrylates, they were represented as fold change relative to the values obtained for 2 µg/ml 
on glass. Error bars are represented by the standard deviation of three different experiments. * conditions with 





Figure 17 Immunofluorescence for actin and matrix metalloproteinases MMP2 and MMP9 on SAMs. 
Cells were stained after 1 day of culture on the FN-coated SAMs (identified by the percentage of OH groups). 
Scale bar is 50 µm. (Llopis-Hernandez et al., 2011) 
 
Due to the big difference found in the FN remodeling between PEA and PMA, further insights 
in matrix degradation were obtained by investigating MMPs activity by gelatin zymography 
(Figure 18). Both the pro-form of the protein and the active one (MMP2) are highly 
dependent on the underlying material surface and the observation time, with higher level of 
activity on PEA than PMA (Figure 1a, c). Increasing the concentration of the FN solution 
does not significantly alter the activity of the protein (Figure 18c). The activity of MMP9 and 
their forms (Figure 18b) can only be observed after 1 day of culture, while pro-MMP13 
behaves as MMP2 for the higher concentration of the FN solution (Figure 18e). That is to 
say, MMP-13 is more active on cells seeded on the material-driven FN network after 1 day. 
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Using model surfaces (SAMs), Figure 16 suggest a correlation between RunX2 and MMP9 
activation on all the surface chemistries. That is to say, it shown that both protein and gene 
expression levels of RunX2 and MMP9 are directly correlated, with low values on the CH3-
rich SAMs, that increases as the OH content in the surface does. This result supports the 
idea that surface chemistry-mediated activation of MMP9 occurs in a physiological-like way, 
as its activation at the cell-material interface involves also the up-regulation of its direct 
target RunX2, as occurs in vivo. Our results show that the activation of proteolytic routes in 
these cells is MMP-dependent phenomenon sensitive to surface chemistry. MMP2 has FN 
type II repeats inserted into the catalytic domain (Page-McCaw et al., 2007) and it has been 
found to cleavage FN and vitronectin into small fragments in vivo, which leads to increased 
cell adhesion and migration (Kenny et al., 2008; Page-McCaw et al., 2007). In this sense, 
MMP2 expression was constant on every SAM FN-coated surface, regardless the 
underlying chemistry (Figure 15,16). By contrast, MMP9 expression increases as the 
fraction of OH groups in the sample does (Figures 15, 16), which suggests a direct 
relationship between FN activity at the cell-material interface and MMP9 expression, as a 
consequence of a sequence of events that include integrin expression (Figure 13), focal 
adhesion formation (Figure 10), matrix reorganisation (Figure 14) and FAK phosphorylation 
(Figure 11). A direct relationship between MMP9 and FN activity at the material interface 
found in the SAMs, was also found when using the acrylates: FN activity is higher on the 
assembled FN fibrils (Figure 9d), as well as the qualitative interpretation of the band for 
MMP9 activity is in Figure 18 (without quantification). Moreover, MMP2 and MMP-13 
activities (zymography) are much higher on the material-assembled FN matrix, after 4 h and 






Figure 18 Matrix degradation quantified by enzymatic activity of MMP2 and MMP9 on PEA and PMA. a 
Acrylates are identified by their acronyms. Representative bands of gelatin zymography for pro-MMP9, 
MMP9+TIMP-1, pro-MMP9, MMP9, pro-MMP2, MMP2, and pro-MMP13 after 4 h and 1 day of culture on the 
different substrates (PEA, PMA, Glass). b Amplification of representative bands of gelatin zymography for pro-
MMP9, MMP9+TIMP-1, pro-MMP9, MMP9, and pro-MMP13 with the different substrates and FN adsorption 
at 1 day of culture. c, d, e Quantification of MMP2, pro-MMP2, and pro-MMP13 activity on the different 
substrates. Error bars are represented by the standard deviation of three different experiments. * conditions 
with a significant difference. (P ≤ 0.05) TIMP (Tissue inhibitors of metalloproteinase). (Llopis-Hernandez et al., 
2013) 
 
As said before, MMP2 could be degrading the assembled fibrils at the material interface 
and, as a result enhancing the exposure of adhesion sites, which would support enhanced 
integrin (α5) expression and focal adhesion formation. It also supports the proposed 
relationship between FN activity at the cell-material interface, the ability to reorganise the 
underlying layer of proteins at the material interface and proteolytic cascades: higher MMPs 
activity is required to remodel the provisional matrix when cells are not able to reorganise 
this layer of proteins at the material interface, as in fact occurs with the material-driven 
fibronectin network. It is precisely this initial proteolytic activity (after 4 h) that enhances 
cellular behaviour on the FN fibrils assembled on PEA. This result supports the hypothesis 
that cells need to rearrange the initial layer of proteins at the material interface, and that this 
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is very much related to the biocompatibility of materials: when the protein-material 
interaction is so strong that reorganisation cannot occur, proteolytic cascades are enhanced 
to degrade FN, seeking to start micro-scale movements at the material interface to direct 
cell function. While mechanical strain is known to be able to enhance MMP expression 
(Yang et al., 2004), only a few examples in the literature have related the use of synthetic 
materials on the transcription and activity of MMPs (Chung et al., 2009; Ducy et al., 1997; 




This work investigates matrix protein dynamics on mixed SAMs of –OH and –CH3 terminated 
alkanethiols (model surfaces) and on two very similar acrylates (potential future 
biomaterials). SAMs assembled on gold are highly ordered organic surfaces able to provide 
different chemical functionalities and well-controlled surface properties. Material-driven FN 
fibrillogenesis provides physiological-like FN fibrils upon simple adsorption on specific 
material chemistries, such as PEA. Small variations in this chemistry, would affect the 
conformation of the FN, as happens with PMA. FN was adsorbed on the different surfaces 
and quantified in terms of the adsorbed surface density, distribution and conformation. Initial 
cell adhesion and signalling on FN-coated was characterised via the formation of focal 
adhesions, integrin expression and phosphorylation of FAKs. Differences in the availability 
of FN adhesion domains after adsorption on the SAMs and acrylates, influence the initial 
cell-material interaction, in terms of integrin expression, focal adhesion formation and F-
actin cytoskeleton development. Afterwards, the reorganisation and secretion of FN was 
assessed. Finally, matrix degradation was followed via the expression of matrix 
metalloproteinases MMP2 and MMP9 and correlated with RunX2 levels. We show using 
SAMs that matrix degradation at the cell material interface depends on surface chemistry in 
MMP-dependent way. On PEA, we have shown that FN assembly results in protein 
 
105 
conformation and distribution at the material-interface that enhanced the availability of the 
integrin-binding sequence. Thus cell adhesion occurs primarily through the specific α5β1 
receptor occupancy, with enhanced focal adhesion formation and FAK signalling. 
Furthermore, we have shown that MMP activity is also enhanced on the material-driven FN 
fibrils, through a mechanism that is dependent on the ability of cells to reorganise the 
adjacent layer of proteins at the material interface.  
As a conclusion, not all the same-looking FN conformations can be considered the same. 
Both OH-SAMs and PMA adsorbed FN in a globular conformation and CH3-SAMs and PEA 
adsorbed FN forming a network. In this last case, on both surfaces there are FN networks 
but they promote different cell activity at the degradation level (MMPs).  
The reported findings improve our understanding of the role of surface chemistry as a key 
parameter in the design of new biomaterials. It demonstrates the ability of surface chemistry 
to direct proteolytic routes at the cell-material interface, which gains a distinct bioengineering 
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Here we report a simple, robust and translational material-based approach to enhance the 
activity of growth factors during tissue healing. The approach is based on the self-
organisation of fibronectin (FN) into nanonetworks at the material interface upon adsorption 
on poly(ethyl acrylate) (PEA) and afterwards, exploiting this protein network to capture and 
present growth factors (GFs) in combination with the integrin binding domain of fibronectin. 
 
Fibronectin is known to possess specific interactions with a variety of GFs, for example TGF-
1, HGF, connective tissue growth factor (CTGF), and platelet derived growth factor (PDGF)-
A, BMP-2 (Martino & Hubbell, 2010; Mooradian et al., 1989; Rahman et al., 2005; Smith et 
al., 2009; Xu et al., 2004). Moreover, it has been demonstrated, in vivo, that VEGF-A165 is 
released from platelets in complex with FN (Wijelath et al., 2002), and the presence of IGF-
I/IGF binding protein (IGFBP)-3/FN ternary complexes in human plasma has been detected 
by coimmunoprecipitation (Gui & Murphy, 2001), while IGFBP-3 and FN colocalize in human 
cartilage (Martin et al., 2002). More precisely, FGF-2 and VEGF-A165 have been shown to 
bind with high affinity to a domain consisting of the 12th to 14th type III repeats of FN (FN 
III12–14), also known as the FN heparin-binding domain II (Bossard et al., 2004; Errol S. 
Wijelath et al., 2006). More recently, BMP-2 has been also shown to bind to the FN12-14 




Tissue environments control stem cell differentiation in response to regenerative demands 
using ECM protein and GF cues. In tissues, the activity of GFs is regulated by their binding 
to ECM proteins (Dave et al., 2014). In vitro, highly engineered recombinant environments 
have been synthesised to demonstrate that cell signalling can be enhanced by the 
nanoscale colocalisation of integrins and GF receptors (Martino & Hubbell, 2010; Martino et 
al., 2011). A major hurdle to translation of these seminal in vitro observations to medical 
devices is that while in vivo tissues have evolved to present complex cues in concert, man-
made materials rely on complex engineering strategies to maximise GF activity (Martino et 
al., 2014; Martino et al., 2013). The spontaneous formation of synergistic environments 
would represent a significant advance in driving next-generation biomaterials development 
through amplification of differentiation cues presented to e.g. stem cells. As mentioned in 
the previous chapter, simple synthetic materials would also offer a major advantage in drug 
administration in terms of driving down cost and overcoming safety issues due to the current 
clinical use of therapeutic GFs at supraphysiological levels (Lo et al., 2012). For example, 
current clinical delivery of BMP-2 involves the incorporation of the GFs in a collagen sponge 
carrier at a concentration of 1.5 mg/ml to promote robust bone repair (Woo, 2012). However, 
serious respiratory, neurological, and inflammatory complications have been reported that 
eventually led the FDA in the USA to issue a Public Health Notification of life threatening 
complications associated with this therapeutic gold standard for bone repair (Silver Spring, 
2010). The lack of an effective way to safely deliver GFs has thus limited their large potential 
clinical impact. 
There have been some approaches to control the delivery (localising and limiting release) 
of GFs, including BMP-2, used in combination with biomaterial carriers with some successes 
in restoring tissue function and controlling stem cell differentiation (Lutolf & Hubbell, 2005; 
Vo et al., 2012; Wylie et al., 2011). It has been mentioned previously in this dissertation that 
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previous work shows that cell signalling can be synergistically enhanced by the formation of 
clusters between integrins and GF receptors (Comoglio et al., 2003). This concept was used 
to promote significant bone repair and wound healing via the incorporation of recombinant 
FN fragments (FN III9-10 and FN III12-14) within a fibrin matrix (Martino et al., 2011). The 
adequate presentation of GFs bound to the ECM is so crucial that a new generation of GFs 
has been engineered with super-binding affinity for a variety of ECM proteins (M. M. Martino 
et al., 2014). Here it will be used the formerly introduced material-driven FN fibrillogenesis 
to present very low amount of BMP-2 in combination with the integrin binding domain of FN 
for the first time, in a simple, robust and translational material-based approach. This 
approach makes use of the whole FN molecule and its natural ability to assemble into 
interconnected networks of ECM fibrils (Frueh et al., 2015). This strategy is based on the 
ability of certain materials to drive the self-organisation of FN into (nano)networks upon 
simple adsorption from a solution and, subsequently, exploiting this nanofibrillar matrix to 
capture and present efficiently GFs, i.g. using very low amounts of GFs (Figure 8) 
(Salmeron-Sanchez et al., 2011). 
 
 






Samples were prepared as explained in the Materials and Methods section found in the 
Chapter 5. 
 
Atomic Force Microscopy 
 
AFM experiments were performed according the procedure found in the Materials and 




For AFM studies, fibronectin was adsorbed from solutions of 3 µg/ml in DPBS. To observe 
the sole growth factor on the surface, 100 ng/ml was used as the concentration of BMP-2. 




FN from human plasma (Sigma) was adsorbed from solutions of 20 µg/ml for 1 hour at room 
temperature (RT) and blocked in 1% bovine serum albumin (BSA) (Sigma)/Dulbecco’s 
phosphate-buffered saline (DPBS) for 30 min at RT. 
 
FN III12-14 ELISA (FN conformation, cell binding domain) 
 
A monoclonal antibody for the FNIII12–14 domain (also known as heparin II domain) was 
used (Santa Cruz Biotechnology, sc-18827; 1:30, 2 hours at 37°C) on FN-coated samples. 
The samples were afterwards washed three times with DPBS/0.5% Tween 20. An anti-
mouse IgG horseradish peroxidase–conjugated antibody (Invitrogen, 626520; 1:2000, 1 
hour at RT) was then used. After the samples were washed twice, they were exposed to the 
substrate solution (R&D Systems, DY999) and incubated for 20 min at RT in the dark. A 






For GF adsorption, BMP-2 (25 ng/ml; R&D Systems, 355-BM or 355-BM/CF for AFM 






For synergy-blocking assays, FNIII12–14 domains were blocked before BMP-2 coating 
using the monoclonal P5F3 antibody against this specific region (Santa Cruz Biotechnology, 
sc-18827; 15 mg/ml) at a molar ratio with 1 with FN. 
 
BMP-2 immunogold staining 
 
To be able to detect specific proteins under tapping mode using AFM and specifically, 
localise the growth factor after the fibronectin adsorption, an immunogold assay was 
developed (Figure 21). See Materials and methods section for more information. 
 
BMP-2 adsorption quantification 
 
The amount of non-adsorbed GF that remained in the supernatant (on both bare or FN-
coated surfaces) was measured via a sandwich ELISA (R&D Systems, DY355) following 
the kit manufacturer’s instructions. The standard curve was calculated using a 4 parameter 
logistic curve fit (Prism). To study the stability of the BMP-2 adsorbed, using the same 
ELISA, the release of the GF was measured at 10 different time points (2 hours and 1, 2, 3, 
4, 5, 6, 7, 11, and 14 days). 
 
 
Human mesenchymal stem cell culture 
 
 
Human bone marrow MSCs were bought from PromoCell and maintained in basal medium 
[α-minimum essential medium, 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, 
1% fungizone, 2 mM L-glutamine, FGF-2 (1 ng/ml)] at 37°C with 5% CO2. Using a 104/cm2 
cell density, the cells were seeded onto the materials using a seeding medium (high-glucose 
Dulbecco’s modified Eagle’s medium, 1% penicillin/streptomycin, 1% FBS). The medium 
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was changed twice a week. For all cultures, the first 2 hours (early cell adhesion) were in 
the serum-free and GF-free media. When the cells had GF, the concentration used was 25 
ng/ml. Cells were used at passages P0 to P3. Each experiment was performed in triplicate. 
 
Integrin β1 and BMPRIa coimmunoprecipitation 
 
After 45 min of cell culture, cell lysates [radioimmunoprecipitation assay (RIPA) buffer] were 
used to perform immunoprecipitation of integrin β1 and the BMP-2 receptor BMPRIa, as 
described in Materials and Methods. Protein expression was quantified by image analysis 
using ImageJ. 
 
ERK 1/2 phosphorylation 
 
ERK 1/2 phosphorylation was quantified using phospho-ELISA kits. Briefly, ELISA plates 
were coated with a capture antibody for ERK 1/2. Cell lysates were taken after 45 min and 
incubated with the coated plates. Phosphorylated ERK 1/2 proteins were detected with an 
anti-phosphotyrosine capture antibody. The results were normalised to a standard according 




Cell lysates (RIPA buffer) were used after culture for 45 min. Proteins (10 µg) were collected 
per sample. Western blot assays were run in denaturalising conditions for Smad 1, Smad 
1/5, and GAPDH. NuPAGE 4-12% bis-tris gels were purchased from Life Technologies. 
pSmad antibodies (pSmad 1 and pSmad 1/5) were obtained from Cell Signalling Technology 
(12656; 1:1000). As a secondary antibody, antirabbit IgG antibody (Cell Signalling 
Technology, 7074; 1:2000) was used. A substrate for sensitive immunodetection system 
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(Life Technologies, Novex) was used before the blot was exposed to x-ray film. Protein 
expression was quantified by image analysis using ImageJ. 
 
Immunofluorescence staining (OCN and ON) 
 
After 14 days of culture, cells were washed in DPBS and fixed with 4% formaldehyde in 
DPBS at 37°C for 15 min. Afterward, the samples were stained using the protocol described 
in Materials and methods for osteocalcin (Santa Cruz Biotechnology, sc-73464; 1:50) or 
osteonectin (Santa Cruz Biotechnology, sc-10758; 1:50). 
 
Quantitative real-time PCR (OCN, ON, GAPDH) 
 
For the quantitative real time PCR, hMSCs were cultured on materials for 14 days. 
Following, the same protocol as explained in Materials and methods was used. For short: 
cells were lysed and total RNA extracted using a Qiagen RNeasy micro kit. Real-time qPCR 
was carried out and analysed to assess the expression of osteocalcin, osteonectin, and 
GAPDH (used as a house-keeping gene) using SYBR reagents. 
 
 
Alkaline phosphatase staining 
 
For the alkaline phosphatase assay (ALP), the cells were cultured on materials for 28 days. 
The inhibitor noggin (50 ng/ml) was added in a set of samples, and phosphate deposition 
was analysed by an alkaline phosphatase assay (Sigma, 86C-1KT). Cells were fixed with 
the fixative solution (citrate-acetone-formaldehyde solution) at RT for 30 s. Next, the 
samples were incubated with the alkaline dye mixture (15 min at RT in dark). Afterwards, 









Fibronectin and BMP-2 adsorption in the FN/BMP-2 microenvironments 
 
 
In all the work in this chapter, PMA is used as a reference polymer on which FN is adsorbed 
and maintains a globular conformation (Figure 8). As mentioned in the previous chapter, 
PMA behaves similarly to PEA in terms of surface wettability, stiffness and total surface 
density of adsorbed FN. First assay was a FN III12-14 ELISA to quantify how exposed the 
domain was, as we hypothesised that the FN conformation acquired on PEA promotes the 
exposure of the GF binding domain (in addition to the cell binding domain previously 
demonstrated, Figure 9). Figure 19 shows that FN was adsorbed on PEA in a conformation 
that favours the simultaneous availability of the GF binding domain (FN III12-14) next to the 
integrin binding region (FN III9-10) (Figure 9, 19) (Gugutkov et al., 2009). Next, the adoption 
of recombinant human BMP-2 was studied. Total surface density of BMP-2 on these two 
FN-coated surfaces was quantified by ELISA. The total amount adsorbed using a 25 ng/ml 
original solution was similar for PEA and PMA (Figure 19). To study the stability of this BMP-
2 coating, a release assay after 14 days was performed. BMP-2 remained stably adsorbed 






Figure 19 GF binding domain availability, BMP-2 adsorption and release on PEA and PMA. a Heparin II 
domain ELISA (also called FN III12-14 domain or GF binding domain). FN organised into fibrils on PEA 
displays higher availability of the GF binding region than FN adsorbed on PMA in a globular conformation. b 
BMP-2 adsorption quantified by ELISA. Similar surface density of BMP-2 on FN-coated PEA and PMA occurs 
regardless of the organisation and conformation of FN on both surfaces. c Cumulative release of BMP-2 over 
14 days as determined by ELISA. d Skecth of FN adsorption on PEA. After FN material-driven fibrillogenesis 
on PEA, FNIII9-10 and FN12-14 are exposed and available. Error bars are represented by the standard 
deviation of three different experiments. * conditions with a significant difference. (P ≤ 0.05) (Llopis-Hernandez 
et al., 2016) 
 
 
To study how and where the BMP-2 was adsorbed on the acrylates, AFM pictures were 
taken on PEA and PMA. In Figure 20 it can be observed that BMP-2 molecules directly 
adsorbed on PEA and PMA (without FN), shown as individual globules. BMP-2 dimer 
molecule stimated size is around 70 nm x  35 nm x 30 nm (Scheufler et al., 1999). BMP-2 
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molecules were adsorbed isolated on PMA (8.4 nm BMP-2 particles), while on PEA 
aggregates of BMP-2 were found (17.9 nm). The sequential adsorption of FN and BMP-2 
was also studied under AFM. Figure 20b shows that upon adsorption on FN-coated material 
surfaces, BMP-2 was sequestered by the nanonetwork of FN fibrils assembled on PEA but 
not by globular FN adsorbed on PMA. AFM images show that BMP-2 was preferentially 
adsorbed on top of FN molecules on PEA, whereas no evidence of any direct interactions 
between FN and BMP-2 occurred on PMA; on PMA the GF was preferentially adsorbed on 
the polymer surface (Figure 20b). Figure 20b also shows molecular scale AFM images of 
individual BMP-2 molecules sequestered on top of FN dimers previously adsorbed on PEA 
















Figure 20 BMP-2 and FN adsorption using AFM a AFM images of BMP-2 adsorbed from a 100 ng/ml BMP-
2 solution after 1 hour. Magnified areas are images after a particle analysis, blue areas correspond to the 
BMP-2 (size of particles indicated in blue) b AFM images at different magnifications after the sequential 
adsorption of FN (3 μg/ml) and BMP-2 (25 ng/ml) on PEA and PMA. (Llopis-Hernandez et al., 2016) 
 
To confirm that these globular molecules that were interacting with the FN on PEA were 
BMP-2 molecules, it was implemented an immunogold technique adapted for AFM. The 
identification of BMP-2 molecules was then assessed using first an anti-BMP-2 antibody and 
then a gold-labeled secondary antibody that allows the unequivocal identification of these 
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gold nanoparticles in AFM images (Figure 21). The secondary antibody had bound a 
nanogold particle of 15 nm. The FN concentration used for this assay was smaller (3 µg/ml) 
than the standard where a fully connected network is formed (20 µg/ml), allowing the 
visualisation of individual FN molecules. The isolated FN molecules were simultaneously 
observed on PEA by using the phase magnitude in AFM (as described for direct observation 
of proteins on material surfaces) (Rodríguez Hernández et al., 2007), with gold nanoparticles 
depicted using the height magnitude. In the Figure 21, is shown a high resolution AFM image 
of one of these FN molecules in an extended conformation adsorbed on PEA with one gold 
nanoparticle per FN arm. The cross-section shows a height profile of ~ 7 nm that is 



















Figure 21 AFM images of BMP-2 interacting with FN molecules on PEA. A secondary antibody bound to 
a 15 nm gold nanoparticle was used to univocally identify BMP-2 on the material surface. (Llopis-Hernandez 
et al., 2016) 
 
Human MSCs signaling in the FN/BMP-2 microenvironments 
 
 
After having verified that FN nanonetworks assembled on PEA sequestered and retained 
BMP-2, we test if these microenvironments allowed co-ligation of integrins and BMP-2 
receptors to modulate signalling and direct mesenchymal stem cell (MSC) differentiation 
more efficiently (i.e., with lower BMP-2 doses) compared to the presence of soluble BMP-2. 
A coimmunoprecipitation experiment of integrin β1 and BMP-2 main receptor (BMPRIA) 
shows that clusters of β1 integrins and BMP-2 receptors were formed when BMP-2 was 
presented via the FN network assembled on PEA (Figure 22). One condition was blocking 
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using a monoclonal antibody (P5F3, against FNIII12-14) the GF-binding domain before 
BMP-2 adsorption. These integrin-GF receptor clusters were much less defined on either 
FN nanonetworks assembled on PEA without any BMP-2 or if the GF binding site of FN (FN 
III12-14) had been previously blocked (Figure 22) (note that coimmunoprecipitation on 12 
mm diameter coverslips deals with vanishingly small amounts of protein and so the blot had 
to be overexposed).  
 
 
Figure 22 Coimmunoprecipitation of integrin β1 and BMP-2 receptor I. Western blot images and 
quantification of the bands. The monoclonal antibody P5F3 was used to block the GF binding domain of FN 
before BMP-2 adsorption. The sample without BMP-2 was used as a control in the quantification. Error bars 
are represented by the standard deviation of three different experiments. ¥ conditions with a significant 
difference (P < 0.01) (Llopis-Hernandez et al., 2016) 
 
 
This colocalization of integrin and GF receptors could also be seen at an individual cell level 
using immunofluorescence (Figure 39, Appendix). It was shown that colocalization is 




The formation of these BMP-2 receptor/integrin clusters had clear effects in subsequent cell 
signalling. First, integrin regulated signalling through the phosphorylation of the mitogen 
activated protein kinase ERK1/2 was higher for MSCs that bind BMP-2 sequestered on FN 
fibrils compared to standard delivery of BMP-2 as a soluble factor in the culture medium 
(Figure 23). This suggests that non-canonical BMP signalling (BMP signalling through 
mitogen activated protein kinases) (Fu et al., 2008; Greenblatt et al., 2010) was enhanced 
by the presence of immobilised BMP-2 at the material interface, but that synergistic 
presentation conferred no advantage.  
Figure 23 Phosphorylation of ERK1/2 on PEA with adsorbed or soluble BMP-2 presentation. 
Phosphorylation was measured by ELISA and total ERK after 45 minutes of cell culture. Error bars are 
represented by the standard deviation of three experiments. * conditions with a significant difference. (P ≤ 
0.05) (Llopis-Hernandez et al., 2016) 
 
However, as well as initiating non-canonical BMP signalling, e.g. ERK, BMP-2 can also 
initiate canonical signalling through Smads (small mothers against decapentaplegic) 1/5/8 
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that are phosphorylated by BMP-2 type I receptor (BMPR1) and then translocate into the 
nucleus to activate RunX2 (runt related transcription factor 2), the osteogenic master 
transcription factor (Kimelman-Bleich et al., 2011; Phimphilai et al., 2006). At the transcript 
level, Smad 1 and 5 were not affected by BMP-2 in absorbed or soluble format (Figure 24) 
and this observation concurs with previous reports ( Martino et al., 2011).  
 
 
Figure 24 Transcriptional expression of Smad 1 and 5 of hMSCs on FN/BMP-2 microenvironments. 
qPCR for Smad 1 and 5 after 5 days of hMSCs culture. GAPDH gene expression was used as a control. 
Values relative to PEA without BMP-2. Error bars are represented by the standard deviation of three 
experiments. (Llopis-Hernandez et al., 2016) 
 
However, Figure 25 shows that Smad 1 phosphorylation was significantly increased when 
BMP-2 is presented after binding to FN assembled on PEA, i.e. in synergistic conformation. 
Phosphorylation of Smads 1/5 was also significantly higher in MSCs on BMP-2 sequestered 
on FN (Figure 25). Blocking the GF binding region of FN (FN III12-14) with the P5F3 antibody 
and adding BMP-2 in the medium reverse pSmad-1 and pSmad1/5 phosphorylation to 
control levels, confirming that enhanced Smad signaling is due to BMP-2 bound to the 
integrin binding region of FN. These results support that enhanced canonical BMP-2 
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signalling is a consequence of the simultaneous occupancy of integrins and BMP-2 
receptors (Figure 26) (Kimelman-Bleich et al., 2011; Phimphilai et al., 2006). 
 
Figure 25 Phosphorilation of Smad 1 and Smad 1/5 on the FN/BMP-2 microenvironments. Wester blot  
was used to detect absolute phosphorylation levels and quantification of the bands after 45 minutes of cell 
culture. GAPDH was used as a control. Error bars are represented by the standard deviation of three 














Figure 26 Hypothesis of the cell signalling on the FN microenvironments created with BMP-2 on PEA. 
Sketch showing the first part of the synergistic signaling. Canonical (Smad) and non-canonical (ERK1/2) 
signalling was studied. An antibody (P5F3) against the FN III12-14 domain was used to block the FN domain 
and prevent the binding of BMP-2. When the antibody was used, the canonical signalling was reduced. P 
indicates phosphorylation. (Llopis-Hernandez et al., 2016) 
 
Human MSC differentiation in the FN/BMP-2 microenvironments 
 
Figure 27a shows qPCR results for osteogenic markers and the corresponding 
immunofluorescence images after 14 days of bone marrow-derived MSC culture. 
Significantly higher osteocalcin and osteonectin expression was found both at the 
transcription and protein levels (Figure 27) when BMP-2 was adsorbed on FN nanonetworks 
on PEA and hence presented synergistically. Importantly, this system was significantly more 
effective than the soluble administration of the GF (BMP-2 medium, Figure 27a). Also, when 
the same experiments were done using PMA (where FN is adsorbed in a globular 
conformation and no GF binding occurred on FN), the level of cell differentiation was the 
same regardless the route used to present the GF (Figure 27). These results suggest that 
the presentation of BMP-2 in synergy with adhesion sites on FN on PEA is more effective to 
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trigger MSC differentiation compared to both the same concentration of the GF on PMA and 
the soluble administration of the GF.  
 
 
Figure 27 Transcriptional and protein expression of OCN and ON on FN/BMP-2 microenvironments. a 
qPCR for osteocalcin and osteonectin after 14 days of hMSCs culture. GAPDH gene expression was used as 
a control. b Immunofluorescence for osteocalcin and osteonectin after 14 days of hMSCs culture (red: 
osteocalcin/osteonectin, blue: DAPI). Error bars are represented by the standard deviation of three 
experiments. * conditions with a significant difference. (P ≤ 0.05) (Llopis-Hernandez et al., 2016) 
 
Figure 28 includes the measurement of alkaline phosphatase activity (ALP) that was higher 
when BMP-2 was presented bound on FN on PEA compared to the soluble administration. 
It includes also the blocking of BMP-2 with noggin, in both soluble and bound on FN on PEA. 
 
126 
Noggin is an extracellular antagonist of BMP-2 that can bind to it with high affinity and can 
abolish BMPs activity by blocking binding to cognate cell-surface receptors (C.J. Wu & Lu, 
2008; Zimmerman et al., 1996). It is noteworthy that only when BMP-2 was bound on PEA, 
a significant reduction in ALP activity was found, which confirms the enhanced activity of 
BMP-2 presented in synergy with integrin receptors on PEA. 
 
Figure 28 Alkaline phosphatase (ALP) staining and quantification on the FN/BMP-2 
microenvironments. Stained areas were quantified on PEA comparing BMP-2 bound to FN fibrils versus 
soluble BMP-2. Noggin (50 ng/ml) was used in both conditions as the BMP-2 inhibitor to prevent activity (image 
quantification included in the graph). Error bars are represented by the standard deviation of multiple areas 
quantified in three different experiments. * conditions with a significant difference. (P ≤ 0.05) Scale bar 50 µm. 





In vivo, the synergistic presentation of structural and signalling proteins is key to MSCs 
regulation in the niche to control cell growth and differentiation in response to tissue 
regenerative demand with discrete areas of the niche having specific roles. It was evaluated 
the potential of the synergistic presentation of GF in vivo using a murine non-healing radial 
bone defect model. Results of the μCT, including quantification of bone volume show that 
only when FN and BMP-2 had been pre-adsorbed on PEA did the defect repair and the gap 
was bridged. The effect can only be ascribed to the simultaneous presence of FN and BMP-
2, which promoted enhanced activity of the GF (See Annex for more details). 
 
 
First, it has been demonstrated that MSC differentiation can be driven with very low doses 
of BMP-2 adsorbed on FN nanonetworks on PEA and that this happens much more 
efficiently than the standard soluble administration of the growth factor (Figure 27). There 
are other strategies to present GF from a material surface, including protein engineering 
techniques and the use of LbL (layer-by-layer) technologies (J. M. Silva et al., 2016). 
However, these technologies typically ignore the interaction of the GF with the receptor. The 
concept of synergistic integrin/GF signalling has been known in biology for some time 
(Martino & Hubbell, 2010) and a first system was engineered that included a recombinant 
fragment of FN covalently linked to a fribrin matrix (Martino & Hubbell, 2010; Martino et al., 
2011). These findings show that we can use the whole FN molecule (e.g. isolated from a 
patient) and a simple polymer to promote highly efficient presentation of GFs. Beyond the 
scientific novelty of the system, this has huge translational potential first as this allows to 
engineer a large number of 2D and 3D scaffolds based on this system, but more importantly 
because the standard dose of GF used in existing clinical applications can be reduced up 
to 500 times. At the moment, the use of GF has been only partially successful and even 
controversial. Poor clinical translation is due to the rapid breakdown and clearance of GF 
from tissue sites in vivo. Strategies to improve GF retention within the healing site have 
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included use of collagen sponges with high doses of GF, with catastrophic collateral risks, 
including FDA warning regarding increased cancer risk (Silver Spring, 2010; Woo, 2012). 
This novel concept has the potential to overcome these difficulties as here very low doses 
of GF are used which moreover remain stably bound on the systems (Figure 19), i.e. 
effective presentation of low doses of GF  is promoted rather than delivered. We have shown 
that the overall concept works in vivo. We have demonstrated, for the first time, a surface-
induced regeneration of bone (volume) in a critical size defect. An empty polyimide sleeve 
coated with PEA, FN and BMP-2 (15 ng) was able to promote bone growth and bridge a 2.5 






Over the last decade, there has been major focus on materials chemistry, stiffness and 
nanoscale topography and how these parameters control MSC fate (Tsapikouni & Missirlis, 
2007). In vivo, the synergistic presentation of structural and signalling proteins is key to MSC 
regulation in the niche to control cell growth and differentiation in response to tissue 
regenerative demand with discrete areas of the niche having specific roles (Amaral et al., 
2005; Bae et al., 2006; Baneyx & Vogel, 1999; Gumbiner, 1996). Furthermore, the critical 
importance of protein conformation has been shown in vitro (Baugh & Vogel, 2004; Baujard-
Lamotte et al., 2008; Bergkvist et al., 2003). Until now, however, a simple engineered system 
that allows reliable control of this interface, and synergistic integrin/GF signalling within the 
interface, has been elusive. The approach promoted here is facile, in that the surface can 
be spin coated onto planar substrates or deposited onto more complex 3D geometries, such 
as the cylinder used in this work, but also on 3D scaffolds and electrospun membranes 
(Gugutkov et al., 2009). It is a material-based system that does not require either complex 
protein engineering or surface chemistry. Instead it takes advantage of the ability of certain 
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synthetic polymers (PEA and the acrylate family) to spontaneously organise adsorbed FN 
in a conformation that allows GF to bind and be presented in a cell-exploitable manner. 
This approach unlocks the potential for artificial synergistic signalling using chemistries 
(PEA) that can be applied to large areas of complex (2D and 3D) biomaterial scaffolds. We 
examined the effects of these microenvironments using BMP-2 and human MSCs in vitro. 
This simple approach directs growth factor binding on fibronectin and synergistically drives 
integrin–growth factor receptor signalling to direct stem cell differentiation. In vivo, we 
achieved the (acellular) surface-induced regeneration of a critical size bone defect using 









Chapter 6. Engineered cellular 
microenvironments to direct 
stem cell fate II. Growth factor 






























*Part of the results presented in this chapter were obtained during an internship at the Center 
for Cell Engineering, Institute of Molecular Cell and Systems Biology, University of Glasgow, 
(UK) under the supervision of Prof. Matthew Dalby.  
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Engineered cellular microenvironments to 
direct stem cell fate II. Growth factor 







ECM plays an important function in morphogenesis. Tissue repair needs the presentation of 
GFs since it can control processes of cell proliferation, differentiation, migration and 
morphogenesis. GFs interactions with the ECM modulate their release from the ECM to the 
soluble phase. The ECM serves as a reservoir of GFs to instruct cell decision processes 
controlling their local concentration, signalling, diffusion, and dissipation. GFs bind ECM 
components, such as heparan sulfate proteoglycans and FN (Lindahl & Li, 2009). On the 
other hand, GFs bind to cell-surface receptors and trigger signalling either in solution or 
matrix bound (Makarenkova et al., 2009). The role of GFs in tissue repair is broadly 
recognised, but on the other hand the way to deliver GFs to enhance tissue healing and 
maintaining their activity, has led to poor clinical impact. A wide range of strategies have 
been employed for the controlled delivery of GFs: direct loading, electrostatic interaction, 
covalent binding, and the use of carriers, incorporation of protease-degradable sites, 
adhesive ligands to direct GFs release (Hahn et al., 2006; Lutolf & Hubbell, 2005; 
Makarenkova et al., 2009; Moon et al., 2009; Silva et al., 2009). 
 
Engineering cellular environments to promote tissue healing involves the design of complex 
systems that combine materials, ECM proteins and GFs. However, even if the importance 
of each component is acknowledged in tissue repair, the role of their interactions to provide 
control over cell behaviour is usually ignored. Tremendous knowledge has emerged on the 
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roles of GFs in tissue repair, but the progress in translating this knowledge into clinical 
impact has been more limited (Axelrad & Einhorn, 2009; Falanga, 2005; Fonder et al., 2008; 
Garrison et al., 2007; Gautschi et al., 2007). The rapid breakdown and clearance of GFs 
from tissue sites in vivo could be one of the reasons for this poor clinical translation. The 
natural interactions existing between GF and the ECM have inspired biomolecular 
engineering approaches (Macri et al., 2007; Schultz & Wysocki, 2009). In the case of FN, 
the 12th–14th type three repeats of FN (FN III12–14) have been shown to bind IGF binding-
protein-3, FGF-2, VEGF-A and BMP-2 with high affinity. In addition to GF sequestration, 
ECM-GFs interactions also directly modulate GFs signalling through co-association of 
integrins with GF receptors. In this context, complexes between ECM proteins and GFs can 
mediate enhanced GF receptor–integrin signalling by the formation of clusters between GF 
receptors and integrins (Comoglio et al., 2003; Giancotti & Tarone, 2003; Guo & Giancotti, 
2004). This has been shown for α5β1 integrin and the GF receptors when FN III9-10 and FN 
III12-14 are proximally presented in the same polypeptide chain (Guo & Giancotti, 2004; 
Martino & Hubbell, 2010).  
 
 
The application of recombinant human BMP-2 and BMP-7 has been intensively studied for 
the treatment of different diseases, e.g. osteoporotic bone (Lee et al., 2009). However, a 
large amount of BMPs is required for successful outcomes and BMP-containing devices fail 
in a certain percentage of cases (14.9% in multilevel fusions), raising concerns over costs 
and safety (Bridwell et al., 2004; Geesink et al., 1999; Lieberman et al., 2002). The reasons 
for this may be related to the absence of controlled and sustained BMPs delivery, its short 
biological half-life, and the inability of its presentation to mimic the biological condition 
(Franceschi et al., 2000). Through the combination of known osteogenic signalling pathways 
(BMPs, Hh, RunX2, Wnt, and IGF-1) and screening cDNA libraries, BMPs signalling and 
RunX2 have previously been identified as a potent combination for osteogenic differentiation 




In this chapter, it will be used of the ability of the acrylate material surface (PEA) to direct 
the physiological organisation of FN into fibrillar networks in absence of cells, the material-
driven fibronectin fibrillogenesis (Brizuela Guerra et al., 2010; Salmeron-Sanchez et al., 
2011). This surface triggers the organisation of FN upon simple adsorption from solutions 
and provide a functional biomimetic interface that is efficiently recognised by cells. The 
underlying mechanism is similar to the one explained in the previous chapter (5), were FN 
and BMP-2 were adsorbed on PEA sequentially. In this chapter FN and BMP-2 are 
coadsorbed on PEA. Its hypothesized that the formation of the network in the presence of 
BMP-2 will mimic BMP-2 as in its biological condition, existing a synergistic interaction with 
the integrin receptors. As a consequence, osteogenic differentiation of MSCs can be 
achieved with lower amounts of this GF.  
 
 






Spin casting of PEA thin films was performed on 12 mm and 25 mm (protein and gene 
expression only) glass coverslips at 2000 rpm for 30 s. Samplers were dried in vacuo at 60 
ºC before their use. See general Materials and methods for more details. 
 
Atomic Force Microscopy 
 
AFM experiments were performed according the procedure found in the Materials and 







FN from human plasma (Sigma) was adsorbed from solutions of 20 μg/ml concentration in 
PBS with or without BMP-2. In AFM studies, FN was adsorbed as well from solutions of 3 
μg/ml concentration in PBS Human recombinant BMP-2 (Sigma B3555) was adsorbed from 
solutions of 25 ng/ml concentration in PBS with or without FN. After adsorption, samples 




After BMP-2 adsorption or FN+BMP-2 adsorption on the samples, the concentration of BMP-
2 was quantified in the supernatant with sandwich ELISA (DY55 R&D) following kit 
instructions. Reaction products were measured using an absorbance plate reader (Victor III, 
PerkinElmer) at 450 nm. The standard curve was calculated using a computer generated 4 
parameter logistic curve-fit (Prism) and BMP-2 adsorbed was calculated. 
 
Human mesenchymal stem cells 
 
MSCs were selected from an osteoprogenitor population using a STRO-1 antibody and 
magnetic activated cell sorting as previously described (Yang et al., 2011). MSCs were 
maintained in basal media (10% FBS/aMEM) (PAA, UK) at 37oC with 5% CO2 in humid 
conditions. Sample disks placed in a 24-well or 6-well tissue culture plate (depending of 
sample size) were coated with a solution of FN 20 µg/ml (2 sets of samples, one without 
BMP-2 presence and one with BMP-2 soluble) or with a solution of FN 20 µg/ml + BMP-2 
25 ng/ml in PBS. Negative controls without coating were also used. Then, cells were seeded 
onto the materials at 5 x 103 cells/cm2 and the media changed twice a week. One set of 
sample (with FN and without BMP-2 on the coating) was seeded after the two first hours in 
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the presence of soluble BMP-2  in the medium at the same concentration as in the other 
samples with BMP-2 on the coating (25 ng/ml). Cells were used at passages P0-P1 
throughout. Sample disks previously sterilised in UV and placed in a multiwell tissue culture 
plate were coated with the corresponding  FN and BMP-2 coating (1 h at room temperature). 
Then, 1x104 cells were placed onto each substrate and the experiments were carried out in 




After 14 d of culture, MSCs were washed in PBS and fixed with 4% formaldehyde (Fisher) 
with 2% sucrose in PBS, at 37ºC for 15 minutes. Afterwards, the samples were process as 
explained in Materials and methods section in this thesis. A Zeiss Axiovert 200 M 
fluorescence microscope was used for imaging. 
 
Quantitative real time PCR (RUNX2, OCN, OP, ON) 
 
For the quantitative real time PCR, MSCs were cultured on materials for 14 days. Then, 
cells were lysed and total RNA extracted using a Qiagen RNeasy micro kit (DNase treatment 
included) and the quantity and integrity of the RNA measured with NanoDrop 
(ThermoScientific). Real-time qPCR was carried out and analysed using SYBR to assess 
the expression of OCN, ON, OSP and GAPDH. For RUNX2, taqman quantitative real time 
PCR was done. GAPDH was used as an endogenous control, with expression of all the RNA 







Results and Discussion 
 
 




The molecular distribution of FN coadsorbed with BMP-2 from the same solution was studied 
for the two acrylates, PEA and PMA (and the control glass) using atomic force microscopy 
(AFM). Figure 29 shows protein organisation at the material interface after different 
adsorption times and FN concentrations in the solution. To investigate this phenomenon at 
a molecular level, we have included diluted FN solutions (3 µg/ml) in addition to the standard 
FN concentration used in the cell culture experiments (20 µg/ml).  BMP-2 concentration was 
always kept the same (25 ng/ml) in the FN+BMP-2 coating solution. In the second row the 
adsorption of FN in the presence of the growth factor BMP-2 can be followed. To have 
isolated FN molecules, we performed the FN adsorption from a 3 µg/ml solution on the 
different biomaterials for 10 minutes. Upon FN adsorption on PEA, we can observe that FN 
molecules start to form a network (Figure 29). When the FN adsorption is performed in 
presence of BMP-2, there are more individual FN molecules and there is a loss of network 
connection. As previously described in this thesis, FN adsorption on PEA leads to the 
organisation into protein networks even for this low concentration of the solution, while when 
FN (20 µg/ml) is coadsorbed with BMP-2 (25 ng/ml) there are more isolated FN molecules 
on the material surface, which overall results in a loss of connection of the protein network. 
In the case of PMA, after FN adsorption it can be observed isolated aggregates of FN, but 
when the adsorption is performed in the presence of BMP-2, the formation of these 
aggregates diminishes. In addition, protein adsorption using the standard coating conditions 
used afterwards during cell culture experiments (20 μg/ml and 1 hour) followed the same 
trend: a lower FN density and a less interconnected protein network is assembled on the 
material surface (PEA) when BMP-2 is present in the solution. A similar effect is found on 
PMA as well: the presence of the GF in the adsorbing solution inhibits the formation of the 
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Figure 29 Atomic force microscopy images of FN and BMP-2 coadsorbed on PEA and PMA. Two 
different concentration of FN were used (3 and 20 µg/ml). The images shown are the phase signal and, 
the area scanned correspond to 1 µm. 
 
The FN domain able to bind GFs is the FN III12–14 (M. M. Martino & J. A. Hubbell, 2010). 
This domain is also implicated in network formation (Gugutkov et al., 2009; Mao & 
Schwarzbauer, 2005; M. Salmeron-Sanchez et al., 2011). Fibrils formed through FN–FN 
interactions by the alignment of FN molecules within fibrils might vary depending on which 
domains interact, such as I1–5 binding to III1–2 versus with III12 – 14 (Mao & Schwarzbauer, 
2005). So, it is important to remark here on the double role of FN III12-14 domains, that 
while in this case it is responsible for BMP-2 binding to FN, it is also involved in FN-FN 
interactions during fibril formation (fibrillogenesis). Due to these FN interactions when the 
network is formed, one hypothesis following the AFM results, is that BMP-2 gets buried and 
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arrests the normal FN fibrillogenesis that is happening on PEA in the absence of BMP-2, i.e. 
interferes with the network formation since during the coadsorption BMP-2 binds FN III12–
14 and leave less free domains to lead FN-FN interactions (Figure 30). We suggest that FN-
GF interactions as the adsorption process occurs are involved in this change of molecular 
distribution of FN at the material interface. The AFM results suggest that the presence of 
BMP-2 is preventing the formation of the FN network on PEA because during the 
coadsorption process, FN changes the conformation from the globular state in solution to 
the extended one (opening arms) on PEA. As a consequence, FN III12-14 is then available 
to bind BMP-2 due to the conformational rearrangement induced by the material surface, 
which at the same time diminishes the number of FN III12–14 domains available for the self-




Figure 30 Sketch of BMP-2/FN coadsorption on PEA and PMA. On PEA, BMP-2 gets burried and arrests 
the normal FN fibrillogenesis that is happening on PEA in the absence of BMP-2. On PMA the BMP-2 gets to 
be outside the FN aggregates, as this surface doesn't trigger the opening of the FN and the BMP -2 is not able 




In order to study the BMP-2 adsorption on the different materials in the presence or absence 
of FN, it was quantified the BMP-2 remaining in the supernatants after adsorption. This was 
followed with a sandwich ELISA on the two acrylates (PEA and PMA) and glass as a control. 
Results in percentage of BMP-2 adsorbed are shown in the Figure 31. In all the conditions, 
differences can be found between the BMP-2 adsorbed on the acrylates and BMP-2 
adsorbed on glass. However, the levels of BMP-2 adsorbed were higher when the 
adsorption was done on the acrylates, nevertheless, no differences were founded between 
PEA and PMA. When the adsorption is compared between only BMP-2 or BMP-2 in the 
presence of FN, there were no differences either.  
 
 
Figure 31 BMP-2 surface densities on the different surfaces PEA, PMA and glass. A 25 ng/ml BMP-2 
solution was used to perform the adsorption of the growth factor alone (BMP-2) or coadsorbed with FN (20 
µg/ml, FN+BMP-2). Error bars are represented by the standard deviation of three experiments. * conditions 
with a significant difference. (P ≤ 0.05) 
 
 
Almost all the BMP-2 contained in the solution is adsorbed on the material surfaces, with no 
significant difference between PEA and PMA, regardless how the adsorption is performed 
together with FN. This result suggests that the presence of FN in the adsorbing solution 
does not prevent BMP-2 to reach the material interface. Taking into account that BMP-2 is 
then in fact available at the material interface, the relative distribution of FN and BMP-2 
throughout the surface will determine the availability of BMP-2 for GF receptor activation as 
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well as the possibility of activating the so-called synergistic signalling between integrins and 
GF receptors. Altogether ELISA and AFM experiments allow us to hypothesize that on PEA 
(the material that promotes FN-fibrillogenesis) BMP-2 must be within the FN fibrils that are 
formed during the adsorption process (since fiber formation occurs competitively with GF 
binding). While on PMA, BMP-2 is likely not to interact with FN III12-14, as this domain is 
not available in the globular conformation that the protein attains on this material surface. 
By contrast, a fine molecular distribution of the GF and FN can be found on the material 
(PMA) surface (Figure 29). This spatial nano-arrangement of BMP-2 and FN will most likely 
activate simultaneously integring binding (that we know that in fact occurs on FN adsorbed 
on PMA (Brizuela Guerra et al., 2010), Figure 9) and GF receptors, and trigger stem cell 
differentiation towards osteogenic lineages much more effectively than of soluble BMP-2. 
 
Human MSCs differentiation in the FN+BMP-2 microenvironments 
 
Since the object of study was to see if the presentation to the cells of BMP-2 mimics the 
biological condition, we followed studying osteogenic MSCs differentiation. For doing that, 
first of all, we analysed immunofluorescence staining of RunX2, a transcriptional factor key 
in osteogenesis, that moreover has been related with BMP-2 (Ohba et al., 2009). To assess 
the effect of BMP-2 coadsorbed altogether with FN at the material interface, parallel 
experiments were run with surfaces coated only with FN and soluble BMP-2 in the culture 
medium (14 days of culture).  It is important to remark here that the amount of GF used for 
the engineered FN+BMP-2 interfaces is much lower than the total amount of soluble GF 
added to the culture medium during the experiment. In Figure 32 we can see RunX2 
expression is higher on samples with coadsorption of BMP-2 and FN. Moreover, when 
compared between PEA and PMA, while there is no difference for the soluble GF, RunX2 
expression is higher for PMA than PEA. This experiment suggests that the molecular 
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distribution of BMP-2 and FN attained on this material (PMA) surface is more effective than 
BMP-2 trapped within the material-driven FN fibrils (PEA) to drive cell differentiation. 
 
Figure 32 Immunofluorescent images of RunX2 in MSCs after 14 days of cell culture on PEA, PMA and 
glass in the absence or presence of BMP-2 (in medium or coating, i.e. coadsorbed with the FN). Stro-1 
selected human MSCs from bone marrow were cultured on the diferent materials for 14 days. BMP-2 was 
coadsorbed with the FN on the surfaces or added to the media on the materials with only FN on the surface. 
Scale bar 160 µm. 
 
 
Further insights into this phenomenon were obtained by investigating gene expression of 
osteogenic markers after 14 days of culture. Cell cultures were done using the same 
conditions as in the previous experiment: the first two hours of culture were without serum 
and, when applied, BMP-2 soluble in the medium (i. e. to prevent interaction with other GF 
found in the serum and allow first cell interactions only with the engineered 
microenvironments). qPCR was used to study the mRNA expression of RunX2 and three 
osteogenic markers (osteocalcin (OCN), osteopontin (OPN) and osteonectin (ON)). As seen 
in Figure 33, mRNA expression of the transcriptional factor RunX2 is higher when the cells 
are grown on PMA substrate than on PEA, regardless the presentation way of BMP-2 
 
142 
(coadsorbed with FN or soluble). The difference was much higher for the substrate with 
FN/BMP-2 in the coating, in agreement with the IF results (Figure 32). The same trend was 
seen for the biomarkers OCN and OPN. 
 
 
Figure 33 Osteogenic differentiation using qPCR on PEA and PMA in the absence or presence of BMP-
2 (in medium or coating, i.e. coadsorbed with the FN). Stro-1 selected human MSCs from bone marrow 
were cultured on the diferent materials for 14 days. The markers studied were osteocalcin (OCN), osteopontin 
(OPN), osteonectin (ON) and RunX2. Error bars are represented by the standard deviation of three 




Thereafter, when coadsorbed with FN, BMP-2 is more efficiently presented on the PMA 
substrate. This would be possible due to that BMP-2 is trapped into the FN network bound 
to the III12–14 domain on PEA, while on PMA, there is no exposure of the III12-14 domain 
while the FN is approaching the surface during adsorption, as occurs on PEA. Therefore, 
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FN and BMP-2 are more available on PMA than compared with the coadsorption on PEA, 
where the GF is interfering with the fibrillogenesis process and the GF gets buried. The 
protein distribution occurring on PMA after FN and BMP-2 coadsorption end up into more 




In summary, it is suggested that when FN is adsorbed with BMP-2 on PEA, GF binding to 
FNIII 12-14 interferes with the material-driven FN fibrillogenesis process on this surface to 
organise a new hybrid interphase able to drive the osteoblastic differentiation of stem cells 
as effectively as when the soluble factor is added to the cell culture medium (but in much 
higher quantity). In addition, when BMP-2 is coadsorbed with FN on PMA, even if the GF-
interaction cannot occur, the distribution of FN and GF molecules at the nanoscale enhances 
cell differentiation much more effectively than for the soluble factor, most probably by a 










Chapter 7. Modulation of 






















*Results presented in this chapter were obtained during an internship at the Department of 
Biomedical Engineering, University of Florida, (USA) under the supervision of Prof. 
Benjamin Keselowsky.  
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Dendritic cells (DCs) play a central role as regulators of both innate and adaptive immune 
systems. They are constantly guarding the body and presenting self and non-self antigens 
to lymphocytes (B-cells and T-cells) (Fernandez et al., 1999; Lambrecht et al., 1998; Moser, 
2004). DCs are in an immature state until they mature when interact with pathogen 
associated molecular patterns, danger signals or self-molecules (Matzinger, 2002; 
Medzhitov & Janeway, 1998; Shi et al., 2003). After interaction, DCs mature and up-regulate 
antigen-presenting molecules, co-stimulatory molecules, cytokines and chemokines 
receptors. Subsequently, after migration to a secondary lymphoid tissues, they initiate 
adaptive immune responses. DCs guide the development of T-cell responses and are the 
main antigen-presenting cell involved in activation of naive T-cells. For being activated, 
naive T cells have to provide DCs with three signals: antigen presented in the context of 
major histocompatibility (MHC) molecules, co-stimulatory molecules (e.g., CD80, CD86, 
CD83), cytokines (e.g. interleukin 12 (IL-12)) and other factors that direct T-cell functional 
development. Due to the important regulation function that DCs are involved in, a 
dysregulation of DCs function can result in big consequences. Hence, DCs are involved in 
numerous pathologies such as atherosclerosis (Ranjit & Dazhu, 2006), type-I diabetes (Lo 
& Clare-Salzler, 2006), allergy (Hammad & Lambrecht, 2008) and graft-versus-host disease 
(Xu et al., 2008). 
 
In tissue engineering when a material is implanted, inflammatory responses can alter the 
adaptive immune responses to the biological components present on it (Elamanchili et al., 
2007; Matzelle & Babensee, 2004; Solbrig et al., 2007). The growing use of biomaterials, 
tissue constructs and implanted devices has generated an increasing need to comprehend 
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how biomaterials can modulate immune responses. Therefore, elucidating fundamental 
mechanisms of how immune cells interact with biomaterials are essential in this matter. It 
has been demonstrated that interactions of DCs with biomaterials can modulate DC function 
(Babensee, 2008; Reddy et al., 2006). Evaluating modulation of DCs responses after 
interactions with biomaterials is critical in tissue engineering, as DCs have a key regulatory 
role in the innate and adaptive immune system. Using biomaterials has been demonstrated 
to modulate DCs functions (Babensee, 2008; Reddy et al., 2006). Specific proteins 
adsorbed onto biomaterials can induce different inflammatory responses and can alter the 
adaptive immune response (Acharya et al., 2009; Acharya et al., 2008). In vivo, upon 
implantation, numerous proteins are quickly adsorbed on the implant, including ECM 
proteins. During the last years, different studies have proved the modulatory role of some of 
these ECM proteins (e.g. FN, FG, VN) (Anderson et al., 2008; Hunter et al., 1999; Jenney 
& Anderson, 2000; Keselowsky et al., 2007; Shen & Horbett, 2001; Tang & Eaton, 1993). 
Material properties also have a play in the biological activity of the substrate and, it has to 
be address firstly by studying protein adsorption and conformation on it to correlate 
subsequently this phenomenon with cell behaviour. Extracellular proteins present different 
cell adhesion domains, e.g. the RGD domain ( Garcia, 2006). Upon adsorption, proteins 
might in fact expose different domains, eliciting specific interactions with cell receptors 
(Ballet et al., 2010).  
 
Despite the evidence, that cell/protein/material interactions are critical to the engineering of 
new biomaterials, there is a lack of studies correlating ECM conformation with DCs. From 
the physiological point of view, the mechanism of DC adhesion to ECMs proteins is of 
interest due to the long time DCs spend in connective tissues (Acharya et al., 2008). ECM 
proteins are largely present in lymphoid and non-lymphoid organs, therefore they have the 
potential to influence immune responses in the case of injury, disease or tissue 
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transplantation (Acharya et al., 2008). Succeeding trans-endothelial migration, DCs interact 
with tissue specific ECM proteins present in connective tissues. The receptors responsible 
for mediating DCs adhesion to ECM proteins are integrins (Hynes, 2002). It has been 
demonstrated that integrins can guide cell functions such as proliferation and differentiation 
(Hynes, 2002; Miyamoto et al., 1995). DCs express multiple integrins (αXβ2, αLβ2, αMβ2, αEβ7, 
α2β1, α1β1, α4β1, α4β7, α3β1, α7β1, α6β4, as well as the RGD-peptide binding integrins, αVβ8, 
αVβ6, αVβ3, αVβ5, α5β1 and αIIbβ3) (Ammon et al., 2000; Brown et al., 1997; Dalgaard et al., 
2005; Dubey et al., 1995; Hamakawa et al., 2006; J. Lo & Clare-Salzler, 2006; Sung et al., 
2006). A few investigations into the effects of integrin binding to ECM proteins on DC 
maturation have been done (Acharya et al., 2008). While it has been shown that DC 
adhesion to ECM proteins is an important consideration in biomaterials and can modulate 
the expression of stimulatory and co-stimulatory molecules (Brand et al., 1998; Kohl et al., 
2007), DC modulation depending on the ECM protein conformation has not yet been 
approached in the tissue engineering field. 
 
Eight of the twenty-four known integrins bind RGD peptide (Barczyk et al., 2010; Hynes, 
2002), several of which are expressed by DCs, including the αv integrins (Ammon et al., 
2000; Brown et al., 1997; Dalgaard et al., 2005; Li et al., 2006; Lu et al., 1995; Sung et al., 
2006). Only a few investigations have begun to elucidate the mechanisms involved in the 
modulation of DC functions (Acharya et al., 2009; Acharya et al., 2008; Brand et al., 1998; 
Kohl et al., 2007; Shankar et al., 2010). Grafting peptides derived from FN (e.g., integrin 
targeting RGD peptide) has been demonstrated to differentially modulate macrophage 
fusion into foreign body giant cells (Kao, 1999). The RGD integrin-binding motif is present 
in several extracellular matrix proteins including FN and VN (Dickinson et al., 1994; 
Humphries et al., 2006), and has been investigated extensively with numerous cell types 
(Fittkau et al., 2005; Mann et al., 2001; Schaffner & Dard, 2003). When DCs are cultured on 
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surfaces with uniform RGD gradients, DCs upregulated CD86, MHC-II, IL-10, IL-12p40 and 
αv integrin binding as a function of RGD surface density (Acharya et al., 2010). The 
researchers found that IL-12p40 was the most sensitive marker for RGD surface density. 
Surface expression of activation markers such as CD86 demonstrated a moderate 
correlation with αv integrin binding, while cytokine production was highly correlated with the 
same. When DCs were seeded on collagen, VN or albumin coated surfaces, similar levels 
of DC adhesion and expression of stimulatory and co-stimulatory molecules was found 
(Acharya et al., 2008). However, DC morphology and differential production of pro- and anti-
inflammatory cytokines (IL-12p40 and IL-10, respectively) is substrate-dependent (Acharya 
et al., 2008). 
 
The design of biomaterials with higher potential to be used in clinic has to bring together 
synthetic biomaterial and biological components (such as proteins adsorbed), being used in 
numerous applications such as tissue-engineered constructs and combination products 
(e.g., drug-eluting stents). Fibronectin adsorption on PEA and PMA promotes as seen in the 
chapters before, two different fibronectin conformations. While both, the biomaterial and 
biological component, may be approved separately for use, and the body’s response to each 
may be well-known, the combination of the two can give rise to unforeseen immune 
responses. Furthermore, the importance of the conformation of an ECM protein in DCs 
integrin-based activation hasn’t been studied. The use of the microenvironments created 
using FN on PEA and PMA together with DCs, will help to establish the field of adhesion-
based modulation of DCs as a mechanism that has previously not been defined, and will 
inform the rational design of biomimetic biomaterials for immunomodulation. The goal is to 
get a biomimetic material that has potential not only as a therapeutic material, but can also 
be informative as tools in order to quantitatively determine cellular adhesive responses to 
well-defined ligand presentation. 
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Materials and Methods 
 
Preparation of samples 
 
Poly(ethyl acrylate) and poly(methyl acrylate) samples were prepared as detailed in the 
Materials and Method chapter in this thesis.  
 
Atomic force microscopy 
 




Human fibronectin from plasma (Sigma) was coated onto the substrates PEA and PMA or 
12-well tissue culture-treated polystyrene plates by 1 h incubation of 20 µg/ml protein 




Endotoxins can induce maturation of DCs. In order to assess the amount of endotoxin 
present on the fibronectin and substrates, the chromo-Limulus Amebocyte Lysate (chromo-
LAL) assay was performed as per the manufacturer’s instructions (Cape Cod) using a 50 µl 
reaction volume per substrate with a 20 min incubation time. 
 
Generation of murine bone marrow-derived DC 
 
Immature bone marrow-derived DCs were generated from 7-week-old female C57BL6/j 
mice in accordance with protocol approved by the University of Florida (protocol number 
E751) using a modified 10-day protocol (Acharya et al., 2008; Lutz et al., 1999). Briefly, 
femur and tibia from mice were isolated and kept in wash media composed of DMEM/F-12 
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(1:1) with L-glutamine (Cellgro, Herndon, VA) and 10% fetal bovine serum (Bio- Whittaker). 
The ends of the bones were cut and bone marrow was flushed out with 10 ml wash media 
using a 25 G needle and mixed to make a homogeneous suspension. The suspension was 
then strained using 70 µm cell strainers (Becton Dickinson) and cells were collected by 
centrifugation at 330 g for 6 min. Precursor cells were isolated by centrifuging NycoPrep 
gradient (10 ml) and cell suspension (25 ml) at 670 g for 20 min at 22ºC. Leukocytes were 
isolated by pipetting out the layer of cells that forms at the interface of wash media and 
gradient. The precursor cell suspension was then washed twice with wash media and re-
suspended in DMEM/F-12 with L-glutamine (Cellgro, Herndon, VA), 10% fetal bovine serum, 
1% sodium pyruvate (Lonza, Walkersville, MD), 1% non-essential amino acids (Lonza, 
Walkersville, MD), 1% penicillin–streptomycin (Hyclone) and 20 ng/ml GM-CSF (R&D 
systems) (DC media). This cell suspension was then seeded in a tissue culture treated T-
flask (day 0). After 48 h (day 2), floating cells were collected, re-suspended in fresh media 
and seeded on low attachment plates for 6 additional days. Half of the media was changed 
every alternate day. At the end of 6 days (day 8), cells were lifted from the low attachment 
wells by gentle pipetting, re-suspended and seeded on tissue culture-treated polystyrene 
plates for 2 more days. Cells were then lifted (at day 10) using 5 mM Na2/EDTA solution in 
phosphate-buffered saline (PBS, Hyclone) and used for all the experiments. Purity, yield 
and immaturity of DCs (CD11cþ and MHC-II) were verified via flow cytometry. Marrow 
derived DCs stimulatory capacity in terms of up-regulation of cell-surface markers MHC-II, 






Immature DCs were seeded (1x106 cells/well) in the presence or abcense 
lipopolysaccharide (1 µg/ml LPS; maturation signal) on the different surfaces. The media 
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used was the DCs media mentioned before (DMEM/F-12 with L-glutamine (Cellgro, 
Herndon, VA), 10% fetal bovine serum, 1% sodium pyruvate (Lonza, Walkersville, MD), 1% 
non-essential amino acids (Lonza, Walkersville, MD), 1% penicillin–streptomycin (Hyclone) 
and 20 ng/ml GM-CSF (R&D systems) (DC media). Cells were kept for 1.5 h in serum-free 
media. 
 
Immunofluorescence (DAPI, Actin) 
 
Cells were cultured during 24 h and fixed with permeabilisation/fixation buffer for 30 min on 
ice. The cells were stained with a 1:40 phalloidin solution in permeabilisation buffer during 





Pictures were taken using a fluorescent microscope. Cell morphology was analysed in terms 
of spread area and circularity using Image J.  
 
Flow Cytometry (MHC-II, CD80, CD86) 
 
 
DCs maturation was quantified by measuring cell-surface marker levels by flow cytometry. 
Briefly, DCs were lifted by incubating with 5 mM Na2/EDTA solution in 1 M PBS solution at 
37ºC for 20 min. Dendritic cells were then washed with 1% fetal bovine serum in PBS and 
incubated with antibodies against CD16/CD32 (Fcg III/II Receptor) (clone 2.4G2, IgG2b,k 
(BD Pharmingen)) for 40 min at 4ºC to block Fcg receptors on DC. Cells were washed and 
then stained with antibodies against CD80 (clone 16-10A1, IgG2, k), CD86 (clone GL1, 
IgG2a, k), I-A/I-E (clone M5/ 114.15.2 IgG2b, k), (BD Pharmingen) for 40 min at 4ºC. 
Appropriate isotypes were used for each antibody species as negative controls. Data 
acquisition was performed using (FACScalibur, Becton Dickinson) flow cytometry and the 
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geometric fluorescent intensities determined. More than 20,000 events were acquired for 
each sample and data analysis was performed using FCS Express version 3 (De Novo 
Software, Los Angeles, CA). 
 
Cytokines expression (IL-10 and IL-12) 
 
Cell culture supernatants were collected after 24 h of cell culture, centrifuged to remove any 
cell debris and stored at 20ºC until analysis. The IL-12 cytokine subunit, IL-12p40, and IL-
10 cytokine production was analysed using ELISA. NUNC/Maxisorp plates were coated 
overnight at 4ºC with the captured antibodies at 1:250 dilution in PBS (Mouse IL-12/IL-23 
(p40) ELISA MAX capture antibody and BD OptELA Mouse IL10 purified capture antibody). 
Between each step of the protocol it was performed 3 washes with washing solution (0.05% 
Tween 20/PBS). The wells were blocked using a 1% BSA solution for 1h at room 
temperature. Samples and standard were added to the wells and incubated for 2 h at room 
temperature. Starting point for the standard curves were 1000 pg/ml. Recombinant standard 
mouse IL-12/IL-23 (p40) (Biolegend, 431601) and standard mouse IL-10 (BD OptELA, 
555252) in PBS were used. Detection antibodies from the same company were used at 
1:250 in 10% FBS/PBS at room temperature for 1 hour. Anti-biotin antibodies were used at 
1:10.000 dilution in PBS for 1 h at room temperature. A MUP homemade solution was used 
as a substrate. Samples were kept in a 37ºC incubator and read the absorbance at 355 nm 











Dendritic cell adhesion, morphology and proliferation 
 
The structure of a FN molecule has to be changed in order to promote fibril assembly, as 
the matrix assembling domain have to be available (Figure 34). Several attempts have been 
made to reconstitute the network structure and bioactivity of FN fibrillar matrices in a cell 
free way. PEA induces conformational changes on PEA in the molecule facilitating FN-FN 
interactions and driving FN fibril assembly, as we have previously shown (Chapter 4) 
(Brizuela Guerra et al., 2010). This material-driven FN network owns biological activity in 
terms of cell adhesion, signalling, cytoskeleton organisation, matrix reorganisation, and cell 
differentiation (Gonzalez-Garcia et al., 2010; Gugutkov et al., 2009; Salmeron-Sanchez et 
al., 2011). 
 
The molecular distribution of FN from a 20 µg/ml FN solution on the different substrates 
using AFM can be seen in the Figure 34. FN is self-organised into fibrils on PEA, as the so-
called material-driven fibrillogenesis, whereas individual globule-like molecules or small 
molecular aggregates are present on PMA.  
 
In order to ensure DCs responses were not influenced by endotoxin (perhaps present on 
the materials or FN solution), endotoxin levels were quantified for each FN-coated substrate. 
Endotoxin levels on adhesive substrates revealed undetectable amounts (<0.06 endotoxin 







Figure 34 Sketch of FN adsorption on PEA and PMA and endotoxins in the system. a Structure of the 
fibronectin molecule. b Atomic microscope images of FN adsorbed on PEA and PMA, chemical structure of 
PEA and PMA and FN conformation while FN is approaching the surface. c Endotoxin analysis on bare PEA, 
bare PMA and FN solution (20 µg/ml). 
 
 
The a4β1 integrin (also called “very late antigen-4 (VLA-4)” or “CD49d/CD29”) is an adhesion 
receptor involved in the interaction of lymphocytes, DCs, and stem cells with the ECM and 
endothelial cells. This together with other integrins have the ability to regulate their affinity 
for ligands through a process termed "inside-out" signalling that affects cell adhesion avidity 
(Chigaev et al., 2004). Few years ago was found that the activation state of the β1 integrin 
dictates adhesive and migratory properties of immature and mature dendritic cells to 
fibronectin (Krooshoop et al., 2004). The capacity of DCs to activate naive T cells depends 
on their maturation state and the migration to T-cell areas of the draining lymph nodes. 
Whereas mature DCs are highly migratory, immature DCs are strongly adherent. In the 
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study, the authors investigated whether and how integrin expression contributes to distinct 
adhesive capacities. Although both immature and mature DCs express comparable levels 
of the integrin subunit β1, the adhesion of mature DCs is clearly reduced as well as the 
expression of active β1. In our case, using PEA and PMA, morphological differences in B6-
derived DCs were shown to be modulated by the FN conformation (Figure 35). DCs cultured 
for 24 h on PMA substrates pre-coated with 20 µg/ml FN evidenced round cells. In contrast, 
DCs cultured on PEA substrate formed dendritic processes and not presence of round cells 
was found. Overall, these data demonstrate differential modulation of DCs morphologies in 
a protein conformation dependent manner. In terms of a traditional view of DCs morphology, 
PEA substrates presenting fibrillary FN potentially support increased levels of DCs 
maturation, whereas DCs cultured on substrates with globular FN (PMA) demonstrate 
potentially lower levels of maturation. Nevertheless, although there has been some tradition 
in relating DC morphology to maturation state, this is not a sufficient indicator of maturation 
and further investigation was carried out. Additionally, in order to determine if substrates 
modulated DCs adhesion, it was quantified the number of adherent DCs after 24 h (Figure 
35b). The adhesion and proliferation of cells was quantified (Figure 35). Differences on 
number of cells adhered were found on the different FN conformations (Figure 35b). When 
cells were cultured on a tissue culture polystyrene (TCPS) plate pre-adsorbed with FN, the 
amount of cell adhered was significantly higher than in all the other conditions. Differences 
were found between the two FN conformations: the number of cells adhered on PEA was 
higher than on PMA, i.e. when FN was on a fibrillar conformation, there were more cells 
adhered compared to when FN was on a globular conformation. The number of cells 
adhered on the controls was similar (negative control, immatured DCs (iDCs) and positive 
control (with the presence of LPS)). DC proliferation on adhesive protein substrates was 
observed after 24 h of cell culture, quantified by BrdU incorporation for the last 16 h (Figure 
35c). It was found that proliferation was almost negligible across all the substrates. On 
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globular FN conformation (PMA) and mature cells (+LPS) no proliferation was found. When 
DCs were seeded on a fibrillar FN network (PEA), proliferation was found in a small 
percentage (2%), and similar proliferation ratios were found on iDCs and when DCs were 
seeded on FN-coated TCPS (Figure 35c). 
 
 
Figure 35 Number of DCs adhered and proliferation on PEA and PMA. a Representative optical 
microscope images of dendritic cell adhesion after 24 hours on the acrylates (PEA and PMA), the control 
surface (TSCP, tissue culture polystyrene) and adhesion of iDC. Cells were seeded in serum-free media for 
the first two hours. b Quantification of number of cells adhere on the different materials after 2 hours. c 
Proliferation of dendritic cells on the different surfaces and controls as described in a. Error bars are 
represented by the standard deviation of multiple areas quantified in three different experiments. * conditions 




The presence of numerous long dendrites is characteristic of antigen-presenting DCs. It has 
been shown that the formation of these requires the interaction between β1 integrin (CD29) 
on the surface of the DCs and FN in the ECM. This interaction occurs at the focal contacts 
formed at the extremes of dendrites, where there is a high concentration of β1 integrins, actin 
and cytoskeletal proteins such as vinculin, paxillin and talin (Andersen et al., 2006). The 
unusual combination of a dendritic morphology and high motility is likely to play a major role 
in the efficient function of DCs as sentinels of the immune system (Andersen et al., 2006). 
 
On another hand, myeloid cells can migrate using an integrin dependent migration 
mechanism, requiring tight coordination between actin based cell membrane profusion and 
integrin-mediated adhesion forming a stable leading edge (Calle et al., 2006; Linder, 2009;  
Linder & Kopp, 2005; Monypenny et al., 2011). DCs use this mode of migration. Immature 
DCs assemble specialised adhesion structures known as podosomes at their leading edge. 
Formation of podosomes is restricted to cells with an immature phenotype, indicating a 
specific role for these structures during the early migratory phase (Burns et al., 2001). It has 
been shown that podosome integrity and dynamics vary in response to changes in the 
physical and biochemical properties of the cell environment (Monypenny et al., 2011). Cell 
adhesion and differentiation is regulated by the assembly and disassembly of adhesion 
structures, such as podosomes and focal adhesion (FA). Specifically, on DCs, the effects of 
physicochemical and topographical cues have been extensively studied on FAs but in the 
case of podosomes little is known in how do they behave in respond to these signals. It has 
been recently shown that, unlike for FAs, podosome formation is not controlled by substrate 
physicochemical properties, being cell adhesion the only prerequisite for podosome 
formation and dictating substrate availability the podosome density. After adhesion on FN, 
iDCs but not mature DCs, form podosome structures containing active β1 integrin, 
manifesting that the adhesion of DCs to FN is not regulated by expression levels, but rather 
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by differential regulation of integrin activity during DCs maturation (Krooshoop et al., 2004). 
When looking at the DCs adhesion on PEA (fibrillary FN) and PMA (globular FN), they 
acquire on the two different polymers different morphology (Figure 35). It was done a more 
detailed experiment staining DCs on PEA and PMA to track the actin protein expression and 
assembly. Interestingly, as can be seen in Figure 36a, DCs had different formation of 
podosomes along the time (2 and 24 hours) (Figure 36). That is to say, DCs sense protein 
conformation by presenting podosomes (Figure 36). It can be clearly seen the importance 
of substrate properties regulating podosome formation and suggest that protein 
conformation plays an important role in controlling DCs activation, a key process in initiating 
immune responses (van den Dries et al., 2012). As we have seen before, PEA and PMA 
adsorb the same amount of FN (Figure 8d), but they have different activity regarding the 
availability of the cell binding domain (Figure 9d). These suggest that DC adhesion onto FN 
is not regulated by the amount, but rather by differential regulation of integrin activity.  
 
To determine how FN conformation affects DCs spreading and DCs morphology, we made 
area measurements of xy images on the ventral surface. As the cell plot on Figure 36b 
shows, DCs seeded on PEA and PMA after 2 h didn’t show any difference on surface area. 
The size and shape of protrusions varied widely, making simple measurements of the 
number and length of protrusions (elongated shape on PEA and round on PMA) 
inappropriate for quantitative analysis. We thus measured circularity 
{(4pi)×(area)/(perimeter)2} of projected images, as more protrusions results in higher 
deviation from circularity (the value for a complete circle is 1). Cell plot analysis (Figure 36b) 
shows that DCs grown on PMA had highest circularity median values (0.284 after 2h and 
0.569 at 24 h), confirming that DCs on a globular FN conformation have fewer protrusions 
and more circular morphology. This could be related with the different availability of FN 
domains on the two acrylates and the main integrin (β1) that DCs use to recognise the FN 
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(Keselowsky et al., 2005). The morphology of antigen-presenting DCs is characterised by 
the presence of numerous long dendrites. DCs on PEA have more protrusions than the 
round morphology acquired on PMA (Figure 36a). As mentioned before, the dendritic 
formation is shown to require interaction between the β1 integrin (CD29, part of the main FN 
receptor) on DCs surface and FN in the extracellular matrix (Andersen et al., 2006). As 
mentioned above, this interaction occurs at focal contacts formed at the tips of dendrites, 
which contain high concentrations of the β1 integrins, actin and the cytoskeletal proteins 
such as vinculin, paxillin and talin. And this correlates with the results previously shown 






Figure 36 DCs morphology on PEA and PMA. a Actin staining on DCs cultured for 2 and 24 hours on PEA 




Dendritic cell maduration 
 
In order to define how DCs are affected by the protein conformation, the expression levels 
of surface molecules (stimulatory: MHC-II: co-stimulatory: CD80, CD-86) and secreted 
cytokines (IL-10, IL-12p40) were quantified (Figure 37). Taken collectively, these metrics 
are descriptive of the extent and quality of DCs maturation. DCs expression of stimulatory 
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and co-stimulatory molecules was quantified by flow cytometry. The maximum percentage 
of DCs expressing MHC-II molecules was using LPS as a positive control. A much lower 
percentage of iDCs expressed stimulatory molecule MHC-II (negative control). No statistical 
differences between the two acrylates were found, indicating that both FN conformations 
(fibrillary and globular) induce equivalent levels of MHC-II, CD80 and CD86 positive DCs, in 
a protein conformation independent manner (Figure 37a).  
 
In order to investigate the combined effects of adhesive substrates with a soluble maturation 
signal, we also quantified DC responses in the presence of LPS. With LPS in the cell culture, 
the percentage of DCs expressing MHC-II was found to be slightly elevated for all substrates 
(Figure 37b). Equivalent percentages of cells expressing co-stimulatory surface molecule 
CD80 were found for all the substrates. When compared DCs cultured on FN-coated acrylic 
polymers, DC expression of the co-stimulatory surface molecule CD80 was not remarkably 
elevated in presence of LPS. A 10% increment was found when the cells were cultured with 
LPS on TCPS compared to DCs without LPS. As found in other studies (Acharya et al., 
2008), the percentage of DCs expressing CD86 and the level of expression were statistically 
equivalent on DCs cultured on all substrates, with or without LPS. 
 
Interleukins levels were studied on the different surfaces after 24 h. As the number of cells 
was not the same on PEA and PMA (Figure 35b), interleukins values were normalised using 
the number of cells adhered on each substrate (Figure 37c). DCs cultured on the two 
different FN conformation demonstrated a differential cytokine production profile of the pro-
inflammatory cytokine IL-12p40 and the anti-inflammatory cytokine, IL-10. In general, DCs 
cultured on the different FN conformations secreted low levels of IL-12p40, compared to 
DCs cultured with LPS (Figure 37c). The fibrillar conformation of FN (PEA) induced the 
highest production of IL-12p40 cytokine from DCs, corresponding to the presence of 
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dendritic morphology. These levels of IL-12p40 were statistically lower on PMA. The 
different FN conformation mediated as well a differential DC cytokine production profile of 
anti-inflammatory cytokine, IL-10 (Figure 37c). Antiinflammatory IL-10 cytokine production 
was more pronounced when DCs were cultured on PEA (fibrillar FN on the surface). It is 
remarkable that DCs cultured on FN-coated PEA and PMA substrates up-regulate IL-10 
cytokine production while maintaining relatively low IL-12p40 cytokine production levels. 
Taken together, these data indicate that different ECM protein conformation differentially 
direct DC production of cytokines (IL-12p40 and IL-10), which are known to direct T-helper 
cell type responses and can thereby skew adaptive immunity, as it has been saw before 
(Acharya et al., 2008). It has been shown that although the cytokine IL-12 is the most notable 
cytokine linked to T-cell proliferation, there is a substrate-dependent T-cell proliferative 
responses corresponding with the levels of IL-12p40 cytokine produced by DCs (Yoo et al., 
2002). Our data are the first to link protein conformation-dependent differences in IL-12p40 






Figure 37 DCs maturation on PEA and PMA a Percentage of dendritic cells matured on the different 
materials quantified by flow cytometry in the absence of LPS after 24 hours b Percentage of dendritic cells 
matured on the different materials quantified by flow cytometry in the presence of LPS after 24 hours c 
Expression of interleukins IL-10 and IL-12 on the different materials after 24 hours. Error bars are represented 
by the standard deviation of three experiments. * indicates statistically difference with all the rest of the 
conditions, ϶ statistically different to IL-12 expression on PMA and, ¥ statistically different with IL-10 expression 
on PMA. (P ≤ 0.05) 
 
The purpose of this study was to evaluate the potential for ECM proteins conformation to 
induce DC maturation and DC-mediated adaptive immune responses. FN is known to be 
adsorbed on implanted materials and is a major constituent of numerous connective tissues, 
being also involved in wound healing responses (Pankov & Yamada, 2002). We 
demonstrated that DCs culture on different FN conformations can modulate expression level 
of molecules involved in DC maturation (interleukins 10 and 12). Specifically, we found that 
FN-coated PEA (fibrillar conformation) and PMA (globular conformation) supported different 
DCs morphologies, but equivalent levels of DCs maturation, as characterised by low 
expression levels of stimulatory and co-stimulatory molecules (Figure 37). Nevertheless, 
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even promoting a non-matured profile, it has been found a difference in the interelukins 
expression levels. Even under non-matured profile, the specific levels of interleukins are 
able to trigger different modulation of T-cells, with the subsequent effect in the 
immunological effect, as has been seen in other studies (Acharya et al., 2008). 
 
Figure 38 Sketch of how the DCs interact with fibrillar FN network (on PEA) or globular FN 
conformation (on PMA). Profiles on the expression levels of interleukins (IL-10 and IL-12) and maturation 










Our findings suggest that DCs morphology and phenotype modulation of DCs correlates 
with protein (fibronectin) conformation on the cell-material interface. We have demonstrated 
that DCs cultured on different FN conformations can modulate the profile of molecules 
responsible of DC maturation. More specifically, we have found that DC culture on surfaces 
with FN in a fibrillar conformation or in a globular conformation supported different DC 
morphologies but equivalent levels of DC phenotypic maturation, as characterised by low 
expression levels of stimulatory (MHC-II, CD80 and CD86) and co-stimulatory molecules 
(interleukins 12 and 10). Different FN conformation can modulate finely the co-stimulatory 
molecules levels of DCs, triggering a different modulation of other immunological cells (as 


















The main findings extracted from this thesis are presented below. 
 
I. Surface chemistry controls matrix protein dynamics at the cell-material interface. 
 
I.I.1.When fibronectin (FN) is adsorbed on -OH and -CH3 self-assembled monolayers 
(SAMs) terminated alkanethiols, the ratio CH3/OH in mixed SAMs modulates FN 
adsorption: the adsorbed surface density, distribution and conformation is dependent 
on the surface chemistry.  
I.II.Initial cell adhesion and signalling on FN-coated SAMs is different in terms of 
formation of focal adhesions, integrin expression and phosphorylation of FAKs 
depending on the functional group (hydrophobic or hydrophilic).  
I.III.The reorganisation and secretion of FN is higher with a globular conformation. Matrix 
degradation was followed via the expression of matrix metalloproteinases (MMPs) 2 
and 9 and correlated with RunX2 levels. 
I.IV.The results demonstrate that surface chemistry is an external parameter able to 
trigger proteolytic routes in cells in an MMP-dependent manner. 
I.V.The results show that not all what seems to be the same FN conformation are equally 
active, as demonstrated with the FN networks on CH3-SAMs and PEA. 
I.VI.The reported findings improve our understanding of the role of surface chemistry as 
a key parameter in the design of new biomaterials. It demonstrates the ability of 
surface chemistry to direct proteolytic routes at the cell-material interface, which 
gains a distinct bioengineering interest as a new tool to trigger matrix degradation in 
different biomedical applications. Our results demonstrate the ability of synthetic 
biomaterials as new tools to direct matrix degradation, which must provide the field 
with new strategies to investigate fundamental aspects of the phenomenon, as well 
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as the inclusion of parameters to take into account during the design of scaffolds for 
regenerative medicine, aiming at controlling matrix protein dynamics at the cell-
material interface.  
 
II. BMP-2 adsorbed on FN networks adsorbed on PEA promotes osteogenic 
differentiation (PEA/FN/BMP-2 microenvironments). 
 
II.I.1.PEA has the ability to spontaneously organise adsorbed FN in a conformation 
allowing BMP-2 to bind and be presented in a cell-exploitable manner. 
II.II. It has been created a simple engineered system that allows reliable control of its 
interface, and synergistic integrin/GF signalling within the interface.  
II.III.Occupancy of integrins and BMP-2 receptors simultaneously enhances the 
canonical BMP-2 signalling (SMADs). 
II.IV. It has been shown in vitro that the PEA/FN/BMP-2 microenvironments 
synergistically drive integrin–growth factor receptor signalling to direct stem cell 
differentiation towards osteogenic differentiation (higher expression of osteogenic 
markers as osteocalcin and osteonectin, higher activity of ALP). 
II.V. When used this system in vivo is achieved the (acellular) surface-induced 
regeneration of a critical size bone defect using very low doses of BMP-2. 
II.V.1.The microenvironments approach is facile, can be spin coated onto planar 
substrates or deposited onto more complex 3D geometries, such as the cylinder used 
in this work, but also on 3D scaffolds and electrospun membranes.  
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III. Coadsorbed BMP-2 interacts with the formation of PEA-driven FN matrices 
(PEA/FN+BMP-2 microenvironments). 
 
III.I.When FN is coadsorbed with BMP-2 on PEA, GF binding to FN III12-14 interferes with 
the material-driven FN fibrillogenesis process on this surface to organise a new hybrid 
interphase. 
III.II. The new FN-BMP-2 interphase created on PEA is able to drive the osteoblastic 
differentiation of stem cells as effectively as when the soluble factor is added to the 
cell culture medium (but in much higher quantity). 
III.III. When BMP-2 is coadsorbed with FN on PMA, even if the GF-interaction cannot 
occur, the distribution of FN and GF molecules at the nanoscale enhances cell 
differentiation much more effectively than for the soluble factor. 
 
IV. Cellular microenvironments created by FN on PEA modulates the adaptive 
immunoresponse. 
 
IV.I. Dendritic cell (DC) morphology and phenotype modulation correlates with protein  
(FN) conformation on the cell-material interface.  
IV.II.We have demonstrated that DC culture on different fibronectin conformations 
modulates the co-stimulatory molecules (IL-10 and IL-12) involved in DC maturation. 
IV.III. FN adsorption on PEA and PMA doesn't´t induce maturation of DC in vitro. 
IV.IV.DCs on surfaces either with FN in a fibrillar conformation or in a globular 
conformation have equivalent levels of DC phenotypic maturation (low expression 
levels of stimulatory and co-stimulatory molecules). 
IV.V.FN in a fibrillar conformation (PEA) promotes more expression of IL-10 and IL-12 






Chapter 5 - BMPR and integrin colocalization 
(Performed by Zhe A. Cheng) 
 
Materials and methods 
 
 
Immunofluorescence for BMPR and integrin colocalization  
 
Cells were washed with PBS and fixed with 4% formaldehyde solution at 4°C for 15 min. 
Cells were then permeabilized with a solution of 0.5% Triton X-100 in PBS at 4°C for 5 min. 
A 1% BSA solution was added, and the cells were incubated at 37°C for 5 min to block 
nonspecific binding. After blocking, primary antibodies [anti–integrin β1 (1:50; R&D Systems, 
MAB17781) and anti-BMPRIa (1:50; Thermo Fisher Scientific, PA5-11856) were added to 
the cells and incubated at 37°C for 1 h. Cells were then washed with 0.5% Tween 20 in PBS 
(PBST) three times for 5 min each. Thereafter, a biotinylated anti-rabbit secondary antibody 
(1:50; Vector Laboratories) and a Texas Red anti-mouse secondary antibody (1:50; Vector 
Laboratories) were added to the cells and incubated at 37°C for 1 h, followed by 3 washes 
with 5% PBST. After washing, streptavidin–fluorescein isothiocyanate was added and 
incubated at 4°C for 30 min. A final 3 washes using 5% PBST wash was performed, and the 
nuclei of the cells were stained using Vectashield-DAPI (Vector Laboratories), whereas the 






Figure 29 Colocalization of integrin β1 and BMPRIa in individual hMSCs. β1 stained in red and 




Chapter 5 - In vivo experiments 
(Performed by Cristina González-García) 
 
 




Polyimide implant tubes presenting holes were coated by solvent casting from solutions of 
the corresponding synthesised polymers, PEA or PMA, creating a polymer layer on the tube. 
Implant tubes were dried under vacuum at 60°C to remove solvent traces and were rinsed 
with Milli-Q water several times before ultraviolet sterilisation. FN (Sigma) was adsorbed 
overnight on the polymer layer from a protein solution (20 mg/ml) in PBS at 37°C. Then, 1% 
BSA/PBS solution was adsorbed for 30 min at RT to block nonspecific binding sites before 
the adsorption of the BMP-2 GF (R&D Systems) from a solution (5 mg/ml) in PBS for 1 hour. 
The adsorption of the proteins was performed by creating a vacuum to force the incoming 
of the solution into the implant tubes. After each protein adsorption, the samples were rinsed 
in PBS to remove the nonadsorbed protein and, finally, were kept in PBS until implantation. 
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GFOGER-functionalized PEGmaleimide (PEG-MAL) hydrogels, which have been shown to 
promote osteogenic differentiation and bone healing of radial segmental defects (Shekaran 
et al., 2014), were used as a positive control. Hydrogels were synthesised by reacting the 
four-arm, MAL–end functionalised (>95%) PEG macromer (PEG-MAL; 20 kD; Laysan Bio) 
with the adhesive peptide GYGGGPG(GPP)5GFOGER(GPP)5GPC (GFOGER) (Activotec) 
and BMP-2 (R&D Systems), followed by mixing with VPM cross-linker (AAPTEC) at a 
volume ratio of 2:1:1:1. The final concentration of the BMP-2 in the hydrogels was 75 mg/ml. 
The concentration of VPM used was calculated to provide the same number of cysteine 
residues than the number of free (unreacted) MAL groups remaining in the adhesive 
peptide-functionalized PEG-MAL solution. 
 
Bone radial segmental defect surgery 
 
The Institutional Review Board and the Institutional Animal Care and Use Committee 
guidelines were followed to perform in vivo experiments. C57Β1/6J male mice (8 to 10 
weeks old; Jackson Laboratory) were anesthetized under isoflurane, and the right forelimb 
was shaved and swabbed with isopropyl alcohol and chlorhexidine. After anesthesia 
induction, mice were provided with a single dose of sustained release buprenorphine for 
pain relief. An incision was made in the skin along the forearm, and the muscle tissue over 
the radius was blunt dissected. A 2.5-mm defect was created in the center of the radius by 
using a custom-made double-bladed bone cutter. The implant tube was placed into the 
defect by fitting it at the proximal and distal ends of the radial defect, and the incision was 
then closed with degradable vicryl suture. The defect created was checked by the imaging 
with a radiography system right after the surgery and before the recovery of the animal. Mice 




Faxitron and mCT imaging 
 
The radial defects were imaged with the MX-20 Radiography Equipment (Faxitron; 23-kV 
energy and 15-s scan time) at different time points: 0, 14, 28, 42, and 56 days. For mCT 
imaging, the length of the radius (3.2 mm) centered on the 2.5-mm radial defect was 
scanned in anaesthetised live mice using a VivaCT system (ScancoMedical; 142-mA 
intensity, 55-kVp energy, 300-ms integration time, and 15-mm resolution) at 0, 4, and 8 
weeks after surgery. Bone formation was evaluated by contouring 2D slices (including only 
the radius), which were used to obtain 3D mCT reconstructions, displaying the total length 
of the radius scanned. However, the quantification of the volume of new bone within the 
defect was performed by evaluating only the middle 2.0 mm of the defect to ensure that only 




At the end of the experiment (8 weeks), mice were euthanised and radial bones were 
explanted, fixed in 10% neutral-buffered formalin solution, decalcified (decalcifying solution; 
Ricca), and embedded in paraffin. Sections (5 mm thick) were cut and deparaffinised before 
the Safranin O/Fast Green staining. Samples were deparaffinised, rehydrated in water, and 
incubated in Mayer’s hematoxylin solution for 10 min. After the samples were rinsed in tap 
water, they were incubated in 0.5% Fast Green solution for 10 s and rinsed in 1% acetic 
acid for 3 s. Finally, the samples were incubated in 0.5% Safranin O for 2 min and then 










We evaluated the potential of the synergistic presentation of growth factors in vivo using a 
murine non-healing radial bone defect model. This bone repair model has significant 
advantages: i) the 2.5 mm defect does not spontaneously heal, providing a rigorous critical-
sized model, ii) it allows for simple in vivo imaging approaches (e.g. Faxitron, and μ-CT), iii) 
the ulna provides sufficient stabilisation of the defect and no fixation plates/hardware are 
required, thereby simplifying the surgical procedure and reducing the risk of infection; a 
major advantage over the rat calvaria and segmental femur defect models (Shekaran et al., 
2014). 
 
We implanted thin polyimide sleeves (3 mm long, Figure 40a) with walls coated with a thin 
layer of the polymers PEA and PMA (green fluorescence dye in Figure 40a). Then either FN 
or FN/BMP-2 was adsorbed on the cylindrical polymer surface. We used very low 
concentration of BMP-2 which resulted in ~ 15 ng of BMP-2 on the wall of the coated tubes. 
Note that this is well below the amount of BMP-2 used in the current clinical standard (1.5 
mg/ml – that for the volume of the defect means ~ 3.5 μg of BMP-2, i.e. a dose ~ 300 times 
higher than our case) (Woo, 2012). The material system that we use here is a very 
demanding one as we intend to promote bone regeneration in a critical size defect – a 
volume – by engineering the material surface of a tube where this volume is contained. This 
is very different to what has been done up to now to promote bone formation in vivo using 
engineered 3D environments such as hydrogels (Shekaran et al., 2014). 
 
We evaluated bone healing by radiography and micro-computed tomography (mCT) at 4 
and 8 weeks post-surgery (Figure 40b). We made three groups for each one of the coatings 
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(PEA and PMA): 1) polymer only; 2) polymer coated with FN (20 μg/ml); 3) polymer coated 
with FN and BMP-2 (~ 15 ng). Results of the μCT, including quantification of bone volume 
(Figure 5c) show that only when FN and BMP-2 area adsorbed on PEA does the defect was 
repaired and bridged. The effect can only be ascribed to the simultaneous presence of FN 
and BMP-2 which promoted enhanced activity of the GF. The sleeve coated with either PEA 
only or PEA and FN did not promote the same level of bone growth (Figure 40b). Also, this 
very low amount of BMP-2 was not effective in promoting bone growth when presented from 
PMA surfaces together with (globular) FN, which supports the specificity of the synergistic 
integrin/GF receptor mechanism on PEA previously confirmed in in vitro studies with stem 
cells (Figure 40c). Histological analysis at 8 weeks showed fibrous tissue with no significant 
bone formation within the defect for all the conditions except for PEA/FN/BMP-2 with bone 







Figure 40 Bone regeneration in a critical size defect with very low doses of BMP-2. a A cylindric polyimide 
sleeve was coated with the polymers (either PEA or PMA, the figure shows a picture of the sleeve and to 
coating with a florescence dye) and implanted in a critical size defect, 2.5 mm, in a murine radious. Faxitron 
images shows the evolution of the defect after implanting PEA coated with FN and BMP-2 after different time 
points. The total amount of BMP-2 was ~ 15 ng. b 3D mCT reconstructions for both polymers PEA and PMA 
after 4 and 8 weeks, with three conditions: polymer only (PEA, PMA); FN coating on the polymer (FN), FN 
coating on the polymer followed by BMP-2 adsorption (FN+BMP-2). c mCT measures of bone volume within 
the defects. d Sections of 8 week radial samples stained with Safranin-O/Fast Green. (Virginia Llopis-






Figure 1 Representation of the cell-protein material interaction and how the different 
properties can affect the cell behaviour. 
Figure 2 Fibronectin structure. 
Figure 3 Activation of GF receptors. 
Figure 4 Bone morphogenetic protein signal transduction pathway. 
Figure 5 Stimulatory and regulatory DCs in health and disease. 
Figure 6 Self assembled monolayers representation. 
Figure 7 Surface wettability measured by water contact angle on the CH3/OH mixed SAMs. 
Figure 8 FN adsorption on the CH3/OH mixed SAMs and acrylates (PEA and PMA). 
Figure 9 Availability of the cell adhesion domain on SAMs and acrylates (PEA and PMA). 
Figure 10 Early cell adhesion on FN coated SAMs and acrylates (PEA and PMA). 
Figure 11 FAK expression and phosphorylation of tyrosine Y-397 on FN coated SAMs and 
acrylates (PEA and PMA). 
Figure 12 α5 integrin expression after 4 h on the acrylates. 
Figure 13 Integrin adhesion quantified by gene expression of β1, α5 and αν integrins on FN 
coated SAMs and acrylates (PEA and PMA). 
Figure 14 Reorganisation of adsorbed FN on SAMs. 
Figure 15 RunX2, MMP2 and MMP9 protein expression on SAMs after 1 day of cell culture. 
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PhD Biotechnology, Polytechnic University of Valencia (Spain), May/2011 
Thesis title: Material-driven fibronectin fibrillogenesis to engineer cell function 
During my thesis I studied extracellular-matrix’s protein adsorption and protein conformations, cell behaviour 
to different protein conformation, cell adhesion, the reorganisation and remodelling of proteins at the material 
interface, the role of growth factors (GF) and their interactions with components of the extracellular matrix 
(ECM), the immunology cell response, and the stem cell fate influenced by the extrinsic signals coming from 
the engineered microenvironments using ECM’s proteins. The main porpoise was engineering cellular 
environments to promote tissue healing involving the design of complex systems that combine materials, ECM 
proteins and GF. I exploited synergistic interactions between material surfaces, natural and synthetic ECM 
and GF to control cell behavior and tissue repair and direct cell and stem cell fate. 
 
M.S. Biomedical Biotechnology, Polytechnic University of Valencia (Spain), November/2010-
March/2012 
Thesis title: Remodeling of extracellular matrix at the material-cell-protein interface 
Cell adhesion on different synthetic substrates is mediated by ECM proteins such as fibronectin (FN), 
vitronectin, etc between cells and materials, somehow immobilized on the materials surface. Conformation 
attained by these proteins after adsorption is of outmost importance to trigger subsequent cellular responses. 
Protein conformation will define which proteins domains are available for cell adhesion, promoting the 
activation of cell receptors, integrins, and leading to the formation of focal adhesion complexes. Afterwards, 
cells tend to rearrange the adsorbed protein layer on the surface of a material, secrete new matrix and degrade 
it, a process called remodeling. This work included cell remodeling of the ECM at the cell-material interface 
using substrates of slightly different surface chemistry, which give rise to a very different conformation of FN 
causing different initial cell responses.  
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Self-assembled monolayers (SAMs) have been used for the study of cell-protein-material. The effect of surface 
wettability is one of the most important parameters affecting the biological response to a material. Using the 
design of structures with controlled chemical and physical properties capable of directing cellular activity, such 
as SAMs, was studied at the cellular level (using tumourgenic  osteoblasts) the effect of surface hydrophilicity, 
FN adsorption, cell adhesion and FN reorganization, cell secretion and matrix degradation.  
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